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A bstract
Primary care is currently at the heart of the National Health Service policy. The newly 
established organisations, known as Primary Care Groups and Trusts (PCG/Ts), have 
the crucial role of improving the efficiency and equity in primary care delivery. 
However, not many studies have focused on performance assessment in primary care 
provision.
In this thesis we aim to contribute to a discussion regarding appropriate ways to 
compare the performance of primary care providers and the effective ways to use these 
results in order to improve performance in primary care. Following a review of the 
literature, a conceptual framework for performance assessment in primary care was 
developed in collaboration with a sample of PCG/Ts. This framework aims to establish 
a link between the local needs, the resources used, the services delivered and the 
outcomes achieved in primary care. Based on the relationships between these elements, 
four performance assessment criteria were defined: equity, efficiency, service 
effectiveness and cost effectiveness. DEA is then proposed to measure efficiency, 
service effectiveness and cost effectiveness, given the fact that it can handle multiple 
inputs and outputs without requiring the specification of a functional form.
Following the Government’s policy of focusing on the management of chronic 
diseases, this conceptual framework is then applied to compare the performance of a 
sample o f GP surgeries in terms of their delivery of diabetes care. An exploratory and 
formative comparison is undertaken in order to investigate why certain surgeries appear 
to perform better than others, and in order to identify ways in which some of the 
surgeries can improve their performance. The relationships between the different 
performance criteria are also investigated, together with the ways in which an adequate 
balance between the different criteria can be achieved.
Several conclusions are arrived at and several contributions arc made to this 
research area. The usefulness of complementing efficiency analysis with equity and 
effectiveness analysis; the usefulness of following a formative methodology in the use 
of DEA; the importance of estimating the costs involved in achieving speciality based 
outcomes; the importance of area deprivation in the achievement of effectiveness and 
the limitations of the data available in primary care in England.
xv
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Pream ble
“Even if one accepts that there may be some generic management principles that are 
‘universally’ applicable (and that requires a considerable leap of faith) they are always 
applied in a specific context, including a value context. The nature of the management 
task, and the appropriateness of the management method deployed, can be defined only 
in relation to the objectives of the organization being managed, the values to be upheld 
by its managers as determined by its governors and the status of its relationships with its 
users, whether citizens, clients, consumers or customers.” (Du Gay, 2000: 7)
1 Introduction
1.1 Introduction
Scarcity of public resources and increasing health care needs point towards the 
importance of constantly looking for better ways of delivering and managing health care 
services. Performance assessment in health care delivery is seen as a method of ensuring 
that taxpayers’ money is spent in the best possible way. As a result, performance 
assessment of health care systems is currently the subject of major interest, both 
nationally and internationally. Since 1983, when the first set of Performance Indicators 
(Pis) were introduced in the National Health Service (NHS) in the UK, calls for new 
ways to measure performance in health care delivery has not abated. From hundreds of 
Pis, numerous league tables have been produced and, despite continuous protest from 
health care professionals, the media uses the numbers to produce sensational headlines.
In the NHS the importance given to performance assessment is clear, as means to 
achieve care of uniformly high standards (The Department of Health 1997). Having 
recognised the limitations of the previous system of operation, management and control 
in place during the Conservative Government (in particular, a disregard for primary care 
management and equity considerations), the Labour Government has developed what 
they call ‘a third way’ of managing and delivering public services: a system based on 
partnership and driven by performance (The Department of Health 1997). A new 
framework for performance assessment (PAF) has been developed. In this framework 
six performance assessment criteria have been identified: (1) health improvement; (2)
1
fair access to heath services; (3) effective delivery of appropriate health care; (4) 
efficiency; (5) patient/ carer experience and (6) health outcomes of the NHS care. 
Structures and agencies have also been introduced to guarantee that quality is reviewed 
and improved. The National Institute for Clinical Excellence and National Service 
Frameworks (NSFs) set the standards based on clinical evidence and cost effectiveness. 
The Commission for Health Improvement monitors the achievement of these standards. 
Furthermore, at a local level, each organisation and professional is also responsible for 
continuous improvement of quality in clinical practice. The objective is to make ‘best 
practice the norm’.
For the first time, primary care has been characterised as central to the development 
o f the ‘new NHS’ (The Department of Health 1997). Having recognised its importance, 
the Government implemented structural reforms regarding primary care provision, 
management and accountability.
The reforms initiated in 1997 appear to be based on three basic assumptions
regarding the delivery and management of public services. Firstly, that the methods and
models successful in the private sector can also lead to success in the public sector. In
this respect, the emphasis is “on the development of more flexible, responsive and
entrepreneurial forms of conduct which would overcome the assumed stasis, rigidity
and inefficiency of ‘bureaucracy’” (Du Gay, 2000: 63). Secondly, that performance in
primary health care can be appropriately measured. All that is required is a wide list of
performance indicators (Pis) to collect data to support each one of them and then to
develop a weighting system in order to rank organisations and identify best practice.
Thirdly, that efficiency, effectiveness, fairness of access and patients’ responsiveness
can be improved simultaneously. Altogether, it is assumed that as long as several
dimensions of performance are outlined, regularly monitored and as long as clear2
incentives are in place, it is possible to identify and reward best practice, leading to its 
reproduction across the country.
However, only a few studies have attempted to compare the performance of several 
primary health care providers in order to provide some guidance regarding the validity 
of these assumptions in this context. In this thesis we aim to contribute to a discussion 
regarding appropriate ways to compare the performance o f primary care providers and 
the effective ways to use these results in order to improve performance in primary care.
We developed a conceptual framework for performance assessment in primary care, 
in collaboration with newly established Primary Care Groups and Trusts (PCG/Ts). It 
was our objective to use this framework to compare a sample of General Practitioners 
(GP) surgeries in terms o f their delivery of primary care as a whole. However, 
considering the Government’s strategy of moving towards speciality based delivery and 
performance assessment, and data availability, it became necessary to focus on a 
speciality: diabetes care. In this respect, we compared a sample of GP surgeries in 
England in terms o f their delivery of diabetes services. In order to fully involve all the 
GP surgeries, and in order to achieve a high level o f confidence in the data and its 
comparability, a small sample of surgeries was compared. Furthermore, this allowed us 
to develop more specific performance measures, and to collect the data for its 
measurement within our limited time period. We used the following criteria for 
evaluation: equity, efficiency, service effectiveness and cost effectiveness. These 
criteria and the whole framework for evaluation were developed in collaboration with 
the participating PCG/Ts and validated with the participating surgeries.
The broad aims for this thesis are three fold. Firstly, by developing a comprehensive 
framework to assess the performance of primary care providers, we aim to contribute to
the literature on this under-researched area. Secondly, by applying ‘Data Envelopment
3
Analysis’ (DEA), a frontier technique for performance measurement, to primary health 
care in a formative way, we aim to assess its potential to contribute to performance 
improvement in practice. Past studies using DEA have focused on performance rates, 
rankings and targets, whereas we use DEA to identify key learning networks, and to 
design strategies for performance improvement. Thirdly, by undertaking in-depth 
analyses of the performance results, we aim to draw some conclusions for primary 
diabetes care delivery, management and policymaking. To be more specific, we have 
the following research objectives:
1.2 Research Objectives
(1) To develop a comprehensive performance assessment framework for formative 
evaluation in primary care, that encompasses the following aspects:
• The existence of multiple, incommensurable and often conflicting values 
underlying public service delivery. This points towards the development 
of a framework that takes into account the trade-offs between the 
different criteria. We are particularly interested in studying the 
relationships between equity, efficiency and effectiveness.
• The intrinsically different nature of primary care provision when 
compared with other forms of service delivery. Primary care provision 
involves a relationship established between the patient and the 
professional, which relies on trust and is characterised by a strong 
asymmetry of knowledge and information. This means that performance 
assessment of primary care providers is necessarily partial, because there
4
are essential elements that are very difficult to measure, such as the 
quality of the diagnosis;
• The difficulties in measuring the ultimate outcomes of primary care 
delivery;
•  The existence of many non-controllable factors impacting on the 
outcomes of primary care, such as area deprivation and patient 
compliance;
• The potential for responsive dysfunctional behaviour to any performance 
assessment exercise. This is particularly relevant in primary health care 
because of the asymmetry of information and the partiality o f the 
assessment.
(2) To perform comparative performance analyses at the level of GP surgeries in 
England, in order to provide an assessment of the complexities involved in 
measuring and managing performance in primary care. The specific objectives of 
this empirical case study are:
• To apply the conceptual generic framework developed to diabetes care 
delivery;
• To analyse the revealed implicit trade-offs between the different 
dimensions of performance;
• To analyse the impact of non-controllable factors, such as patient 
compliance and area deprivation on the performance results;
• To explore the usefulness of the DEA results in practice, for example, in 
order to establish learning networks between the surgeries;
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• To analyse the pattern of results to explore some of the potential causes 
behind the differences in performance. This should identify some of the 
factors behind successful performance in primary diabetes care delivery.
1.3 Context-The National Health Service and Primary Care Delivery in the UK
Since its creation in 1948, the NHS is one of the most important public organisations in 
the UK. It was created to provide every citizen with comprehensive high quality health 
care, free at the point of consumption. This single organisation was created to satisfy the 
health care needs of the population, which were expected to decrease over time, 
assuming that the population would become healthier (Ham 1999). The fact that the 
health care needs have not stopped increasing has caused enormous financial pressure 
on this organisation and has motivated successive reforms of the NHS.
As pointed out by Levitt and Wall (1984: 10), the final form of the NHS established 
in 1948 resulted from a compromise between conflicting demands of the several interest 
groups, and therefore it was not a unified health service providing free comprehensive 
health services to every citizen, as initially intended. Rather, a system characterised by 
the fragmented delivery of hospital, community and Family Practitioners care resulted.
1.3.1 Attempts to Unify the NHS
After 1948, several efforts were made to unify the NHS, which are visible in the 
published reports and the parliamentary acts passed (Levitt and Wall 1984). However, 
the different interest groups could not agree on a unified NHS. In particular, GPs 
concerned with their secondary role in the NHS, felt that unification would not satisfy 
their interests. It was not until April 1, 1974 that a new structure for the NHS was put
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into practice. This reorganisation’s main objective was to improve the cooperation 
between the hospital, community and Family Practitioners. It was hoped that by 
working cooperatively, the efficiency and quality of care in the NHS would also 
improve. In this respect, a single administrative unit managing all three parts of the 
NHS needed to be established. Regional Health Authorities (RHAs) were created to 
unify the strategic planning of the NHS at a regional level, whilst newly established 
Area Health Authorities (AHAs) had the task of planning and managing the services 
provision at local level.
This new structure led to an increase in the administration costs, and such an 
expensive structure characterised by multiple tiers of administration was soon to be the 
cause of criticisms (Levitt and Wall 1984). Stronger delegation of powers for decision­
making was seen as desirable. On April 1, 1982, all 90 AHAs were removed and 192 
District Health Authorities (DHAs) were introduced.
1.3.2 The Influence of New Public Management
During the late 1980s, a more radical set of reforms was undertaken by the Conservative 
Government of Margaret Thatcher. These reforms culminated with the publication of 
the White Paper, Working fo r  Patients (Secretary of State of Health and Others 1989a). 
The Government intended to bring the principles of management within the private 
sector into the administration of the public sector. This style of public administration 
became known as the New Public Management (Hood 1995; Du Gay 2000) and is 
characterised by certain elements: (1) changing the identity of public organisations by 
introducing entrepreneurial identity and practice. This leads to management by 
leadership, with clear missions and visions, as opposed to rules and regulations; (2)
managerial decentralisation, encouraging participative management with an associated
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increase in upwards accountability in terms of achieved results; (3) the use of market- 
type mechanisms and practices, and the introduction of competition between service 
providers; (4) redefinition of citizens as customers, and orienting service provision 
towards increasing customer satisfaction; (5) the use of performance assessment as a 
way of improving services, with a strong focus on outcomes achievement; (6) using 
partnerships between the public, private and voluntary sector in order to improve results 
and (7) empowering citizens and communities to take control and responsibility in 
public services.
Most of these ideas were already being applied to the NHS at the beginning of the 
1980s. The publication of a list o f Performance Indicators (Pis) in 1983 can be 
considered the first visible sign o f these ideological reforms. However, the introduction 
of the internal market in 1991 represents the most significant modification on the 
operation of the NHS. The internal market was characterised by the separation between 
service provision and purchasing. On the provider side, self-governing NHS Trusts were 
created to manage and deliver hospital services. On the purchaser side, DHAs and 
Family Health Services Authorities, together with some General Practices (known as 
fundholders), were assigned a budget to purchase health services. This relationship 
between purchasers and providers was formally stipulated in contracts, and aimed at 
improving the efficiency of service delivery. The introduction of fundholding (devolved 
budgets to General Practices) was intended to improve the performance and 
accountability of the doctors, by involving GPs in the management of the assigned 
budget.
The fundholding scheme proved to be quite appealing, by 1997 half of the
population was registered with a fundholding practice (Smith and Goddard 2000).
However, the fact that fundholding was not introduced on a compulsory basis created8
doubts about equity in the service provision. It was suggested that patients belonging to 
a fundholding practice were benefiting from better access to services when compared to 
patients from a non-fundholding practice (Le Grand, Mays and Mulligan 1998).
The main aim of the Conservative Government reforms of 1989 was to increase the 
efficiency of the hospital services, always assumed to be the most important part of the 
NHS. The introduction o f fundholding in 1990, on a voluntary basis, was more a 
consequence of this initial aim than an aim in itself (Bloor, Maynard and Street 2000). 
Furthermore, the accountability structure regarding the delivery of Family Practitioners 
services has also been unclear, and its independent contractor status gives GPs an 
autonomous role. It is only in 1997 that the role of primary care is explicitly considered 
in another set of health system reforms introduced by the Labour Government.
1.3.3 After 1997: A Primary Care-led NHS?
The White Paper, The New NHS: Modern and Dependable (1997), defines the 
objectives of yet another reform on the NHS. According to this document, this is meant 
to be “a ‘third way’ o f running the NHS - a system based on partnership and driven by 
performance” (The Department o f Health 1997, Paragraph 2.2). Concerns regarding 
inequity of service provision derived from the fundholding system gave rise to 
significant alterations of the organisation of primary health care. For the first time, 
primary care has been considered as central to the success of the reforms of the NHS 
(The Department of Health 1997). This shift o f emphasis from hospital services to 
primary care is one o f the major differences of this reform, along with a theoretical 
emphasis on the equity of service provision.
A definition of what constitutes primary health care is essential before we proceed.
The National Health Service Executive (NHSE) defines it as: “first contact, continuous,
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comprehensive, co-ordinated care provided to individuals and populations 
undifferentiated by age, sex, disease or organ system” (NHSE 1997, as quoted in 
Dowell and Neal 2000: 10). Primary care is the first line of support for patients, as most 
patients are registered with one GP surgery. Furthermore, with the exception of 
emergencies; patients gain access to the NHS through primary care. In terms of 
resources used, primary care controls a significant part of the NHS budget both directly, 
through the delivery of primary care services and indirectly, through referrals to 
community care and secondary care. General practice is part of primary care. It involves 
the services delivered by GPs, practice nurses and other staff who work in GP surgeries.
The 1997 reforms instituted by the Labour Government created a new figure in 
primary health care: Primary Care Groups (PCGs). 481 PCGs were established in April 
1999 across England to commission health services for patients. PCGs are composed of 
a set o f individual health practices grouped together on a regional basis, covering a 
population of around 100,000 patients. Each PCG is headed by a Board (governing 
body) constituted by four to seven GPs; one or two community or practice nurses; one 
Social Services nominee; one lay member; one Health Authority (HA) non-executive 
member and one PCG Chief Executive. They have access to a unified budget to 
commission and provide health services, and are accountable to justify how they utilize 
resources.
The early statements from the Government about PCGs’ Board composition
portrayed a pluralistic view o f decision-making, with an emphasis on fair representation
from all the relevant stakeholders in primary care. However, following a long
established tradition, the GPs threatened not to cooperate unless certain demands were
satisfied, which implied a shift towards a GP dominant Board (Smith and Sheaff 2000).
With the current structure, GPs have a clear majority in the Boards, with the legal
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assurance that no meeting can start without a GP majority. This is an important aspect 
as it assures that the decision-making process in the PCGs is dominated by the GPs’ 
values and priorities. Moreover, GPs have preferential status in terms of the way they 
are elected to the Board: while GPs are peer elected, the other members have to be 
selected by the HA.
PCGs were designed to develop over four stages. In stages one and two they only 
have an advisory role towards the HA and, in stages three and four, they become 
established as freestanding bodies accountable to the HA. At the last two stages they are 
called Primary Care Trusts (PCTs) and have the responsibility of fully managing unified 
cash limited budgets to cover General Medical Services (GMS) infrastructure, 
prescribing, hospital and community services. The HA decides when a PCG (level 2) is 
ready to upgrade to PCT, upon a formal application from the PCG. The objective is that 
every PCG will upgrade to PCT status before 2005. PCTs are governed by a chairman 
and lay members appointed by the Secretary of State, and managed by a Chief 
Executive, a finance director and three other executive members.
According to the White paper The New NHS (The Department of Health 1997: 
Paragraph 5.9.), the main functions o f these new primary care organisations are to:
(1) contribute to the development of the annual Health Improvement Plan (HImP);
(2) promote the health of the local population;
(3) commission health services for the local population;
(4) monitor the performance o f NHS trusts delivering services for the local 
population;
(5) develop primary care;
(6) better integrate primary and community health services.
l l
The transference o f the operational role in primary care delivery from HAs to PCG/Ts is 
an essential feature o f the Labour Government reforms. A more strategic role was given 
to the HAs. In collaboration with Local Authorities, PCG/Ts and NHS Trusts, the HAs 
were given the task o f developing HImPs to identify the needs of the population and the 
most adequate strategies to satisfy these needs. HAs are also expected to set 
management and service partnerships with other organisations inside and outside the 
NHS. The role o f performance monitoring is also an important part of HAs tasks. They 
allocate resources to its PCG/Ts and set up local performance targets, holding PCG/Ts 
accountable to the achievement of these targets. PCG/Ts set indicative budgets for their 
individual practices, and have to develop mechanisms to ensure that budgets are not 
exceeded (Bloor, Maynard and Street 2000). Figure 1.1 represents the current 
organisational structure of the NHS, with the several lines of accountability in 
operation.
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Figure 1.1: NHS accountability structure from 1997 (Source: The Department of
Health 1997)
Key:
L
In practice, it can be argued that these latest reforms show strong signs of a 
continuation of the previous policies and models, with a particular emphasis on 
applying the principles of New Public Management in primary care. This is indicated by 
the introduction o f the concept of clinical governance in primary care.
“Clinical governance can be defined as a framework through which NHS 
organisations are accountable for continuously improving the quality of their 
services and safeguarding high standards of care by creating an environment in 
which excellence in clinical care will flourish.”
(The Department of Health 1997: Paragraph 3.2.)
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According to the concept of clinical governance, performance assessment is a 
vehicle for quality improvement and it is the responsibility of each organisation and 
each professional in the NHS to work towards the continuous improvement of quality. 
This concept of clinical governance has clear relationships with the concept of 
‘entrepreneurial governance’ in the private sector.
“Performance management and related techniques, for example, involve a 
characteristically ‘contractual’ relationship between individual employees and the 
organization for which they work. This involves offering individuals involvement in 
activities -  such as managing budgets, training staff, delivering services -  previously held 
to be the responsibility of other agents -  such as supervisors, personnel departments and 
so forth. The price for this involvement is that individuals themselves must assume 
responsibility for carrying out those activities and for their outcomes.” (Du Gay 2000: 85)
To put clinical governance into practice, a Performance Assessment Framework 
(PAF) was developed (National Health Service Executive 1999). PAF measures 
performance upon six dimensions: (1) health improvement, (2) fair access, (3) effective 
delivery of appropriate health care, (4) efficiency, (5) patient and carer experience o f the 
NHS and (6) health outcomes of NHS care. From this framework, a list of Pis was 
published to assess the performance of HAs. The list o f  Pis defined in PAF is presented 
in Appendix A. However, how HAs and PCG/Ts are supposed to leam from these 
indicators in order to improve the quality of services is not clear. It is therefore crucial 
to undertake a formative evaluation in primary care aimed at performance improvement. 
We will next justify why we believe that Data Envelopment Analysis is an appropriate 
technique to compare primary care providers.
14
1.4 Why use DEA for Performance Assessment in Primary Health Care?
One method to assess performance is to benchmark the organisation against others 
performing similar activities. A benchmarking exercise allows the organisation to 
evaluate how well it is doing, when compared to best-observed practice according to a 
particular criterion. Also, a good benchmarking exercise should allow the organisation 
to learn about how other organisations are able to do better. However, the challenge is in 
identifying ‘best practice’, as what constitutes ‘best practice’ is in itself dependent upon 
the perspective taken. Furthermore, what constitutes ‘best practice’ is dependent upon 
the priorities of the organisation under evaluation. Therefore, what constitutes ‘best 
practice’ to one organisation might not constitute ‘best practice’ to another. If one health 
care delivery unit, responding to its local needs, gives priority to the delivery of 
preventive services, its performance should preferentially be compared with the 
performance of units with similar priorities.
DEA is a non-parametric technique used to measure the efficiency of Decision 
Making Units (DMUs) and was first proposed by Chames, Cooper and Rhodes (1978). 
This technique uses a production metaphor. It considers that each DMU is engaged in a 
transformation process, where by using some inputs (resources) it is trying to produce 
some outputs (goods or services). One of the interesting features of DEA is that it 
allows each unit to identify a benchmarking group; that is, a group of units that are 
following the same objectives and priorities, but performing better. In this respect DEA 
aims to respect the priorities of each DMU by allowing each one of them to choose the 
weight structure for inputs and outputs that most benefits its evaluation. As a result, it 
aims to classify each unit in the best possible light.
There are several distinct reasons that make DEA suitable for use in performance 
assessment in primary health care:
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(1) DEA can handle the existence of several non-commensurate inputs and outputs, 
without requiring unit prices for each of them. This is a clear advantage in 
health care studies, when we consider that we are usually confronted with 
processes characterised by the use of several resources, involved in the delivery 
of several distinct services, in order to achieve several distinct outcomes. Whilst 
unit costs for the resources may be obtainable, we do not have information 
regarding the unit value of outputs and outcomes;
(2) DEA uses all the data available to construct a best practice empirical frontier, to 
which each non-optimal production point is compared. This is a distinct 
advantage when compared to regression-based techniques that focus on the 
average units and construct an average production function;
(3) In contrast with parametric techniques, such as Stochastic Frontier Analysis 
(SFA), DEA does not require the specification o f  the functional form that links 
the inputs to the outputs. Moreover, if information is available, it allows the 
incorporation of several distinct assumptions regarding the relationships 
operating at the frontier, regarding the returns to scale, the disposability of the 
inputs and outputs, and the convexity of the production function;
(4) The performance of DMUs can be assessed by using several alternative 
orientations to the best practice frontier, depending on the context of the study. 
The DEA projections to the best practice frontier can reflect an output 
maximisation, an input minimisation, or a combination of both;
(5) Given that most DEA models can be conceptualised as a linear program, a vast 
range of useful information becomes available for research, decision-making and 
policy making.
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Despite these important advantages, we are fully aware of the limitations of this 
technique. These limitations include the following:
(1) DEA assumes that it is possible to fully characterise the production of health 
care by identifying a set o f inputs, outputs and outcomes of production. 
However, some of the outputs and outcomes of primary care are not measurable. 
Furthermore, there are an extensive number of factors operating at different 
levels which impact on this transformation and which may lead to the violation 
of the linear input-output relationship. Awareness of these factors and of their 
potential impact on the results is necessary if useful information is to be 
obtained;
(2) DEA assumes one-way causality between inputs to outputs. In this respect, it is 
assumed that higher levels o f inputs should lead to higher levels of outputs. 
However as pointed out by Smith (1992), in a context where the level of output 
achievement is published, poor levels of outputs can generate pressure for 
increased resources. In this respect, a negative correlation may exist between 
inputs and outputs. Smith (1992) refers to this problem as ‘negative political 
feedback’. Orme and Smith (1996) examined the effects of this problem for 
DEA studies and concluded that, in the presence o f ‘negative political feedback’, 
DEA estimates of efficiency may be subject to bias against DMUs using fewer 
resources. These DMUs may be asked to make greater improvements in 
efficiency than DMUs using higher levels of resources. They further concluded 
that this problem is more pronounced in small samples. In this respect, the use of 
DEA for target setting in a context where the output data is subject to great 
political scrutiny requires further caution.
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(3) Measuring outputs represents a utilitarian approach that values the consequences 
of actions above anything else. In this respect, the use of DEA to assess 
performance leads to a biased representation of success in organisations. The 
delivery of public services is also governed by non-consequentalist principles 
and it is essential to provide alternative representations of success.
(4) Given the arbitrariness involved in the selection of variables used in a DEA 
model (particularly output and outcome variables), a DEA analysis can lead to 
biased and potentially misleading results. For example, there is a danger that 
managers could suggest the introduction of variables that they know will benefit 
their classification. This is one of the reasons why we suggest the use of DEA 
for formative evaluation;
(5) DEA does not take into account stochastic variability in the data and is therefore 
very sensitive to data errors;
(6) DEA assumes proper envelopment of all the DMUs. That is, a meaningful 
measure of efficiency can only be calculated if the DMU under evaluation has a 
comparison set. Otherwise, the DMU will be classified as efficient, simply 
because no comparison can be established. This is a limitation that results from 
the fact that DEA allows full flexibility in the weights applied to each input and 
output. In this respect, if a DMU is characterised by a peculiar mix of inputs or 
outputs, it can find a set of very extreme weights under which it is efficient. This 
problem can be solved by the introduction of weight restrictions regarding the 
admissible ranges of input or output weights.
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1 .5  T h e s is  O u t l in e
This introductory chapter provided an overview of the thesis and of its objectives. A 
brief introduction to the context of study was included, with particular emphasis to the 
reforms that have been implemented in the NHS since its creation. The latest reforms of 
the NHS were discussed in relation to the importance given to primary care in the 
delivery and coordination of health services. The introduction of PCG/Ts, their 
functions, and the new strategic role given to HAs were discussed. The importance of 
performance assessment as part o f the Government’s modernisation agenda was 
discussed together with the suitability o f DEA for performance assessment in primary 
care.
Chapter 2 provides an introduction to DEA. Firstly, we discuss the basic DEA model 
developed by Chames, Cooper and Rhodes (1978). This is followed by a discussion of 
cost efficiency and allocative efficiency, and a method to calculate it by using a DEA 
model. The need to include weight restrictions in order to obtain meaningful results is 
pointed out and several approaches for their inclusion in DEA are discussed.
Chapter 3 reviews the relevant literature. We review the methods that can be used to 
compare primary health care providers and the empirical studies that have been carried 
out. By reviewing the performance assessment studies in primary health care, we 
identify the main issues that still need to be addressed.
Chapter 4 discusses the development of a conceptual framework for formative 
evaluation of GP surgeries. This conceptual framework aims to establish a link between 
the local needs, the resources used, the services delivered and the outcomes achieved. 
The difficulties encountered in applying this conceptual framework to evaluate primary 
care as a whole are discussed and the decision to focus on a speciality (diabetes care) is
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justified. The advantages and limitations of comparing primary care providers based on 
a speciality are also discussed.
Chapter 5 discusses the methodology used to develop the models and, to collect and 
analyse the data. In this chapter we justify the importance of using a combination of 
research methods in order to collect, analyse and interpret the performance data. The 
importance of developing a clear conceptual framework regarding the context of study 
is emphasised as a way of giving coherence to the project. We also discuss the 
development of two questionnaires to collect data that was not available. This is 
followed by a discussion of the design of each one of the questionnaires and the 
methodology used for sample size calculation.
Chapter 6 provides the background for the empirical study. We start by justifying the 
need for a formative evaluation in primary diabetes care and briefly characterising this 
chronic condition. We then return to the conceptual performance assessment framework 
as presented in chapter 4 and discuss its applicability in primary diabetes care delivery. 
In particular, we discuss the local needs, objectives, resources used, services delivered 
and outcomes achieved in primary diabetes care. These are the key elements for the 
development of the performance assessment models presented in chapter 7.
Chapter 7 presents the data, the models and the results of the primary diabetes care 
evaluation undertaken. We discuss the data available and its quality. A brief 
characterisation of the surgeries under evaluation is performed in order to provide a 
background for the results. The results in terms of a comparative analysis of equity, 
efficiency, clinical effectiveness, patient-focused effectiveness and cost effectiveness 
are presented and discussed.
In chapter 8 we analyse the trade-offs between the different performance criteria and
conclude that the performance status of some surgeries varies greatly with the criterion20
chosen. We conclude chapter 8 by assessing the robustness of the performance results to 
the introduction of additional surgeries.
Chapter 9 discusses the effects of the environmental variables on the performance 
results. The visible effects of area related factors and patient related factors are 
discussed. We also discuss the effect of different structures and processes of care in the 
performance results. We report on the workshops undertaken with the PCTs and the 
surgeries to discuss the use of the results in practice.
Chapter 10 provides a summary o f the thesis and the main conclusions of the work. 
It discusses the main contributions of this study for research, decision-making and 
policy making. A discussion of the limitations of this study and suggestions for further 
research is also included.
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2 An introduction to Data Envelopm ent Analysis
2.1 Introduction
In this chapter we introduce the technique used to compare primary care providers: 
DEA. We begin with a discussion o f the measurement of technical efficiency by using 
the standard constant returns to scale model known as the CCR model (Chames, Cooper 
and Rhodes 1978). This is followed by a discussion of the measurement of cost 
efficiency. The decomposition o f cost efficiency into technical and allocative 
components is also presented. We introduce the concept of weight restrictions and 
discuss their interpretation in section 2.3.
2.2 Using DEA to Measure Efficiency
Since it was first proposed by Chames, Cooper and Rhodes (1978), DEA has been 
widely used to compare the efficiency of homogeneous Decision Making Units (DMUs) 
that use a set of inputs to produce a set of outputs. This technique calculates efficiency 
by comparing the ratio of weighted sum of outputs to the weighted sum of inputs across 
DMUs.
Koopmans (1951) is associated with the first definition of technical efficiency: a 
DMU is technically efficient if and only if an increase in one of the outputs cannot be 
made without either decreasing some of the other outputs, or increasing the inputs. 
Debreu (1951) proposed the first radial measure of productive efficiency: a coefficient 
of resource utilisation. Farrell (1957) drew on the work of these two economists and 
proposed a method to empirically calculate the relative efficiency of several DMUs. He
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Farrell (1957) is considered to be the first author to lay down the foundations of 
DEA, by proposing the construction of an empirical production frontier from several 
observed levels of input and output. This defined inefficiency as the radial distance from 
a point below the frontier to a point on the frontier. This distance represents the 
maximal radial expansion of the outputs while keeping inputs constant (output 
orientation), or the maximal radial contraction on the inputs, while keeping outputs 
constant (input orientation). One minus the equi-proportionate reduction in all inputs is 
a measure of input oriented radial efficiency. A score of unity is a necessary condition 
for relative efficiency. Similarly, a score of less than unity means that there is at least 
another DMU achieving the same level of outputs, using fewer inputs.
Chames, Cooper and Rhodes (1978) extended Farrell’s work and defined a linear 
program in order to obtain efficiency values, for a production system characterised by 
multiple inputs and multiple outputs. They also introduced an innovation to Farrell’s 
measure of efficiency. They introduced slack measures to account for non-radial 
adjustments to the frontier. This model became known as the first DEA model, the CCR 
Model. We now present a graphical illustration of the measurement of efficiency by 
using DEA.
2.2.1 Graphical Representation of DEA -  Radial and Non-radial Efficiency 
Measures
Let us assume that there are 6 DMUs (A, B, C, D, E and F) using two inputs (*/ and X2)
to produce one output (y). For simplification, let us also assume that all six DMUs
produce one unit o f output. Figure 2.1 below represents the input space of the
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also suggested a way to decompose productive efficiency into two measures: technical
efficiency and allocative or price efficiency.
production technology. Units A, B, and C are technically efficient because they are 
located on the frontier of technical efficiency. These units envelop all the other units, 
which are located to their right. The space to the right of the convex frontier is known as 
the Production Possibility Set. We have no evidence that it is possible to produce one 
unit of output y, using a combination of inputs situated to the left of the convex frontier 
formed by points A, B, and C. The vertical extension from point A upwards is also part 
of the frontier, but is a dominated part of the frontier, given that any point along this 
vertical line, is dominated by point A. Here, there is evidence that one unit of output y  
can be produced using the same quantity of x\ and less quantity of xi. Any point along 
this vertical line is said to be weakly efficient, and a slack quantity of input x2 can be 
identified. Reduction o f the input usage by that amount of slack would make the DMU 
technically efficient. A similar situation happens to any points along the horizontal line 
from point C.
Units D, E and F are technically inefficient, because it is possible to reduce both 
inputs, while producing the same amount of output. For example, in order for DMU F to 
become efficient, it has to reduce its inputs from point F to point Ft. This reduction in 
inputs is a radial reduction, without altering the input mix (that is the ratio between x\ 
and *2). Its technical efficiency (TEf) can be calculated as:
TEf (x, y) =
OFt
OF
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F ig u r e  2 .1 : T h e  m e a s u r e m e n t  o f  t e c h n ic a l  e ff ic ie n c y
The optimal quantities of inputs for DMU F result from a convex combination of 
observed quantities of inputs used by DMUs B and C, by using the following formula:
FT =A. B(x^,x* ) + A c(x,c,xf ),
where A. B and A. c are the intensity variables associated with each of the two peer 
DMUs. The projection of DMU F into Ft represents the shortest projection to the 
frontier, given that it respects the current mix of inputs used by DMU F. Assuming that 
DMU F wants to keep its current input mix, its peer group is constituted by DMUs B 
and C, with greater intensity being given to DMU B. DMUs B and C can provide DMU 
F with useful information on how to produce the same level of outputs using fewer 
resources, and the path F to Ft can be seen as a path for performance improvement over 
time. Using this path, several intermediate targets can be identified and progress 
towards the frontier can be monitored.
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DMU D is a special case, because it is enveloped by the extension from the best 
practice frontier. DMU D is said to be improperly enveloped. After a radial reduction of 
all its inputs up to point Dw it is still possible to reduce one of its inputs without 
worsening the other input and without worsening the output level. In this example, a 
radial reduction of all its inputs to point Dw puts it on a position of weak efficiency or 
Farrell efficiency. In order to obtain a position of Koopmans efficiency, a further 
reduction of input xi is necessary to achieve point C on the frontier, which is a non- 
dominated point.
2.2.2 The Measurement of Technical Efficiency -  The CCR Model
Let us consider a general case characterised by the existence of n Decision Making 
Units (DMU/, j  -  1, .... n) to be compared, which use m inputs (xk i = 1, .... m) to 
produce s outputs (yn r = 1, ... s). We define the intensity variables attached to DMU, as 
Xj. The input weight or multiplier associated with input i is v; and the output weight or 
multiplier associated with output r is ur. Let us assume that constant returns to scale 
(CRS) prevail at the frontier, i.e., that changes in the inputs should lead to proportional 
changes in the outputs. Furthermore, let us take an input orientation to the frontier, i.e., 
we aim to minimise all the inputs, while keeping the outputs constant.
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In order to simplify the notation used, let us define the following matrixes and
vectors:
Xu Xn -  x tn 'y» y, 2 -  y tm
X  =
X 2 \ X22 -  X 2*
Y =
y  21 y 22 -  y 2«
_x„, X m2 Xmn_ _y* y . -  y m_
A , ' X io ,^0
¿ 2
X o  =
X 2 0
y„ = y »
A  . . _Xm  0 _ y ,  0.
V = [v, V2 -  v j  U = \u t m2 -  U,\
We can calculate the technical efficiency (TE) of DMUoby solving one of the linear 
programs presented in Model 2.1. The envelopment form and the multiplier form are 
two ways of presenting the same problem, given that one is the dual of the other.
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Model 2.1: The CCR Model -  input oriented
Envelopment Form Multiplier Form
TE0 (x, y)iRS = Min 6 TE0 (x, y)CRS = Max uy0
Subject to: Subject to:
6x0 -  XX 2: 0 vx0 =1
YX > y0 - v X  + uY  < 0
X>0.
v > 0, u > 0.
At this point we believe that it is prudent to define Farrell efficiency. A DMU is radially 
efficient if, and only if, it is not possible to improve all the inputs (or all the outputs) by 
a certain rate without worsening some other inputs or outputs. In this respect, a DMU is 
radial or Farrell efficient if the solution to Model 2.1 produces d' = 1.
However, as previously shown, further non-radial input reductions or non-radial 
output augmentations may still be feasible. In order to identify these input shortfalls and 
output augmentations, we can solve a second stage DEA model, aiming at maximising 
the input and output slacks, while keeping 6 = 6 ' .  In this respect, let us define the 
following ‘slack vectors’:
s'  = 6  x0 -  X X ,  s* = Y X -  y 0 
Also, let us define a vector of ones:
e = [\ 1 ... l], so tha t: e s " = X r . i J ' am/ = ^ ' . i s *
In order to identify the maximum non-radial reduction in inputs ( s ' )  and the 
maximum non-radial improvement in outputs ( j *), we use the optimal value of 6
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determined from Model 2.1, and solve a second stage model (Model 2.2), using 
X , s '  and s* as the variables.
We can now return to the definition of Koopmans efficiency. A DMU is Koopmans 
efficient if, and only if, it is not possible to improve any input or output without 
worsening some other input or output. That can be obtained by stipulating the following 
conditions in relation to the solutions of models 2.1 and 2.2:
0’=\ and s f  = 0 (for all i, i — 1, .... m) 
and s*' = 0 (for all r, r — 1, .... s)
Model 2.2: The CCR Model -  Stage 2: maximisation of 
slacks
Max a> = es' + es* 
Subject to: 
s '  = 0 ’x0 -X X
s* =YX — y 0
X>0, s '  >0, s* > 0.
Banker, Chames and Cooper (1984) proposed a DE A model that assumes the 
existence of variable returns to scale (VRS) and is applicable when returns to scale 
exist. In order to introduce the concept o f returns to scale and its implications for
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efficiency measurement, let us introduce another simple example. Figure 2.2 presents 4 
DMUs (A, B, C and D), which use one input (jc) to produce one output (y).
Figure 2.2: Productions frontiers under CRS and VRS (unique most productive
scale size)
In this simple example, two frontiers of efficiency have been constructed. One 
frontier assumes CRS and is represented by the line in bold that passes through the 
origin. The other frontier assumes the existence of VRS and is the line that links point A 
with B and point B with C. The vertical extension from point A and the horizontal 
extension from point C constitute the dominated parts of the VRS frontier.
DMU B is the only unit deemed efficient under the assumption of CRS, because it is 
the only unit located in the CRS frontier. Therefore, DMU B is the only unit operating
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under the most productive scale size. All the other units operate under sub optimal scale 
sizes. DMU A operates at increasing returns to scale, i.e., a greater scale of operation 
would lead to a greater ratio of outputs over inputs; DMU C operates under decreasing 
returns to scale, which means that a smaller scale of operation would lead to a greater 
ratio of outputs over inputs. DMU D is inefficient under any assumption regarding 
returns to scale. However, as shown graphically, its efficiency measure varies with 
different returns to scale assumptions. If an output orientation is used, the efficiency of 
DMU D under CRS and under VRS is respectively:
TEd(x, y)CRS =
OD
OD"
= 0.5
TEd (x, y)VRS =
OD
OD’
0.625
As it can be easily understood, the efficiency measure under CRS is smaller than the 
efficiency measure under VRS. In fact, in any situation, we have the following 
relationship:
TE(x,y)CRS<TE(x, y)VRS.
It is also important to note that the efficiency measure under CRS remains the same 
independently of the orientation taken. However, under VRS this relationship does not 
necessarily hold. In the example shown, if an input orientation is used, the efficiency 
measure for DMU D under VRS is the same as the efficiency measure under CRS, 
which is 0.5. However, as previously stated, with an output-orientation, the efficiency 
measure under VRS is 0.625.
The assumption of VRS imposes an additional restriction in the envelopment form of 
the DEA model. In particular, we impose that the DMU under evaluation can only be 
projected to a convex combination of DMUs o f  the same scale. I.e., we require that the
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sum of the intensity variables be equal to one (Zy Xj =1). Banker, Chames and Cooper 
(1984) developed a DEA model to measure technical efficiency assuming VRS. This 
model is known as the BCC model and is presented in Model 2.3.
Model 2.3: The BCC Model — input oriented
TEg (x, y / KS = Min 6 
Subject to:
6 x0 -  XX > 0 
=1
X>0.
Banker, Chames and Cooper (1984) showed that the CCR measure of technical 
efficiency (assuming CRS) can be decomposed into the multiplication of a pure 
technical efficiency measure obtained from the BCC model (assuming VRS) and a scale 
efficiency measure. I.e.:
TE0 (x. y)CRS = TE0 (x. y)VRS x SE0 (x. y)
In this respect, if we want to calculate a measure of scale efficiency for DMUo (SEo), 
we use the following formula:
SEo (x. y) = TE0 (x, y)CRS /  TE0 (x, y)VRS, with SE„ (x. y)<. 1.
The scale efficiency of a DMU is equal to 1 when the DMU is CRS efficient. If the 
DMU is VRS efficient, but not CRS efficient, then its scale efficiency is smaller than 
one, indicating that the DMU is not operating at the most productive scale size.
The choice over the type of scale assumption used should be contextual and should 
result from an analysis regarding the type of inputs used and the type of outputs used. If 
there is evidence that changes in the inputs should not lead to proportional changes in 
the outputs, then a VRS assumption should be used; otherwise, the CRS assumption 
should be used. However, it is equally important that the VRS model is not used when 
there is no evidence of scale effects.
2.2.2.1 Input-oriented versus Output-oriented Models
The term ‘input-orientation’ defines the objective of the envelopment problem, which 
aims to minimise the value of inputs used in the transformation process. I.e., it looks for 
the value O', which ensures the maximal radial reduction in the input vector. In a similar 
way, the term ‘output-orientation’ defines the objective of maximising the radial 
augmentation in the output vector.
The choice between using an input-oriented model or an output-oriented model must 
first of all reflect the control the decision-maker has over each one of these objectives. 
For example, if we consider as an output “the number of patients registered with a GP”, 
an output-oriented model would not provide meaningful results because the decision­
maker cannot have full control over this output. If the outputs and inputs are such that in 
the short-term the decision-maker has full control over both types o f variables, then the 
orientation should reflect the current priorities of the units under evaluation, or an
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additive model (Cooper, Seiford and Tone 2000) could be used if both objectives are 
sought.
2.2.3 Measurement of Allocative Efficiency and Cost Efficiency
When information about input prices exists, a DEA model can be formulated to measure 
cost efficiency, i.e., the efficiency of a DMU in producing a set of outputs at minimum 
cost. Figure 2.3 represents 6 DMUs (A, B, C, D, E and F) using two inputs (x / and x2) to 
produced one unit of output (y). For simplification purposes, let us assume that all 
DMUs produce one unit of output. We have represented the frontier of technical 
efficiency and two isocost functions, given the current input prices (vv/ and w2).
Figure 2.3: The measurement of technical, allocative and cost efficiency
Based on this example, DMU C is the only unit that is cost efficient. Unit C is the 
only unit that produces the one unit of output at minimal cost: Point C is the point of
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intersection between the performance frontier and the minimal isocost. DMU C is said 
to be both technically and allocativelly efficient. It is technically efficient because there 
is no evidence that it is possible to reduce all the inputs whilst producing one unit of 
output. It is allocativelly efficient because it uses the optimal input mix given the 
current inputs prices. Units A and B are only technically efficient, given that their 
current mix of inputs is sub-optimal. When we consider the current input prices, both 
DMUs A and B use too much of input X2, when in fact they should use greater quantities 
of input x\. If these two DMUs operated with the same mix as that of DMU C, they 
could produce the same amount of output with reduced costs. DMU F is both 
technically and allocativelly inefficient. Its measure of allocative efficiency is calculated 
as:
OF
AEf (x, y) = ^
OFt
Cost efficiency can be obtained by multiplying the measure of technical efficiency 
by the measure of allocative efficiency (Farrell 1957):
OEf (x . y) =
OFT OF, _ OF,
OF OFt OF
A DEA model can be formulated to measure allocative efficiency. Let us define a 
price vector containing the unit prices of each input: w = [wl w2...wm]. Assuming 
constant returns to scale and taking an input orientation, the minimum cost (A/C) of 
production for DMUo can be calculated by solving the Linear Program presented in 
Model 2.4 (Fare, Grosskopf and Lovell 1994).
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Model 2.4: The Cost Minimisation Model
MCo (x, y, w f RS = Min wx0
Subject to:
x0 -  XX > 0
A > 0.
Model 2.4 aims to minimise the total input cost, allowing the input mix to be 
changed, in a way that suits the current input prices. This is in contrast with the 
envelopment form of model 2.1 presented above, where the input mix is assumed to 
remain constant, and only a radial reduction is allowed. This difference is evident in the 
first set of restrictions, where in Model 2.4 the quantities o f inputs are variables to be 
optimised. Once the optimum quantities of inputs have been identified, the minimum 
feasible cost for DMUo can be calculated and is equal to: MC0(x ,y ,w ). This value 
represents the minimum feasible cost, at which one unit of output for DMUo can be 
produced, considering the current input prices. If DMUo is cost efficient, then its current 
cost (w0jc0) is already the minimum cost, and its cost efficiency is equal to one. 
Otherwise, its current cost is superior to the minimum feasible cost, and its cost 
efficiency is smaller than one. In this case, the vector o f optimal input quantities is 
given by
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where the superscript T indicates vector transposition. Cost efficiency (also known as 
overall efficiency) can be calculated using the following formula (Fare, Grosskopf and 
Lovell 1994):
Overall or cost efficiency — OEo (x, y, w) = 0 ^  .
Cost efficiency includes the two components of efficiency. Firstly, it includes the 
component of technical efficiency, which does not take into consideration the input 
prices: it focuses solely on input quantities, and aims at achieving the maximum 
possible radial reduction. Secondly, it includes an allocative component, which takes 
prices into consideration and aims to choose the optimal input mix, given current input 
prices. I f  we want to isolate this allocative component, we need to run both Model 2.1 
and 2.4, and calculate the allocative component using the following formula (Fare, 
Grosskopf and Lovell 1994):
Allocative efficiency = AEo (x, y, w) = ^ ^ o (x ^y>w)
TE0(x,y)
Given this relationship, cost efficiency can be decomposed into two components as 
shown below:
OE0 ( x, y. w) = AE0 (x, y. w) x TE0 (x, j>)
So far we have focused on the measurement of technical and allocative input 
efficiency. The measurement of cost efficiency assumes the existence of input prices. If 
information regarding the exact input prices is not available, an alternative is to include 
information regarding a range of technologically realistic trade-offs between the 
different inputs. Similarly, information regarding the technologically realistic trade-offs 
between the different outputs can also be included in order to obtain more reliable 
estimates of efficiency. In DEA, this type of information is introduced via the use of
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weight restrictions. We will now discuss the different approaches that have been 
proposed to introduce weight restrictions in DEA in order to justify the approach used in 
our case study.
2.3 Introducing Weight Restrictions in DEA
In the previous sections we have discussed the use of DEA to calculate measures of 
relative efficiency in the presence of multiple inputs and multiple outputs. One of the 
great advantages of DEA is that it produces efficiency measures without the need to 
specify the weights associated with each input and with each output. DMU specific 
weights are calculated during the optimisation process in order to produce the highest 
possible efficiency measure. However, if total flexibility of the weights is allowed, it is 
very common to find results where most of the variables have been given a zero weight. 
This situation is unsatisfactory, given that if the optimal weight associated with a certain 
input is zero, this means that this input was excluded from the efficiency measurement.
The ratio between the weights assigned to two inputs or two outputs should reflect 
realistic production trade-offs. In that respect we argue that, whenever possible, 
information regarding realistic production trade-offs should be included in the DEA 
model in order to improve the economic validity of the results. For example, if we know 
that one senior doctor can be substituted by two or more training doctors, without any 
effect on the services delivered, then this information should be included in the DEA 
model. This information is introduced in a DEA model via the introduction of 
restrictions on the weights assigned to the different inputs and outputs (please refer to 
the multiplier form of the CCR model presented in Model 2.1).
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Several approaches have been suggested regarding the best way to formulate and 
introduce weight restrictions (WR) in a DEA model. We will now review these 
approaches in order to justify the one that we have followed in this thesis.
2.3.1 The Assurance Region Approach
Thompson et al. (1986) developed the first approach known as the ‘assurance region’ 
approach. This approach imposes restrictions regarding the relative magnitude of the 
weights for certain inputs or outputs. In this respect, it limits the variability of weights 
between certain inputs or certain outputs. Assurance region restrictions are usually 
introduced on the multiplier form of the DEA model. For example, if a restriction on the 
relationship between the weights of inputs 1 and 2 were to be imposed, it would take the 
following form:
Li,2 s - s u u
v,
2.3.2 Absolute Bounds
Dyson and Thanassoulis (1988) suggested the inclusion of restrictions on the individual 
inputs and outputs weights, based on economic information regarding the average level 
of input needed to produce particular outputs. By imposing absolute bounds on the 
weights, the exclusion of certain inputs or outputs from the efficiency measurement, by 
assigning them a zero weight, is not allowed. Absolute weight restrictions are usually 
introduced on the multiplier model and are of the following form:
v, i  Lj or Vj <, Uj (for inputs) and u, à  L, or u, <, Ur (for outputs)
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2.3.3 The Cone-ratio Envelopment Approach
A more general approach to the introduction of weight restrictions has been proposed by 
Chames et al. (1990), and is known as the ‘cone-ratio envelopment’ approach. This 
approach involves the definition of the admissible area for the weights by using convex 
cones, spanned by several direction vectors.
The multiplier form of a DEA model after the introduction of restrictions using this 
approach is readily interpretable: it solves the CCR problem, but it limits the input 
weights to belong to the cone space defined by the direction vectors determined by the 
weight restrictions introduced. The envelopment form of the problem can be defined as 
a problem equivalent to the CCR model on its envelopment form, but with transformed 
data1. This is an important advantage given that once the data has been transformed we 
can use the standard DEA software available to solve a problem without weight 
restrictions but with transformed data.
2.3.4 Imposing Restrictions on the Virtuals
Wong and Beasley (1990) proposed a method based on the relative contribution of each 
input (or output) to the total costs (or benefits) of the DMU. The relative contribution of 
one input to the global cost is called the virtual weight of that input. Wong and Beasley 
(1990) suggested the imposition of lower and upper bounds on the virtuals, by means of 
introducing restrictions of the following type: 1
1 Cooper, Seiford and Tone (2000: 160, 161) show how the envelopment form is derived from the 
multiplier form.
4 0
St / , .
Pedraja-Chaparro, Salinas-Jimenez and Smith (1997) built on this idea of imposing 
weights on the virtuals, but suggested that the important aspect is to place restrictions 
between the virtuals of different inputs (or different outputs). The idea is that the 
proportion of the costs assigned to a particular input should not be allowed to exceed the 
proportion of costs assigned to another input by a certain multiple. This multiple is 
dependent upon the set of inputs and outputs included in the model and should be 
chosen by the analyst or decision maker. This approach leads to the imposition of 
weight restrictions of the following type:
civixij ^  vkxv < dtv,xy with i * k .
Some variations of these approaches have also been proposed. Allen et al. (1997) 
review the literature on the introduction of weight restrictions. Independently of the 
approach used, the introduction of weight restrictions has been mainly motivated by the 
need to improve discrimination in the DEA results. However, as pointed out by 
Podinovski (2002), this has led to a great deal of confusion regarding the meaning of the 
weight restrictions imposed and the meaning of the efficiency measures obtained from a 
DEA model with weight restrictions. Some technical problems regarding the validity of 
the DEA results after the introduction of certain types of weight restrictions have also 
been highlighted (Podinovski and Athanassopoulos 1998; Podinovski 1999 and 
Podinovski 2001).
Podinovski (2002) suggests that the confusion that exists regarding the effects of 
introducing weight restrictions in a DEA model results from the fact that in most
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approaches the weight restrictions are included in the multiplier form, without an 
attempt to interpret its effect in the envelopment form. Podinovski (2002) argues that 
the weight restrictions should be added to the envelopment form of the problem and a 
clear economic interpretation of their meaning should be sought. He demonstrates that 
each linear weight restriction, in the multiplier form, generates additional terms in the 
envelopment form (Podinovski 2002: 3) and then shows that “these terms can be 
thought of as the trade-offs between the inputs and/or the outputs” (Podinovski 2002:3). 
Podinovski names his new approach to the introduction of weight restrictions as ‘the 
trade-offs approach’.
The trade-offs approach has several advantages. Firstly, if the weight restrictions are 
defined based on technologically realistic trade-offs between the variables, the 
efficiency results will be more meaningful. Secondly, it can be shown that by adding 
weight restrictions based on trade-offs, the meaning of the efficiency results is 
preserved (Podinovski 2002). That is, in an input-oriented model, 6* means the 
maximum radial reduction that can be applied to all inputs without worsening the level 
of outputs produced, exactly the same meaning as for a problem solved without weight 
restrictions. Thirdly, prior to the introduction of weight restrictions, we can be sure of 
their feasibility. We shall use the trade-offs approach to introduce weight restrictions in 
our case study. We will now briefly review this approach.
2.3.5 The Trade-offs Approach
We shall focus only on the inclusion of homogeneous weight restrictions, given that 
these are the only types of weight restrictions we shall be including in our empirical 
case study. We will use the notation introduced by Podinovski (2002) and present an
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example regarding the introduction of a homogeneous weight restriction. Let us take a 
general homogeneous weight restriction of the form:
a,u ,+ a2u2 +... + a,u, — ¿>,v, - b 2v2 < 0 ( 1)
Where each of the coefficients a, and bt can be positive, zero or negative. For example, 
let us consider the following pair of weight restrictions:
These two restrictions can be translated into two linear equations that fit the general 
form presented in (1):
Podinovski (2002) shows that if each one of these linear equations is a restriction in 
the multiplier form o f the DEA model, it gives rise to a new term p  in the envelopment 
form. In particular, for each weight restriction of the form (1), we can see the following 
effects on the envelopment form of the DEA model: 1
(1) A new term arp  is added to each output restriction;
(2) A new term btp  is added to each input restriction.
Model 2.5 below represents the envelopment form of the CCR model, after the 
inclusion of one generic weight restriction of the form stated in (1).
(2)
v,
-  2v, + v2 < 0.
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Model 2.5: The CCR Model after the inclusion of one WR (envelopment form)
TE0 (x, y)CRS-subject lo WR = Min 9 
Subject to :
Z"=! À i  y  J r  + a r P  *  y Or (for »U ?  , With K  = 1,.. s )
x ; ,  ¿ix ji+ biP < 9 xa (forall/, with/' = 1,.,.,m) 
AiO.
2.3.6 Interpretation of Homogeneous Weight Restrictions in Terms of Production 
Trade-offs
The CCR model without weight restrictions identifies a composite DMU that is feasible 
in the production possibility set. The new term added to each restriction in the 
envelopment form is therefore a modification of this composite DMU, and according to 
Podinovski (2002: 7), has the following interpretation: we assume that it is possible to 
change the outputs by the vector [a, a2 ... ar ] provided that the inputs are changed 
by the vector [/>, b2 ... b,\, in the proportion p  > 0.
Using this approach, we can interpret the meaning of each one o f the weight 
restrictions presented in (2) as follows:
v, -  v2 <, 0 <=> The outputs should remain constant, if a decrease by one unit in input 1 
is compensated by at least an increase of one unit in input 2.
-2v , +v; SO o  The outputs should remain the same if a decrease by one unit in input 2 is 
compensated by an increase of at least two units of input 1.
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Whilst the introduction o f a weight restriction implies a reduction in the feasible 
admissible region of the multiplier form  of the model, it implies an extension of the 
feasible region of the envelopment form of the model. Given that the feasible region of 
the envelopment form represents the production possibility set, we can indeed conclude 
that the production possibility set of a model with weight restrictions is broader than 
that of a model without weight restrictions. Therefore, the value obtained for 6' 
preserves its meaning as a radial reduction applicable to all the inputs. However, after 
the introduction of weight restrictions, the maximum radial reduction deemed feasible 
may in fact be greater, leading to a decrease in the value of efficiency for the DMU 
under evaluation.
2.4 Conclusion
In this chapter we have discussed the technique that we have used for analysis. We 
started by discussing the basic CCR model and then discussed the different returns to 
scale assumptions that can be included in DEA. Furthermore, we discussed the 
measurement of cost efficiency and allocative efficiency. Finally, we discussed the need 
to include weight restrictions, the different approaches that can be used, and the 
interpretation of the weight restrictions.
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3 C om paring the Perform ance o f Prim ary Care Providers: A
Literature Review
3.1 Introduction
In this chapter, we review the methods that can be used to compare primary health care 
providers and the empirical studies that have been carried out. This literature review 
also considers the issues that still need to be addressed in order to develop a 
performance assessment framework that can lead to performance improvement in 
primary care.
We start by discussing the nature of primary care. Secondly, we review the use of 
Performance Indicators (Pis) and discuss some o f the frameworks that have been 
proposed to compare primary health care providers. Thirdly, we discuss the studies that 
have used DEA and parametric techniques to compare primary health care providers. 
Finally, we discuss some of the potential unintended consequences that can result from 
performance assessment and distinguish between summative and formative evaluation.
3.2 The Nature of Primary Care
The recognition that primary care is a very important part of any national health care 
delivery system and the recognition that primary care provision is responsible for a 
significant proportion of the health care budget, suggest that efforts should be made to 
identify systematic variations in performance between primary care providers, with the 
view to improving performance across the system.
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However, there are some considerable challenges in performing a fair comparison. 
Perhaps the greatest challenge in comparing primary care providers relates to the nature 
of primary health care provision. Whilst a hospital is an organisation with clear 
boundaries, where patients are admitted and discharged; primary health care delivery is 
an open community-based system with unclear boundaries. Furthermore, primary care 
has a fundamental role in terms of providing a long-term, continuing and generalist 
support towards individuals and families (Fry 1993). This long-term, continuous 
relationship is essential to build trust between the health care professionals and the 
patients and is one of the founding principles of primary care. In attempting to evaluate 
primary care providers, it is therefore important to take this aspect into account and aim 
to develop a framework that recognises the holistic nature of primary care.
3.3 Frameworks used to Evaluate Primary Care Providers
Several frameworks have been proposed to evaluate primary care providers. These 
frameworks tend to rely on the use of Pis detailing different aspects o f quality in health 
care delivery.
Donabedian (1980) provides a framework that can be used to classify the different
Pis into categories. This framework is characterised by three essential elements in
health care delivery: structure, process and outcome. Structure refers to the “relatively
stable characteristics of the providers of care, of the tools and resources they have at
their disposal, and o f the physical and organizational settings in which they work”
(Donabedian 1980: 81). In this respect, it refers to what is known in the production
literature as inputs. The term process refers to the activities that take place between
health care practitioners and patients, and the term outcome refers to the impact on the
patients’ current and future health status that can be attributed to the health care
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provided to the patient (or to the lack of medical care). Donabedian (1980) argues that 
an evaluation of medical care needs to study these three elements together, because they 
are interconnected and work as a whole.
By focusing on different aspects of Donabedian’s model, several different 
frameworks have been proposed to compare primary health care providers. For 
example, Baker (1992) proposed a list of 76 Pis related to the structure and process of 
General Practices in England. Eight categories of items were considered: (1) equipment, 
(2) clinical activities, (3) the team composition, (4) records, (5) organization, (6) 
premises, (7) availability of care and (8) clinics. If a particular feature was present a 
score of one was allocated to the practices and from the consideration of the 76 Pis, a 
global score was calculated and used to compare the practices in Gloucestershire, Avon 
and Somerset. This global score was then regressed on a number of explanatory 
variables to explain the variability found between the scores for different surgeries. 
Training practices and practices which employed a practice manager were found to be 
more developed. Furthermore, the lower the mean age of partners and the greater the 
total number of patients, the more developed were the practices. The underprivileged 
area score for the practices addresses was also found to explain part of the variability, 
with practices located in underprivileged areas presenting lower scores.
Van den Hombergh et al. (1998) also proposed a list of 129 Pis regarding the
different aspects of structure and quality o f management in general practice. The Pis
proposed related to the following five aspects: (1) premises and equipment, (2)
delegation and collaboration, (3) service and organization, (4) record keeping and (5)
organisation o f quality improvement programs. This framework was then used to
compare a sample of 88 practices in the Netherlands. From these results, it was
concluded that single-handed GP practices had less equipment and delegated fewer
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tasks to assistants, but scored better in terms of accessibility and availability of care. 
Furthermore, in agreement with the results obtained by Baker (1992), it was found that 
training practices scored higher in terms of equipment availability, task delegation and 
organization of preventive services.
These frameworks are deficient however, as although they can be used to compare 
primary care providers and to point towards areas that can be improved, it is also 
desirable to include information regarding outcomes achievement, in order to provide an 
indication regarding the success in making an impact in the health of the patients -  the 
ultimate aim of primary care. The importance of measuring outcomes in health care 
relates with the fact that patients demand health, not health care. It is the expected 
benefit from diagnosis and treatment that justifies the action of going to the doctor.
Smith (1996) and Williams (1996) also emphasise the importance of measuring 
outcome in the public sector. They argue that, whilst for a private good, the consumer’s 
willingness to pay for a good offers an indication o f its value and impact on society, in 
the public sector the absence of a market means that there is a need to measure the 
impact o f the services delivered. Smith (1996) suggests that, in the public sector, 
outcome measurement has both a retrospective and a prospective role. “In its 
retrospective role, outcome measurement can be used to determine whether the expected 
benefits o f a public sector programme have materialized. ... In its prospective role, 
outcome measurement is used to guide public sector resource allocation decisions” 
(Smith 1996:4, 5).
McColl et al. (1998) proposed an evidence-based approach to monitor the
performance of primary care providers, which includes measures of outcome. The use
of evidence based Pis is defended in order to guarantee that for each indicator there is
clinical evidence that an improvement in the value of the PI means an improvement in
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the health of the patient. A list of evidence based Pis was suggested for specific clinical 
interventions in primary care. For example, for the treatment of hypertension, 7 Pis are 
suggested, such as: proportion of population whose blood pressure (BP) has been 
recorded in the past five years and proportion of population with a BP recording under 
the desirable threshold. This approach to performance evaluation could be taken as one 
component of the internal performance assessment framework in primary care. 
However, as recognised by McColl et al. (1998), primary care delivery is not solely 
about applying the guidelines from clinical research. There are other important 
dimensions o f performance, which would not be adequately monitored using this type 
o f Pis, such as patient satisfaction and efficiency. Broader frameworks have also been 
proposed and we shall now focus on them.
Campbell et al. (1998) have undertaken a national survey of Health Authorities 
(HAs) to identify Pis in use or in consideration for use in general practice. A total of 
240 indicators were identified in terms of access, organizational performance, 
preventive care, chronic disease management, prescribing and gatekeeping. The validity 
o f these indicators was then investigated by consulting a sample of HA managers, 
general practice course organizers and GPs. This type of approach aims to establish the 
face validity of indicators, that is, the extent to which the professionals being evaluated 
can agree on the appropriateness of the indicators. Indicators regarding access, 
organizational performance, preventive care and chronic disease management were 
shown to have high face validity, whilst indicators regarding prescribing and 
gatekeeping (appropriateness of referral decisions) were shown to have lower face 
validity. Campbell et al. (1998) emphasise the partiality of the Pis identified, given that 
no indicators had been proposed to measure effectiveness of communication, care of
acute illness, health outcomes and patients’ evaluation. The importance of
30
distinguishing between indicators designed to measure the achievement of minimum 
standards and indicators designed to reward higher levels of performance was also 
highlighted.
Proctor and Campbell (1999) were also concerned with the face validity of Pis in 
general practice. They used semi-structured interviews with GPs, nurses and practice 
managers in England in order to develop a framework for performance assessment in 
general practice. Seven priority areas were identified: patient satisfaction; clinical 
activity; service development and innovation; access; health promotion; cost 
effectiveness and outcomes. Proctor and Campbell (1999) point out the conflicts 
between the views of the different professionals regarding what is good primary care, 
suggesting that it might be difficult to develop a framework that pleases everyone.
Greenhalgh and Eversley (1999) review the literature on the definitions of quality in 
general practice and also suggest that “perspectives on quality can and do conflict 
across different professions” (Greenhalgh and Eversley (1999: 63). In this respect, they 
argue for a pluralistic framework for quality assessment in primary care. It is suggested 
that the specific Pis used for evaluation should be locally developed and should portray 
the views of the different interest groups in primary care provision. An example of a 
framework developed at the HA level in two London districts is presented. It includes 
Pis covering 15 areas of primary care provision, from screening to disease management 
and outcomes of care. Five performance bands are proposed for each type of indicator 
from Band A (unacceptable performance) to Band E (leading edge) and each 
organisation is then assessed on how it scores on each indicator.
The importance of including measures o f health outcomes in performance
assessment is also visible in the UK Government’s policy for the NHS. After
undertaking a consultation exercise, the National Health Service Executive published a
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Performance Assessment Framework (PAF) (1999), which includes 42 high level Pis to 
compare HAs, where 10 of the indicators relate to outcomes. Appendix A presents the 
list of high level Pis included in PAF. This framework includes six dimensions of 
performance:
(1) health improvement, aiming to reduce mortality rates and risk factors in the 
population;
(2) fair access, aiming to provide services in relation to need, irrespective of 
geography, socio-economic or demographic group;
(3) effective delivery of appropriate health care, aiming to improve clinical 
effectiveness and timeliness of services delivery;
(4) efficiency, aiming to reduce the costs per unit of care;
(5) patient/carer experience, aiming to improve patients’ satisfaction with the 
services delivered;
(6) health outcomes of the NHS care, aiming to reduce the levels of disease and 
complications and to improve the quality of life for patients.
Despite the fact that an effort was made to develop a broad framework, covering 
measures of structure, process and outcome, it is not clear how this framework can be 
used to improve performance, because the different Pis are analysed individually and 
this can lead to distorted analyses. For example, Giuffrida, Gravelle and Roland (2000) 
investigated the variability of one of the Pis used in PAF and warn against its isolated 
use to assess performance. They studied the variability on hospital admission rates at the 
level of Family Health Service Authorities (FHSAs) between 1989/90 and 1995/6 and 
found confounding problems due to the multiple inputs and multiple outputs nature of 
primary care delivery. In this respect, they point out the importance of taking into
account the level of resources used, the socio-economic environment and the level of
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alternative services delivered. Standardisation of the performance measures, cluster 
analysis, DEA and multiple regression analysis are proposed as alternative methods that 
can be used to perform a fairer comparison of primary care providers.
The limitations of Pis in performance assessment have also been pointed by 
Thanassoulis, Boussofiane and Dyson (1996). They have compared the use of Pis and 
DEA as alternative techniques to measure the performance of District Health 
Authorities in England. It was concluded that Pis are not suitable for setting 
performance targets for efficiency improvement, given that they only take into account 
part of the information. In contrast, DEA was found to be very useful for this purpose 
because it can take into account all the resources and all the outputs of production, as 
long as these inputs and outputs can be measured. The authors concluded by suggesting 
the combined use of these two tools: DEA should be used to measure efficiency and Pis 
can be used to better explain the DEA results.
The review of the different frameworks proposed has shown that considerable 
progress has been made in terms of the development o f comprehensive frameworks for 
performance assessment in primary care by using Pis related to different aspects of 
primary care delivery. However, a framework can better contribute to performance 
improvement if an attempt is made to establish a link between resources usage, services 
delivery and outcomes achievement.
The importance of undertaking such an evaluation should not disregard the 
difficulties involved in this task and the potential limitations of this type of evaluation. 
Firstly, there are considerable difficulties in measuring outcomes in primary care and 
secondly, using a production metaphor can be seen as a restrictive framework for 
performance assessment in primary care. In the next chapter we discuss these
difficulties in more detail.
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Multiple regression analysis, and frontier based analysis can be used to link 
resources, outputs and outcomes. The relative efficiency of providers can be calculated 
by comparing the level of resource usage with the level o f services delivered, and the 
relative effectiveness of the providers can be calculated by comparing the level of 
services delivered with the level of outcomes achieved (Gardner 1998). Most empirical 
studies have compared primary care providers in terms of efficiency but have failed to 
include measures of outcome achievement. We will now review these studies.
3.4 Beyond Pis -  Using Regression and Frontier Based Analysis to Compare 
Primary Care Providers
We can classify the methods that can be used to measure efficiency into stochastic and 
deterministic, and into parametric and non-parametric. Firstly, stochastic methods 
include an error term, whilst deterministic methods assume that all the deviations from 
the model estimate are due to inefficiency. In this respect, DEA is a deterministic 
method. With regards to the second type of classification, DEA is a non-parametric 
method, because it does not impose a functional form on the production transformation 
of inputs to outputs. On the contrary, parametric techniques require the specification of 
a functional form for the production function. In terms of parametric techniques, there 
are two types of parametric approaches to compare the efficiency of providers: frontier 
based approaches, also known as Stochastic Frontiers Analysis (SFA) and regression 
based approaches. Frontier based approaches aim to estimate the maximum amount of 
outputs that should be produced from the inputs, whilst regression-based approaches 
estimate the average amount of outputs that can be produced from the inputs.
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3.4.1 The Parametric Approach -  the Use of SFA and Regression
Defelice and Bradford (1997) applied SFA to study the issue of differential efficiency 
between solo and group physician practices. They applied SFA to data from 924 
primary care physicians in solo and group practices working for several Health 
Maintenance Organisations (HMOs) in the USA between 1984 and 1985. The 
dependent variable used was the logarithm of the number of physician visits per week. 
This variable was regressed on a large number of explanatory variables accounting for 
physical inputs and for physician effort. A dummy variable was included to distinguish 
between physicians working on solo and physicians working on group practices. From 
the results of a non-linear model, the authors concluded: “it seems that group practice is 
not, ceteris paribus, a mechanism which fosters efficiency in the production of office 
visits” (Defelice and Bradford 1997: 462).
Giuffrida, Gravelle and Sutton (2000) used regression to estimate a cost function for 
primary care administration using panel data for Family Health Service Authorities 
(FHSAs) in England. The variables used to explain the administrative costs of the 
FHSAs were the number of general practitioners, practice nurses, ophthalmic medical 
practitioners, dentists and community pharmacies working for each FHSA. Information 
regarding the number of GPs reaching the 90% target for cervical cytology screening 
was used as a quality proxy, and the standardized mortality rate was used to control for 
population characteristics. The cost function estimates were then used to compare the 
relative efficiencies of the FHSAs and it was observed that there was little difference in 
the estimated efficiency scores for the different FHSAs. Furthermore, caution regarding 
the use of cost estimates to label certain FHSAs as inefficient was emphasized given the 
potential endogeneity of some of the explanatory variables. In this respect, the authors
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called for careful specification of the decision-making process that generates health care 
costs.
Bryce, Engberg and Wholey (2000) examined the efficiency of 585 HMOs using 
three alternative techniques: DEA, SFA and fixed effects regression. The results 
suggested that the techniques provide similar results in terms of the general trend of 
efficiency evolution for the industry. However, there were differences regarding the 
individual estimates of performance, and regarding which DMUs were rated as efficient 
by each method.
Giuffrida and Gravelle (2001) also compared DEA and SFA estimates of efficiency 
in primary care. They were interested in investigating the robustness of the efficiency 
results between alternative models and methods. From the results, the authors concluded 
“DEA average efficiencies are similar to those from the regression based methods” 
(Giuffrida and Gravelle 2001: 170). As for the robustness of the results for individual 
DMUs, the authors concluded that under alternative models, DEA results appear to be 
robust. The same applied to alternative econometric models. However, correlations 
between regression and DEA individual efficiencies were low, suggesting that the 
“choice between DEA and regression does make a considerable difference to the 
rankings” (Giuffrida and Gravelle 2001: 171).
It can be argued that SFA has a fundamental advantage over DEA; it includes a noise 
term, accounting for measurement errors and other non-systematic disturbances in the 
data. In standard DEA no allowance is made to this possibility; the deviation from the 
frontier is taken to be totally due to inefficiency2. Another advantage of SFA is that the
2 Some authors have proposed stochastic versions of DEA. Sengupta (1996) provides a method to 
estimate the efficiency distribution approach in DEA, allowing for the inclusion of a noise term.
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problem of variable selection can be addressed by running statistical tests of 
significance. However, SFA’s advantages come at a price; the potential for specification 
bias, given that a parametric form for the production function has to be chosen. In 
contexts such as public service delivery where the transformation function is difficult to 
specify, it is argued that the non-parametric approach is more appropriate (Chames, 
Copper and Rhodes 1978). We will now review the studies that have used DEA to 
compare primary care providers.
3.4.2 DEA Applied to Primary Health Care
The number of applications o f DEA to primary health care is limited (Hollingsworth, 
Dawson and Maniadakis 1999). A substantial part of these studies have used DEA to 
compare primary health care providers in the UK (Szczepura, et al. 1993, Thanassoulis, 
Boussofiane and Dyson 1995, Bates, Baines and Whynes 1996, Salinas-Jimenez and 
Smith 1996, Giuffrida 1999, Buck 2000 and Giuffrida and Gravelle 2001). Pina and 
Torres (1992), Goni (1999) and Garcia et al. (1999) compared the efficiency of Spanish 
primary care centres. Luoma et al. (1996) used DEA to compare the efficiency of Finish 
health centres, and Zavras et al. (2002) have used DEA to compare Greek primary care 
centres. In America, DEA has been used to compare primary care clinics (Huang and 
McLaughlin 1989) and to compare mental health care programs (Schinnar et al. 1990). 
DEA has also been applied to HMOs (Rosenman, Siddarthan and Ahem 1997,
Following a different approach, Olesen and Petersen (1995) use chance constrained efficiency (CCE) 
evaluation to allow for the inclusion of endogenous perturbations in the input-output set. Efficiency 
scores are calculated allowing for all perturbations within a specified confidence region. CCE evaluation 
requires panel data to calculate the confidence regions.
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Siddarthan, Ahem and Rosenman 2000), and individual physicians (Chilingerian and 
Sherman 1996, 1997, Ozcan 1998, Wagner, Shimshak and Novak 2003).
A large number of applications of DEA have focused on the measurement of 
efficiency of hospitals. Examples include Nunamaker (1983), Grosskopf and Valdmanis 
(1987), Rosko (1990), Ozcan (1992), Byrnes and Valdmanis (1994), Parkin and 
Hollingsworth (1997), Mobley and Magnussen (1998), Sola and Prior (2001) and Tsai 
and Molinero (2002). A full review of these studies is outside the scope of this thesis, as 
our focus is on primary care evaluation.
Table 3.1 (at the end of this chapter) presents a summary of the studies that have 
used DEA to compare the efficiency of primary health care providers and we will now 
review some of these studies in more detail.
Given the wide range of services delivered by primary care providers, the 
identification of outputs of primary care is a great challenge. A common feature in most 
o f the studies reviewed here is that the number of patients registered is used to measure 
output. The use of the number of patients registered is particularly common in America, 
due to the publication of this data by HMOs. For example, Ozcan (1998) used the 
number of patients registered as outputs, separated by severity categories: low severity, 
medium severity and high severity. Chilingerian and Sherman (1996 and 1997) also 
used the number of patients registered with each physician, in this case separated into 
sex and age groups.
There are two problems associated with using the number of registered patients to 
compare the performance of primary health care providers. Firstly, it assumes that all 
the patients registered with a particular health care organisation are receiving the 
necessary services. Secondly, it assumes that the services provided to the patients
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registered are appropriate and of similar quality. These problems have been addressed 
by some of the studies and we shall focus on them.
Recognising that having patients on the lists does not necessarily mean service 
delivery, we find some studies that have used the number o f consultations undertaken as 
an output measure in primary health care. Huang and McLaughlin (1989) used the 
number of consultations by physicians, nurses and non-health care professionals. Pina 
and Torres (1992) used output measures related to the average number of consultations 
per inhabitant and the average number of consultations by professional. Similarly, 
Luoma et al. (1996) included several output measures related to the number of patient 
visits to physicians.
Using the Whole Time Equivalent (WTE) health care professionals as inputs and 
using the number of consultations as outputs will lead to a system that rewards shorter 
consultations. For this reason, Goni (1999) has used output measures related to the 
number of consultations and also related to the time devoted to the consultations. 
However, despite the fact that a consultation is an opportunity for contact with the 
health care professional, frequent consultations, per se, do not mean better primary 
health care. It is desirable to include measures of output that aim to capture the 
appropriateness of the consultations in terms of the delivery of the services deemed 
necessary to improve health outcomes. We will now review some studies that have 
attempted to include data regarding the appropriateness of service delivery.
Szczepura et al. (1993) studied the efficiency and effectiveness of General Practices 
in the region of Warwickshire in England. Unfortunately, unavailability of adequate 
data prevented the authors from building a more comprehensive model. The outputs 
used to measure efficiency refer solely to preventive care. For example, output measures
included the number o f immunizations and the number o f cervical cytology claims.
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Similarly, effectiveness was defined as the achievement of Government targets for 
cytology and child immunization. When we consider that preventive care represents 
only part of the functions of primary care, the study is potentially biased and there is a 
need to include measures of service delivery and outcomes achievement in terms of the 
other functions of primary care.
Szczepura et al. (1993) concluded that the efficiency ratings did not appear to vary 
according to practice size for surgeries with a single location. However, for surgeries 
with multiple locations, larger surgeries were found to be on average more efficient. It 
also did not appear that efficiency related significantly to the practices’ characteristics. 
As for the relationship with effectiveness, the study showed the difficulty of some 
efficient practices in achieving the effectiveness target levels without further resources.
Schinnar et al. (1990) have also investigated the relationship between the efficiency 
and effectiveness in their comparison of 54 mental health care programs in the USA. 
They concluded that for lower than average levels of efficiency, there is a positive 
correlation between efficiency and effectiveness. However, for higher than average 
levels of efficiency, they were unable to find a clear relationship. Moreover, it was 
suggested that at an average level of efficiency, programs may be able to achieve the 
highest levels of effectiveness.
Thanassoulis, Boussofiane and Dyson (1995) used data on the provision of perinatal
care in England to build three alternative DEA models for target setting. The main
objective of the study was the proposal of several technical enhancements in the DEA
model formulation. In particular, the authors were concerned with the inclusion of
output quality information in the models. Measures of activity performed were included
as the main outputs. In addition, they proposed the inclusion of satisfaction measures in
order to reflect the quality of the services delivered. Furthermore, an attempt was made
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to include data regarding the quality of the outcomes. They included the number of 
babies at risk as an input and then included the number o f survivals from babies at risk 
as an outcome. Weight restrictions were used to link the weights of these two variables.
Another extension proposed in Thanassoulis, Boussofiane and Dyson (1995) was a 
model based on the specification of ideal input-output levels, from the decision-makers 
point of view. This model aimed at determining targets as close as possible to these 
levels, allowing the decision-maker to set its own priorities regarding performance 
improvements. The study’s emphasis was on enhancing the DEA models towards the 
achievement of more useful results for management.
Chilingerian and Sherman (1996, 1997) were also concerned with incorporating 
managerial preferences for target setting with DEA. They used a Cone Ratio DEA 
model to incorporate this information. Both of the studies focus on the same aspect: the 
evaluation of practice patterns of individual physicians, in order to achieve resource 
savings. Preferred practice patterns are identified using a two-stage DEA model. In the 
first stage, a standard DEA model without weight restrictions is run to identify the best 
practice frontier and the optimal weight bounds. In the second stage, these weight 
bounds are imposed in the form of assurance regions, and the DEA model is re-run to 
determine the restricted best practice group of physicians. The model also provides 
targets for performance improvement according to the chosen practice pattern. 
However, it was suggested that more research is needed to improve the measures of 
service quality, before we can be confident that these results genuinely represent 
resource saving potential.
Salinas-Jimen6z and Smith (1996) were also concerned with the need to include
quality indicators in the measurement of efficiency. In this study, data from 90 District
Health Authorities in England is used to compare their relative efficiency. Due to non-
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availability of outcomes data, the DEA model constructed uses structure and process 
indicators as proxies for the quality of the service, such as the proportion of practices 
employing a practice nurse and the proportion of practice premises that satisfied the 
minimum quality standards. The argument behind this approach is that having a good 
structure of care and following sound processes of care increases the probability of 
producing good outcomes. More recently, Davies and Crombie (1997); Crombie and 
Davies (1998) have also defended the use of process measures in the measurement of 
performance. Salinas-Jimenez and Smith (1996) recognized the potential of DEA as a 
benchmarking technique in primary care, whilst emphasizing the need to include more 
reliable measures regarding the quality of services delivery in this context.
García et al. (1999) made another attempt to include information about the quality of 
primary care services in a DEA study. They studied the efficiency of 54 Primary Health 
Centres in the province of Zaragoza, Spain. Using the results from a previous study 
analyzing the opinion of primary health care managers in Spain (Urbina et al. 1997), 
some distinctive output variables were identified. From a managerial perspective, two of 
the most important output variables were found to be: (1) ‘The Synthetic Index 
Product’, which provides “information about the coverage of the different services and 
the special effort (burden) that the services imply” (García et al. 1999: 71); and (2) ‘The 
Minimal Technical Standard’, which measures the compliance with the minimum 
standards of quality in the delivery of preventive and curative services. These two 
variables were used in this study, respectively, as a measure of the access to services 
according to need, and the quality of services delivered. Despite the progress made in 
the output variables used, the authors still pointed to the need to improve the definition 
of quality and case-mix in primary care in order to undertake a more comprehensive 
evaluation of providers.
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García et al. (1999) also wanted to analyze the sensitivity of the results to different 
sets of outputs. The results suggested a significant amount of sensitivity to model 
specification, pointing towards the importance of model validation. This is particularly 
important because performance assessment in primary care is necessarily partial, as we 
cannot measure all the essential quality aspects.
Our review of the literature so far points towards the fact that most DEA studies 
applied to primary care have failed to include measures of outcome achievement, when 
this measure is an important part of the evaluation in primary care. Having reviewed the 
studies that have used DEA to compare primary care providers, we will now discuss 
some of the unintended consequences that can result from performance assessment.
3.5 Moving Towards Formative Evaluation
Smith (1995) pointed out that performance assessment in the public sector can lead to 
dysfunctional behaviour. He identified five potential unintended consequences that can 
result from the publication of performance measures:
(1) tunnel vision, which relates to the focus on the areas being measured at expense 
of other important aspects;
(2) sub-optimisation, which can occur when managers focus on narrow local 
objectives, and ignore the broader organizational objectives;
(3) myopia, when a focus on short-term measures takes prevalence over long-term 
issues;
(4) misrepresentation, which relates to the potential for altering the data in order to 
show better performance results;
(5) gaming, which relates to the potential for altering the behavior in a dysfunctional 
way, in order to achieve better performance results.
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Casalino (1999) also emphasized the potential for dysfunctional responsive 
behaviour to performance assessment in health care. Taking account of these potential 
problems, Smith (1995) and Goddard, Mannion and Smith (2000) outlined a number of 
strategies that can help addressing these potential problems. One of the strategies 
suggested relates to the need to involve staff at all levels when developing a 
performance assessment framework, and the need to move beyond the use of 
performance measures for control. This relates to an important aspect regarding 
performance assessment; the perceived purpose of the assessment exercise and the way 
the results are interpreted. Dyson (2000) points out situations in which the use of league 
tables and rankings can misrepresent and exacerbate the situation under evaluation and 
suggests the use of DEA as an exploratory tool to promote learning.
In this respect, it is our conviction that performance assessment in primary care can 
be most useful if the perceived purpose is one of learning and improvement, and as long 
as the results are interpreted very cautiously, in a formative rather than judgemental 
way. We feel that the theory behind program evaluation, with its emphasis on providing 
useful information regarding ways to improve programmes and interventions, can offer 
some useful guidelines in performance assessment.
Patton (1986: 14) defines program evaluation as “the systematic collection of 
information about the activities, characteristics, and the outcomes of programs for use 
by specific people to reduce uncertainties, improve effectiveness, and make decisions 
with regard to what those programs are doing and affecting”. Despite the apparent 
similarities between performance assessment and program evaluation, these two 
research areas have been concerned with different questions, and have tended to use 
different methods.
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Scriven (1967) distinguishes between two types of evaluation, depending on its 
objectives and on the types of methods used, summative evaluation and formative 
evaluation. Summative evaluation involves the collection and analysis of data with the 
aim of determining whether a program should be continued or stopped and whether an 
organisation is performing better or worse than another. Its aim is solely descriptive and 
classificatory. In contrast, formative evaluation involves the collection and analysis of 
data with the aim of developing and improving the program or the organisations. 
Formative evaluation studies are characterized by an effort to involve the stakeholders 
and to provide useful feedback to the decision-makers and policy makers in terms of 
organizational improvement and knowledge development. The ultimate aim of a 
formative evaluation study is the promotion of learning.
The integration between program evaluation and performance assessment literatures 
and methods can be very valuable, given that each one of these traditions has been 
concerned with different aspects. While quantitative performance assessment studies 
have been mostly concerned with the comparison of large numbers of organisations 
aiming at description and classification, evaluation studies have been mostly concerned 
with the in-depth analysis of programs and their success or failure in different contexts.
Blalock (1999) also calls for the integration between these two research areas: “used 
as complementary tools, the two movements can offer more valid and reliable 
information to decision makers, and can more accurately guide improvements in 
programs” (Blalock 1999: 142). It is this type of integration that we aim to achieve in 
this thesis. In order to obtain results that can be used in practice, we have developed the 
framework for performance assessment with a sample of PCG/Ts, as well as validated 
and discussed the results with these PCG/Ts and the participating GP surgeries.
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3.6 Conclusion
In this chapter we have discussed the nature of primary care and then reviewed the 
literature on the evaluation of primary care providers. The use of Pis is discussed and it 
is concluded that they are inadequate in themselves, as they typically do not link 
resources to outputs and outcomes. We also reviewed the use of parametric methods to 
compare primary care providers. The fact that these methods require the introduction of 
assumptions regarding the functional form of the transformation function was pointed 
out as a drawback, because in primary care the technology involved in transforming 
inputs into outputs is not well understood.
DEA is then introduced as a performance evaluation methodology that can include 
and link multiple inputs and outputs and therefore in principle encompass structure, 
outputs and outcomes. DEA studies of primary care are then reviewed and the various 
approaches to defining the inputs and outputs required for a DEA evaluation considered. 
It is shown that most of the previous studies have focused on structure and outputs, but 
have not included outcomes. It is argued however that evaluation in general practice 
does need to be holistic in the sense that it is the general service as a whole that should 
be evaluated rather than the individual aspects and in principle DEA can provide such a 
methodology.
Evaluation in public services tends to be of a summative nature involving rankings, 
classifications and targets often set arbitrarily and in isolation from the overall 
performance. This approach can be dysfunctional and it is argued that for service 
improvement a formative approach, engaging the decision-makers is appropriate. It is 
thus argued that for DEA to be useful in performance improvement in primary care it 
needs to be deployed in the formative mode.
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In summary it is argued that evaluation and performance improvement in primary 
care needs to be inclusive of structure, process, outputs and outcomes; that evaluation in 
primary care must be holistic in recognition that it is a general health care service; that 
evaluation must be formative, engaging stakeholders, if  it is to lead to performance 
improvement; and in principle DEA provides the basis of an appropriate methodology. 
In the following chapter a model is developed for holistic, inclusive and formative 
evaluation of primary care.
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4 T ow ards a C om prehensive Fram ew ork for a Form ative
E valuation in Prim ary Care
4.1 Introduction
In this chapter we discuss the development of a conceptual framework for formative 
evaluation of primary care providers. This framework was developed during a series of 
workshops with Board members of two PCGs and two PCTs in England. This 
conceptual framework is to be used at the level o f GP surgeries and aims to establish a 
link between local needs, resources usage, service delivery and outcomes achieved in 
primary care.
The issues and difficulties involved in developing a comprehensive framework for 
primary care are discussed with particular emphasis on the difficulties associated with 
measuring the outcomes of primary care. The eventual decision to focus on a speciality 
rather than evaluate primary care as a whole is discussed, together with the limitations 
of this approach.
4.2 The Participating PCG/Ts
Our main research objective is to undertake a formative evaluation in primary care and, 
for this reason; we believe it was essential to involve the decision-makers from the very 
beginning. In this respect, we decided to approach a number of PCG/Ts to assess their 
interest in taking part in this research project.
In May 2000, we wrote to the Chief Executives (CEs) of 16 PCG/Ts in 
Warwickshire, Herefordshire, Bedfordshire, Cambridgeshire and Suffolk. The initial
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correspondence provided a summary of the research objectives and suggested a meeting 
between myself and the CE of each PCG/T in order to discuss their interest in taking 
part in the research project. Rugby PCG, Bedford PCT, West-Suffolk Borders PCG, 
Hereford PCT, Luton PCG and South Peterborough PCT expressed an interest and 
separate meetings with the CE of each of these PCG/Ts took place to assess their 
availability to take part in this research project. After two meetings with the CEs of 
Luton PCG and Hereford PCT, they decided not to take part in the project due to time 
constraints regarding participation in the workshops.
The second stage of the research involved two rounds of workshops with a group of 
6-8 members of each PCG/T Board. All the members from the Board of each PCG/T 
were invited to take part in the workshops, but due to timetable restrictions, it was only 
possible to meet with some o f the Boards’ members. The composition of the groups 
who took part in the workshops was as follows: two to four GPs, one nurse, one Lay 
member, the Director of finance and performance and the Board’s CE. These workshops 
took place during the year o f 2001 and lasted approximately ninety minutes each. 
During the first round of workshops, we discussed the research objectives, the 
methodology to be used and the concepts related to performance assessment in primary 
care.
Using the ideas generated in the first round of workshops, a simple conceptual 
framework was developed. This framework was the basis for the discussions, which 
took place during the second round of workshops. The final conceptual framework 
developed resulted from an attempt to include all the issues highlighted during the 
workshops.
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4.3 The Level of Analysis
The identification of the appropriate level of analysis is a crucial part of any 
performance assessment exercise. With the present accountability structure in the NHS, 
two meaningful levels of analysis were identified. The highest level is the PCT. At the 
PCT level strategic decisions are taken and the resources are allocated into their several 
components. A comparison of several PCTs could provide useful information regarding 
fair access to services, efficiency and effectiveness o f different strategies. Below the 
PCT level, there are the GP surgeries, which deliver the services to the patients and 
make operational decisions regarding day-to-day resource allocation. A comparison of 
several GP surgeries should lead to an important contribution towards gaining an insight 
of why there are differences in performance at the PCT level. Furthermore, a 
comparison of the GP surgeries within a PCT can provide useful information regarding 
fairness of access to services, efficiency and effectiveness, and coordination of different 
structures and practices. Performance assessment at this level can have an important 
role by supporting a process of accountability from the surgeries to the PCT.
The initial research objective was to compare all PCG/Ts in England and then focus
on the performance of the four participating PCG/Ts and compare all their GP surgeries.
In early 2000, contacts were established with the National Primary Care Research and
Development Centre in Manchester. This group has been developing a national database
for PCG/Ts, which aims to provide linked information on population characteristics,
primary care provision and health status for all PCG/Ts in England. Despite initial
promises regarding availability of data for resources usage, services delivered and
outcomes, by September 2000, we were told that there was a significant delay in the
development of the database and that only data in terms of resources usage would be
available in the near future. As a result, the focus o f this study became the comparison
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of GP surgeries in terms of their service delivery. Below we present the conceptual 
framework that was developed to compare GP surgeries in England and discuss the 
methodology used for its measurement.
4.4 Developing a Conceptual Framework for Performance Assessment in Primary 
Care
Wholey (1996: 146) states that performance “is not an objective reality out there 
waiting to be measured and evaluated”. But more intrinsically, performance is socially 
constructed and means different things to different people. Whilst the Treasury may be 
concerned with budgets and financial performance; the PCT may be concerned with an 
efficient and equitable use of resources; the health care professionals may be concerned 
with meeting the individual needs of the patients, and the patients themselves may be 
concerned with the quality o f the services they get. In this respect, whilst assessing 
performance appears to be associated with sorting out the good from the bad (Pollitt 
1986), what is good from one point of view may actually be bad from another. For 
example, whilst health care professionals and patients see the amount of time spent with 
a group of patients as something that should be maximized, the PCT may see this as a 
resource that should be minimized, because it represents an opportunity cost in terms of 
the delivery of services to other patients. In this respect, in order to measure 
performance, we first need to make explicit from which perspective it will be measured.
In terms of public services provision, performance assessment is legitimate from the 
perspectives of the several stakeholders of the services. Stakeholders are the groups of 
people who have a legitimate interest in the services (Smith 1996). Williams (1996) 
identified a long list of potential stakeholders for the NHS, such as the patients and their
representatives, the taxpayers, the professionals working in the NHS, local government
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bodies and the Department of Health. Each one of these groups of people has its own set 
of objectives for the NHS and these should form the basis for the development of 
different performance assessment frameworks. Fitzgerald and Storbeck (2002) point out 
the importance of addressing the question of whose interests are organisations 
answering to, and we see this as a very important part of any performance assessment 
exercise.
In this study, we are concerned with performance assessment from the perspective of 
the PCG/T responding to external forces, in particular, Government pressure to improve 
primary care delivery for the local population using the limited resources available. 
However, it is important to recognize that a PCG/T is a very complex organization in 
itself and different professionals within each PCG/T will hold different objectives in 
terms primary care delivery, dependent upon their roles within the organization. For 
example, some o f the GPs that belong to the PCT’s Board will have concerns for the 
efficient allocation o f resources, but also will have concerns for meeting the individual 
needs o f their patients. In this respect, within each PCG/T there are different and 
potentially conflicting values at the decision-making level concerning resource 
allocation and service delivery. We will now discuss the different values that form the 
basis of decision-making in public service delivery.
4.4.1 The Role of Value Heuristics in Decision-making and its Effect on 
Performance Assessment
Fisher (1998) identified six value heuristics used in decision-making in the public 
sector: (1) individual need; (2) deservingness; (3) fairness; (4) utility; (5) ecology; and
(6) personal gain and competence. Fisher (1998) discusses these value heuristics in
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terms of two dichotomies: Policy versus Principle and Objective versus Subjective. 
Figure 4.1 presents the value heuristics in a matrix using these two dichotomies.
Figure 4.1: The value heuristics of resource allocation (Fisher 1998: 137)
Personal gain and competence
Ecology refers to the need to accommodate the views of the most influential interest 
groups and lobbies. Deservingness refers to the allocation of resources and services 
according to people’s moral worthiness. According to this heuristic a patient who 
systematically fails to cooperate with the treatment is seen as less deserving than
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someone who is seen to cooperate and comply. These two heuristics reflect subjective 
ways of allocating resources.
From an objective standpoint, Fisher (1998) identified three heuristics that can be 
used in resource allocation and service delivery. Utility uses economic evaluations and 
cost-benefit analysis to determine the best way to allocate resources and services. 
According to this heuristic, the objective is to achieve the greatest good for all. Utility is 
concerned with the consequences of the actions and therefore, it is located in the upper 
side of the matrix. Fairness aims to treat everyone equally. According to this heuristic, 
drawing lots or a ‘first come, first serve basis’ are the best ways to allocate services. 
Fairness is concerned with the consequences of the actions, but it is also a question of 
principle. The heuristic of individual need is concerned with the satisfaction of the 
needs of each patient, independently of the consequences for others and independently 
of its cost-effectiveness.
Lastly, there is the heuristic of personal gain and competence, which cuts across each 
of the dichotomies. The application of this heuristic in service delivery means that the 
decisions are made in a way that benefits the decision-maker. The argument is that 
everyone uses this heuristic to a greater or lesser extent. People will try to make a 
decision using the appropriate methods because this leads to greater self-esteem and 
professional pride. People may also make the decision from which they expect to gain 
some personal advantage, such as keeping their job.
As Fisher (1998) points out, people do not just use one heuristic in order to make and
justify their decisions. He suggests that depending on their hierarchical position in the
organisation, people will use different heuristics. Furthermore, Fisher (1998) suggests
that under pressure, people tend to use a different set of heuristics. In this respect, he
argues that each professional faces a conflict between two main heuristics due to the
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contradictions associated with his or her role within the organisation. Figure 4.2 
presents Fisher’s model of the location of the value heuristics in public sector 
organisations. For example, doctors and nurses follow their training and tend to use the 
individual need heuristic. However, in a situation o f tight budgets, for example, they use 
the fairness heuristic as a way of allocating resources and delivering services.
Figure 4.2: The organisational location of the value heuristics in the public sector 
organisations (Fisher 1998: 145)
Utility
According to Fisher (1998), each professional will take a decision that fits  the 
purpose, whilst being compatible with his/her values and beliefs. When decisions are 
made using a heuristic process, resources are not allocated optimally. Instead, a process 
of argument tends to occur and the Final solution is an ill-defined compromise.
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Once we recognise that public service provision is informed by multiple, 
incommensurable and often conflicting values, we can no longer arrive at a single view 
of performance. The evaluation of a public organisation has to portray different views, 
based on the multiple values that underlie public service provision. We will now present 
the conceptual framework developed for formative evaluation in primary care and 
discuss the different criteria used for evaluation.
4.4.2 Towards a Simplified Framework for Formative Evaluation in Primary Care
Our purpose of undertaking a performance assessment in primary care is a formative 
one, from the perspective of a PCG/T. In order to identify the criteria for evaluation and 
to decide on how to measure each criterion, we used the workshops with the 
participating PCG/Ts to develop and validate a simplified representation of primary care 
delivery in England (Figure 4.3).
In the rectangular light grey boxes we have the elements that characterise primary 
care delivery, the elements that drive it and the impact of this activity on the 
population’s health. Graphically shown below these boxes are four criteria that can be 
used for performance assessment: (1) equity, (2) efficiency, (3) service effectiveness 
and (4) cost effectiveness. For example, efficiency is considered to be a measure of how 
well each provider is able to use its resources to deliver relevant services of high 
quality. An important aspect we would like to emphasize is that the measurement of the 
different dimensions of performance requires the use of different models. A single 
model would not be appropriate to measure all the dimensions as they relate to different 
parts of the process.
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The simple ‘one way’ causality assumed to exist between needs, resources, service 
delivery and outcomes achievement represents a strong abstraction from the complex 
problem that characterises health care delivery. In order to make an attempt to 
conceptualise some o f the complexities involved, we have added other elements to this 
simple representation.
In the rectangular dark grey boxes, we have factors that impact upon the 
performance of each surgery, but are not directly controllable by the surgery. For 
example, perceptions of local health and need will drive the demand for primary care 
services and surgeries have to respond to that demand by consulting the patients. The 
guidelines and targets imposed by the government will necessarily have an impact on 
the objectives and priorities followed by each surgery. The surgery’s past achievement 
in terms of performance can also be expected to influence the level of resources 
allocated to a particular type of service delivery, particularly if past performance results 
were the subject of political scrutiny (Smith 1992). Finally, the characteristics of the 
population covered by each surgery, patients’ propensity to consult and willingness to 
comply with treatment will also have a great influence on the level of resource usage, 
service delivery and outcomes achievement.
As previously discussed, it is important to recognise that decision-making and 
resource allocation is not only driven by utility considerations. In fact, a number of 
multiple and potentially conflicting values inform decision-making from individual 
need considerations to personal gain, habit and competence.
The elliptical boxes represent the organisations with which GP surgeries most 
directly engage, and which indirectly affect their performance. For example, the quality 
of the services provided by the local hospital can certainly be expected to impact on the 
level of resource usage, service delivery and outcomes achievement of the surgery.
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This type of representation is not intended to accurately describe primary care 
delivery and the decision-making process associated with it. Instead, this representation 
is only intended to be an auxiliary device to understand how the different values and 
factors can relate to each other in a single decision. This leads to the recognition of the 
limitations involved in using a simple production metaphor to compare primary care 
providers.
Despite being a simplification, by focusing on the complexities involved in primary 
care delivery, this representation makes clear that a strong abstraction process is 
required in order to measure performance using the production metaphor. Firstly, if 
decision-making results from the heuristic application of multiple and potentially 
conflicting values, is it valid to assume that a clearly defined homogeneous ‘decision 
making unit’ (or agent) exists? We need to recognize that this metaphor results from an 
abstraction from many other aspects. However, we also need to recognize that such an 
abstraction can be useful, as it can lead to the identification of large discrepancies in the 
use of resources and the delivery of services, leading to a process of inquiry.
Finally, it is essential to recognise that performance assessment in the public sector 
will always be incomplete. Stewart and Walsh (1994: 47, emphasis added) make this 
point quite clearly. “The reason why adequate performance measures cannot be found in 
the public domain is, therefore, not a matter of technical problems alone, it is inherent in 
its character. It means that no set of indicators can ever be assumed to be complete, 
since in the public domain no relevant issues can be excluded”. In this respect, it is 
essential to recognise the limitations of any performance assessment framework in the 
public sector and proceed with great caution in terms of its use.
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4.4.3 Performance Assessment Criteria
During the workshops, four essential criteria were identified for performance 
assessment: (1) efficiency, (2) service effectiveness, (3) cost effectiveness and (4) 
equity. Below we discuss each one of these criteria and the methodology proposed to 
measure them.
4.4.3.1 The Measurement of Efficiency
One of the objectives of performance assessment in the public sector is to answer the 
question about whether an organisation is achieving ‘value for money’ (The Audit 
Commission 2000a). This is, first of all, a managerial concern regarding the optimal use 
of public resources. In this respect, performance assessment is often associated with the 
measurement of efficiency.
The measurement of efficiency relies on the production metaphor. A set of inputs is 
used to produce a set of outputs. Inputs are the resources that are used to produce goods 
or deliver services. These may be materials or labour (human energy). Outputs are the 
goods produced or the services delivered. In primary health care, we are interested in 
services delivery. Services can be characterized as an action or set of actions that are 
desirable because of their effects (the outcomes). In particular, in health care, services 
delivery is desirable because it aims to help in maintaining or improving patients’ health 
or patients’ perceptions of it. In primary health care, this may be done by performing a 
diagnosis of patients’ health status, by prescribing appropriate medication or treatment, 
or simply by providing advice or comfort to the patients.
There are two types of efficiency: (1) technical efficiency and (2) allocative 
efficiency. Technical efficiency assesses the relationships between the outputs produced 
and the resources used. It aims to maximize the amount of outputs produced from a
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certain level of resources usage (output orientation). Alternatively, it involves the 
minimization of resource usage in order to produce a certain level of outputs (input 
orientation). In order to perform a fair assessment of efficiency both the resources used 
and the outputs produced are assumed to be of similar quality.
Allocative efficiency relates to an assessment of the optimality of the mix of 
resources used given their current prices and the optimality of the outputs produced 
given the relative valuations placed on them. A provider may be technically efficient, 
but allocativelly inefficient. If the perfect set of values could be identified for the 
resources and the outputs, a measure of overall efficiency could be obtained.
In the public sector, we are usually faced with situations where we do not have good 
measures for the prices of the resources or for the valuations of the outputs. Therefore, 
the use of a technique like DEA is advantageous, because it allows each provider to 
choose the best set of weights for its inputs and outputs. In this respect, and in the 
absence of any information regarding the trade-offs between the different inputs and 
outputs, DEA legitimizes all possible trade-offs and provides a conservative measure of 
technical efficiency.
Therefore, we express the measurement of technical efficiency using the following 
formula:
Technical Efficiency = Weighted Sum o f Outputs 
Weighted Sum o f  Inputs
This is a relative measure and for our study, it results from a comparison of several 
different providers.
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4.4.3.2 Service Effectiveness and Cost Effectiveness
Carter, Klein and Day (1992) discuss the ambiguity and confusion associated with the 
concept of effectiveness. An effective organisation can be defined as an organisation 
that achieves its objectives. Schinnar et al. (1990) proposed an alternative definition of 
effectiveness that we find very useful. They defined effectiveness as the ratio of 
outcomes achieved to services delivered and proposed the use of DEA to compare the 
effectiveness of different organisations. This is done by using an output-oriented DEA 
model, which aims to maximise the level of outcomes achieved, given the amount of 
services delivered; and aims to evaluate the ‘added value’ of the services delivered, 
independently of the resources used. Lovell, Walters and Wood (1994) have used DEA 
to measure service effectiveness in the education sector. Porto (2000) used this 
approach to compare the service effectiveness of substance abuse programs.
In this study, we use the definition proposed by Schinnar et al. (1990) to measure 
service effectiveness. Furthermore, we have extended this approach to measure cost 
effectiveness. This can be done by solving a DEA model that aims to minimise the total 
cost of production (or the level of resources used), whilst maintaining the amount of 
outcomes achieved. Alternatively, a comparison can be established by aiming to 
maximise the outcomes from a given level of resource usage. Below we present the 
formulas proposed to calculate service effectiveness and cost effectiveness:
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_ _ Weighted Sum o f  OutcomesService Effectiveness = ------------------- ---------------
Weighted Sum o f Outputs
_ . Weighted Sum o f  OutcomesCost Effectiveness = ------------------- ---------------
Weighted Sum o f  Inputs
The formulation presented for the measurement o f service effectiveness highlights 
the potential trade-offs between efficiency and service effectiveness given that in terms 
of efficiency measurement; the outputs appear in the numerator whilst in the 
measurement of service effectiveness, they appear in the denominator. The need to 
make this trade-off explicit was emphasised during the workshops. It was believed that 
one o f the ways to improve service effectiveness was by focusing on the delivery of 
services towards a restricted number of more cooperative patients.
Despite the importance o f ‘Value for Money’ assessments, this type of assessment is 
only concerned with the value of utility. Concerns for individual need and fairness are 
also legitimate and performance assessment cannot ignore these values. As pointed by 
Ozcan and Smith (1999: 1), “it may be the case that perfectly efficient managerial 
solutions may be unacceptable to patients, and can be implemented only if they also 
satisfy additional criteria relating to fairness”. We now discuss the criteria o f equity in 
terms of performance assessment and three alternative approaches for its measurement.
4.4.3.3 Equity Between Groups of Patients
Equity is concerned with justice and fairness in the treatment o f cases. With regards to 
health care provision, equity is concerned with justice in the treatment o f different
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patients and particularly in the treatment of different groups of patients. An equitable 
health care system provides services of the same standard independently of, for 
example, patients’ income group, age, sex and area of residence.
Aristotle provided two essential definitions of equity. (1) Horizontal equity: equal 
treatment of equals; and (2) vertical equity: unequal but fair treatment of unequals. Each 
one of these definitions can be operationalised in a number of ways, and it is within this 
process that one finds divergences. For example, how do we assess ‘equalness’? The 
most basic criterion is one of being human, and in that respect one can say that there 
should be equal treatment of human beings (Culyer and Wagstaff 1992). This criterion 
is behind the health care budget allocation of some countries, where the formulas for 
distribution aim at equal expenditure per capita. This approach fails to recognise an 
important aspect, that of need. Human beings can have different levels of health care 
need, and equality of treatment only becomes meaningful if there is need for that 
treatment. Therefore, horizontal equity can be re-defined as ‘equal treatment for equal 
need’. Identically, vertical equity would be re-defined as ‘more favourable treatment of 
those with higher need’.
Given the difficulties associated with the assessment of vertical equity, in this thesis 
we have concentrated on assessing horizontal equity only. We will now clarify what we 
mean by equal need and equal treatment.
4.4.3.3.1 The Concept of Need
Need for health care is an ambiguous concept, and we can find different definitions in
the literature, as well as different approaches to its assessment. One definition that has
been used in several recent studies (Smaje and Le Grand 1997, Waters 2000, Urbanos-
Garrido 2001) equates need with patient self-reported illness. For example, Smaje and
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Le Grand (1997: 488), define need for health care as “the presence of long-term illness 
which limits activities and/ or an illness experienced within the previous two weeks”.
We believe that using a single indicator of need derived from patient reported illness 
has some limitations. Firstly, there are different levels of need, given that the health care 
needs of a patient reporting being ill in the previous week (for example having flu) 
cannot be compared with the health care needs of a patient who reports suffering from a 
chronic illness. Secondly, different groups of patients may have different pre­
dispositions to recognize and report morbidity (Goddard and Smith 1998). Finally, and 
more fundamentally, equating self-reported illness with need for health care can be 
misleading for two reasons. (1) A patient might need health care without being ill, or 
perceiving to be ill. Preventive health care and disease screening are two examples. An 
undiagnosed person suffering from diabetes might feel perfectly fine at the moment, but 
is in fact in great need of health care. (2) A patient might be ill or perceive to be ill and 
not need health care, in the sense that currently available health care will not be of 
benefit to the patient.
Williams (1974) and Culyer (1976) proposed an early definition of need, which in 
our view, is preferable. This definition equates need for health care with the patient’s 
capacity to benefit from the consumption of health care. In this respect, if someone 
cannot benefit from health care, although ill, he/ she is not said to be in need of health 
care. More recently, Culyer and Wagstaff (1992) proposed a modification to this 
definition in order to quantify need. They define need as the minimum amount of 
expenditure required to eliminate patients’ capacity to benefit from health care. Despite 
the obvious advantages o f such a definition, we believe that its operationalisation can 
bring additional difficulties. The amount of resources needed to eliminate the patients’
capacity to benefit will depend on the efficiency of the health care system as well as on
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the effectiveness of the services provided. We have to assume that the term minimum 
amount of expenditure refers to the resources needed to deliver the necessary services, 
using efficient and effective systems. Given the difficulties involved in estimating this 
minimum amount of expenditure, we choose to work with the earlier definition where 
need is equated with capacity to benefit, although acknowledging that different patients 
can have different levels of need.
One question remains to be answered. How is the judgment about the capacity to 
benefit made? In practice, this judgment is made by health care professionals, patients 
and carers and it is the interplay of these judgments that drives health care delivery. In 
this study, we consider that a group of patients has health care need i f  it is clinically 
expected that their health status would improve (or deteriorate slower) due to receiving 
appropriate primary care. Having clarified what we mean by need for primary care, we 
now turn to the conceptualisation of equality of treatment.
4.4.3.3.2 The Concept of Equality of Treatment
Equality of treatment can be measured using three criteria (Culyer 1991):
(1) Service inputs - resources used in the provision of health care for population 
groups;
(2) Service outputs - services delivered to population groups;
(3) Service outcomes - the impact of the services delivered on population groups. 
Based on these three criteria to assess equality of treatment, we can operationalise three 
definitions of horizontal equity:
(1) Equal resources for equal need;
(2) Equal service provision for equal need;
(3) Equal health care outcomes for equal need.
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The first definition (inputs/need) is an important one, and tends to be the one that is 
most used. However, it can be misleading, if we do not adjust for the relative 
inefficiencies of the providers. For example, the fact that provider A has a higher ratio 
of expenditure for need than provider B, does not imply that the patients serviced by 
provider B are suffering from inequity of health care. In fact, they might receive a 
relatively higher level of services per need. This is because provider A might be 
inefficient when compared to provider B.
The second definition proposed (services/need) overcomes this problem, when we 
consider that it compares the amount of services provided with the needs of different 
population groups. At the most basic level, this definition is concerned with equality of 
access to services. However, given the difficulties in assessing equality of access, most 
studies have focused on equality of utilisation of health care. This poses some 
challenges because different people have different propensities to consult. Goddard and 
Smith (1998) state that it is important to distinguish between the inequity that is caused 
mostly by poorer supply of services to certain groups and the inequity that is explained 
mostly by different propensities to utilise services. These two types of inequity require 
very different types o f policy intervention.
Definition (2) does not consider how effective each service provider is. It might be
the case that provider A, although inefficient, delivers the right services to patients, in
such a way that the effect these services have on the patients is higher than the impact of
the services provided by B. If we are concerned with an equitable distribution of health
care outcomes, then we need a different definition. The last definition (outcomes/need)
is the most ambitious of all; it requires equal health outcomes across the different
groups of patients. Regardless of health care efficiency and effectiveness, this definition
requires that all groups have equal levels of health care outcomes for equal needs. In
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this respect, its achievement requires positive discrimination, towards those patients for 
which health services are less effective.
Despite the support shown by some researchers towards the use of definition (3) 
(Culyer and Wagstaff 1992), we feel that its use poses some challenges. We are back 
into the fact that people have different attitudes towards health care and towards health. 
The goal of ‘outcomes equality’ presupposes that everyone has the same preference for 
‘being healthy’, puts the same effort into ‘being healthy’ and has the same attitude to 
risk. Mooney and Jan (1997: 82) make this point: “Even if we had a society which 
started from a position of equal health (with the same genetic endowment for all) and 
even if we all had perfect knowledge of the health effects of all activities in which we 
might indulge [and had equal access to effective health care], it is unlikely that within 
one year or two we would all have the same level of health”. The question becomes 
whether it is reasonable to measure health care equity by assessing equality of 
outcomes. Sen (1992) states that equity is better assessed in terms of freedom to achieve 
rather than actual achievements. Others might propose that we should discard definition
(3), and work solely with definitions (1) and (2), focusing particularly on equality of 
access. Fair access to services is in fact one of the founding principles of the NHS and 
the White Paper published in 1997 makes it one of the six dimensions of performance. 
Nevertheless, we feel that a comparison of health outcomes across different groups is 
relevant because it allows us to assess if different groups appear to be systematically 
subject to less effective care and point towards providers who may need extra resources 
in order to secure similar standards in terms of outcomes achievement.
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4.4.4 Conflicts Between the Different Performance Criteria
One consequence of using several criteria for evaluation is that this may lead to 
alternative and potentially conflicting views of best practice. Furthermore, if the 
objective is to identify strategies for performance improvement, it may lead to several 
potentially conflicting views regarding the need and direction for change. For example, 
in our case study, we found a set of surgeries that are performing very well under the 
equity criterion, but these surgeries are not necessarily efficient or effective in their 
services delivery. Furthermore, we have identified surgeries that are clinically effective, 
but are not efficient. The question is, do these surgeries need to change the way they 
operate, and if so, what direction for improvement should they take? This is in fact a 
difficult question, and one which appropriate discussion is outside the scope of this 
thesis. Nevertheless, some tentative suggestions regarding methods to handling this 
question are proposed below.
One method is to admit that each organisation will have to undergo a process of 
negotiation and decide based on its priorities and values if it wants to change, and if so, 
what is the direction of change it wants to take. The problem with this solution is that it 
can lead to the perpetuation of the values of the most powerful stakeholders. We 
propose two alternative strategies regarding performance assessment and improvement 
whenever we are in presence of multiple incommensurable and conflicting objectives. 
The first alternative uses the concept of robustness proposed by Dryzec (1983):
“Optimisation is a legitimate procedure only if we are in possession o f  a single theoretical 
perspective in w hich we have a high degree o f  confidence, and believe there is only a 
single possible context in which the effects o f policy w ill be felt. Given, though, that the 
components o f  our system are unreliable, one should pursue robustness rather than
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optimisation. A robust policy alternative is one expected to perform tolerably well across 
the whole range o f scenarios given  any one o f the pertinent theoretical perspectives.”
Dry zee (1983: 360)
This alternative assumes that all values and criteria are equally legitimate and 
desirable. Furthermore, it assumes that a hierarchy of importance cannot be established 
between values. Therefore, no limits are imposed on the types of trade-offs that are to 
be accepted between the different values. However, depending on the context, it might 
be more appropriate to use a ‘qualified robustness’. This would entail an identification 
of the levels of trade-offs that were to be deemed acceptable between specific values 
and evaluation criteria. For example, we might want to impose that no decrease in the 
level of equity is to be accepted, independently of the increases in efficiency or 
effectiveness that it may generate. Le Grand (1991) defends that equity should be the 
primary objective in public services provision. Only when this criterion has been 
satisfied, should we be concerned with an improvement in the level of efficiency. 
Alternatively, we may say that the level of equity should never fall below a particular 
level, independently of the benefits it may generate in the other measures. A further 
alternative is to say that a decrease in the level of equity is only accepted if it leads to 
increases in the other evaluation criteria of a certain magnitude.
Independently of the criterion used to handle the trade-offs between the multiple 
values that underlie public services delivery, the important aspect to recognise is that 
this is a political decision that should be explicitly made. The complexity and 
responsibility involved in making such a decision should not be overshadowed by 
rhetoric about delegation of decision-making power. It is a political decision, whose
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effects should lead to a clear chain of central accountability independently of local 
decision-making (Du Gay 2000).
4.5 The Impact of Environmental Variables in the Assessment of Performance in 
Primary Care
There are some factors outside the clinicians’ control that can impact on the relative 
performance of each surgery. As a result it is important that these factors not be 
overlooked. During the workshops we identified the following factors that can 
contribute to the level of resources used, services delivered and outcomes achieved by 
each surgery:
(1) The case-mix of the patients registered with each surgery, in terms of age, 
gender, ethnicity and health status;
(2) The level o f socio-economic deprivation of the area covered by each surgery. 
Socio-economic deprivation aims to measure the extent to which one area is 
disadvantaged in terms of the essential socio-economic factors. The Department 
of the Environment, Transport and the Regions (DETR 2000), suggests six 
domains o f area deprivation: (1) income, (2) employment, (3) health deprivation 
and disability, (4) education skills and training, (5) housing and (6) geographical 
access to essential services. Area deprivation can influence the patients’ 
propensity to pursue health care and the patients’ lifestyle;
(3) The level of patient compliance with the treatment and recommendations of the 
clinicians;
(4) The quality of the services delivered by other local providers;
(5) Random variation in the data.
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4.6 The Appropriateness of the Production Metaphor for Primary Care Delivery
The importance of measuring outcomes and linking the achievement of outcomes with 
the level of resource usage and the level o f services delivered relates with the need to 
make an assessment regarding which structures and processes of care appear to lead to 
best value for money. However, it has been stated that measuring the outcomes of 
primary care delivery poses considerable challenges (Harris 1993, Salinas-Jeminez and 
Smith 1996). These difficulties relate to several essential aspects. Firstly, different 
groups of people have different objectives for primary care and therefore give value to 
different outcomes. This emphasises the pluralistic nature of primary care delivery and 
implies that any outcome assessment in primary care is necessarily partial. Secondly, 
some outcomes of primary care are only visible after many years of intervention, for 
example the outcomes of preventive care. Thirdly, some outcomes are difficult to 
quantify because they relate to subjective aspects of quality. For example, it is very 
difficult to assess the appropriateness o f diagnosis and the appropriateness of the 
support given to patients. Furthermore, in the absence of well-determined models of 
primary care delivery it is very difficult to establish a link between resources usage, 
services delivery and outcomes achievement.
As pointed out by Williams (1996), these difficulties should not imply that the task is
impossible or inappropriate. Firstly, it is important to make clear from which
perspective outcome is being measured and then it is important to arrive at outcome
measures that have been shown to relate strongly with the activities undertaken by
health care professionals. Furthermore, patients’ characteristics or other non-
controllable factors that are thought to have an effect on the relationship between
resources usage and outcomes achievement should be taken into account when
comparing the different providers (Salinas-Jeminez and Smith 1996). We will next
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discuss alternative measures of health outcomes that can be used to compare primary 
care providers.
4.6.1 Measures of Health Outcomes for Primary Care
There are several types of measures that can be used to assess the outcomes of primary 
care. The first type o f health outcome measure is rooted in the biomedical model of 
health, which takes a disease-based view of ill health. According to this model, health is 
the absence of disease diagnosed by using medical criteria. An alternative approach to 
outcomes assessment takes the patient’s subjective experience of health and aims to 
measure health outcomes based on patient reported symptoms and feelings (Jenkinson 
1994).
From a biomedical point of view, examples of health outcomes are mortality-based 
measures such as death rates, condition-specific death-rates, infant mortality, maternal 
mortality, life expectancy, suicide rates and measures of avoidable deaths. The use of 
mortality based indicators is relatively unsatisfactory to assess primary care providers 
because they occur in relatively small numbers, cover only the effects of a small 
proportion of the services delivered in primary care and, in many cases, it is very 
difficult to establish a link between the primary care delivered and mortality rates. 
Indicators of morbidity and disability can also be used as outcome measures.
An alternative to the use of mortality and morbidity rates, still using the biomedical
model of health, relates to the use of indicators of physical well being of the patients. In
this case, indicators of blood pressure and cholesterol control can be used as measures
of health outcomes. The justification to use these measures relates to the fact that, in
general, the probability of developing health complications is reduced if the essential
clinical indicators are kept under control. The use of these indicators usually requires
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clinical evidence in terms of determining the exact thresholds of abnormality. The 
evidence regarding the optimal levels of clinical outcomes tends to be linked with the 
management of certain specialities, such as diabetes, heart disease and cancer (Hunter 
and Fairfield 1997).
The subjective measures propose an alternative to the traditional biomedical model 
of health outcomes assessment, by emphasizing the importance of patients’ general well 
being and social functioning. Jenkinson (1994) identified three reasons to use subjective 
measures of health assessment. First, the difficulties involved in developing objective 
measures of outcome, with clear thresholds of abnormality. Second, the frequently 
reported discord between objective and the patients’ subjective assessments of health. 
Patients may feel ill without objective symptoms of disease and patients may feel very 
well whilst having a medical disease. Third, in cases of diseases with high levels of 
prevalence, patients who experience the disease may not see it as an illness. In this 
respect, it is suggested that the assessment of health outcomes should aim to capture 
both the objective and subjective accounts of health.
Subjective assessments of health are part of the broader concept of health related
quality of life. Patrick and Erickson (1993: 22) define health related quality of life as
“the value assigned to the duration of life as modified by the impairments, functional
states, perceptions and social opportunities that are influenced by disease, injury,
treatment, or policy”. Numerous instruments have been developed to measure health
related quality of life in its numerous domains (Bowling 1991). These instruments are
designed to measure the different domains of health related quality of life, including
physical, cognitive and social functioning, self efficacy, well-being, life satisfaction,
self-esteem and happiness (Albrecht 1994). Despite the importance of including
patients’ subjective assessment o f health care, there is disagreement between the
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appropriate domains that should be included in the assessment of health outcomes 
(Bowling 1997). This aspect is of fundamental importance if we are to fairly attribute 
the results of outcome assessment to the clinicians.
Health related quality of life measures have also been used to evaluate the cost-utility 
of different interventions by using Quality-Adjusted Life Years or QALYS (Williams 
1985). This methodology aims to calculate a single indicator that estimates the duration 
of life weighted by the quality of life during that period. One year o f healthy life is 
scored as one, but one year of unhealthy life is scored as less than one. The specific 
weights given to different states of health have to be elicited in an experimental setting 
with a sample of patients, or other stakeholders. The difficulty in eliciting these weights 
is one of the difficulties associated with this measure (McAlister 1994). Furthermore, it 
has been argued that outcome assessment should go beyond the measurement of the 
technical aspects of care in order to make an assessment regarding the quality of the 
interpersonal aspects of care, by using patient satisfaction surveys (McAlister 1994).
Patient satisfaction surveys aim to assess whether the access to the services is
appropriate and the extent to which the services delivered are of acceptable quality. In
this respect, satisfaction surveys provide information regarding the patients’ perspective
about the performance of the primary care providers. Furthermore, satisfaction surveys
can provide very important information regarding the most appropriate structures and
processes of delivering services. The use of patient surveys in a performance assessment
exercise can also represent a useful way of data triangulation. We do recognize the
limitations associated with this method of health care evaluation. High levels of
satisfaction tend to be reported, particularly if a general question about the level of
satisfaction with the services is used. Furthermore, it has been suggested that patient
satisfaction levels can be influenced by question wording and by the response format
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offered. For a discussion of these limitations please refer to Bowling (1997). Despite 
these limitations, we feel that the use of patient satisfaction surveys can be very 
valuable in providing an assessment from the patients’ perspective.
4.6.2 The Need to Focus on a Specific Disease
The feasibility of extracting data from the GP surgeries of the participating PCG/Ts in 
order to implement the conceptual framework developed was discussed with the 
participating PCG/Ts. Our aim was to include both measures of objective and subjective 
health outcomes. We concluded that this exercise would be very difficult, given that all 
the data available for outcomes related to objective measures of specific diseases, such 
as diabetes, Coronary Heart Disease (CHD), cancer, asthma and hypertension. The 
measures available did not cover all the areas of activity of primary care and it was 
believed that it would be inappropriate to establish a link between resources usage, 
services delivery and outcomes achievement. Furthermore, it was believed that a 
formative evaluation focusing on a specific disease would provide more in-depth results 
regarding performance improvement. The evaluation of primary care as a whole was 
thus dropped at this stage, but the issue of general versus speciality evaluation is 
discussed later in this chapter.
Three specialities that could benefit from a formative evaluation were identified: (1) 
Cancer, (2) CHD and (3) diabetes. From these three specialities, we decided to focus on 
diabetes care for three reasons. Firstly, because of its rising prevalence and its rising 
financial burden to the NHS; Secondly, because there is evidence of great variations in 
the standards of diabetes care provided (The Audit Commission 2000b); Finally, 
because diabetes is a condition coordinated in primary care, the area we want to 
investigate.
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The benefits of managing primary care by focusing on a speciality (also known as 
disease management) relate to the fact that this approach views the patients as 
experiencing the clinical course of a disease and uses the clinical evidence available to 
develop guidelines and protocols of care, aiming to improve the process and outcomes 
of care (Hunter and Fairfield 1997). The existence of clear protocols of care facilitates 
the establishment of a link between service delivery and outcomes achievement. 
Confidence in establishing this link is essential in order to compare providers based on a 
production metaphor (Brignall and Modell 2000).
In terms of our application of DEA to compare primary care providers, there are thus 
several reasons to focus on diabetes care rather than primary care as a whole:
( 1 ) the absence of appropriate outcome data for primary care as a whole;
(2) the existence of relatively well defined measures of outcomes for diabetes 
care;
(3) the absence of a ‘well-determined’ model of primary care delivery that works 
within the production metaphor;
(4) the pluralistic nature of what good primary care means;
(5) the existence of relatively well defined production functions (in terms of 
structure, process and outcomes) for diabetes care delivery.
In this respect, the fact that the ‘product’ characteristics of diabetes care delivery are 
more clearly defined than those of primary care as a whole better facilitates the 
construction of production models for performance assessment and makes the notion of 
formative evaluation possible. By focusing on a particular disease, the identification of 
needs for primary care is also facilitated.
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However, we recognise the problems associated with the performance assessment of 
a single speciality in primary care delivery. Given its general practice focus, primary 
care professionals should aim towards a comprehensive and coordinated, patient- 
focused service delivery. A range of synergetic relationships can be explored between 
different specialities. Very often the preventive messages are similar across many 
specialities. Furthermore, the treatment of one health problem can interact with other 
health problems that the patient may have. Primary care management by focusing on 
specialities has also been criticised because it may lead to the fragmentation of care for 
patients (Harris 1996), and also because it may lead to the potential loss of skills of 
primary care professionals in terms of the management o f certain diseases 
(Bodenheimer et al. 1999). The importance of continuity of care is emphasised, 
together with the role of primary care physicians as coordinators o f care. These issues 
suggest that efforts should be made to undertake an evaluation of primary care providers 
that recognises their role as coordinators of care. This should be the subject of future 
research.
4.7 Conclusion
In this chapter we have presented the conceptual framework developed for formative 
evaluation in primary care at the level of GP surgeries. This framework aims to 
establish a link between the local needs, resources used, services delivered and 
outcomes achieved in primary care. By linking these four elements, four criteria for 
evaluation are proposed: (1) equity, (2) efficiency, (3) service effectiveness and (4) cost 
effectiveness. DEA is then proposed as a methodology that can be used to measure 
efficiency, service effectiveness and cost effectiveness.
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The difficulties encountered in the implementation of this framework to evaluate 
primary care as a whole are discussed. We conclude that the pluralistic nature of 
primary care delivery places difficulties in the measurement of outcomes for primary 
care. Furthermore, the fact that clear models of primary care delivery cannot be 
identified questions the appropriateness of the production metaphor for performance 
assessment at this level. The need to focus on diabetes care delivery is justified in order 
to better establish a link between resources usage, services delivery and outcomes 
achievement. Finally, the advantages and disadvantages of evaluating GP surgeries by 
focusing on a specialty were discussed.
In the next chapter we discuss the methodology followed to develop the specific 
measures for diabetes care evaluation and the process followed to collect the necessary 
data.
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5 Research Design and M ethodology
5.1 Introduction
This chapter provides the background for the empirical study undertaken in this thesis. 
Firstly, we discuss the workshops undertaken with the PCG/Ts in order to develop the 
models for formative evaluation in primary diabetes care, together with the selection of 
the participating surgeries. Secondly, we discuss the methodology followed in this 
research. We have used a combination of quantitative and qualitative methods in order 
to better understand the context of study and to better understand the results of the 
comparative evaluation. We finish with a discussion of the methods used to collect the 
necessary data, including a discussion of both two surveys undertaken.
5.2 Research Design
In the previous chapter we have discussed why we have decided to focus on a specific 
disease rather than an evaluation of primary care as a whole. Once it was decided to 
focus on diabetes, a second round of two workshops with each PCG/T was arranged to 
develop the framework for performance assessment in primary diabetes care. The final 
framework agreed by the participating PCG/Ts is discussed in detail in chapter 6. This 
framework is a compromise of several drafts developed in collaboration with each 
PCG/T. In general, we did not find a great deal of disagreement. The definition of the 
clinical outcomes of care was an aspect that caused some disagreement, particularly in 
terms of the thresholds for some of the measures. We also found some disagreement
107
regarding the use of measures of outcomes achievement (such as the proportion of 
patients with cholesterol levels under control) and measures of outcomes improvement 
(such as the change in the proportion of patients with cholesterol levels under control). 
As a result, it was decided that as part of this first exercise we should focus on outcomes 
achievement, as this measure would indicate how well each surgery is performing in 
terms of achieving the outcome targets outlined by the Government. In general, 
whenever disagreements were raised, research evidence was used to reach a consensus 
between the several members involved.
Once the final framework for evaluation was approved by all the PCG/Ts, several 
meetings with the information facilitators of each PCG/T were arranged in order to 
confirm that the necessary data could be extracted from the surgeries’ records. 
Unfortunately, at this stage, it was found that West Suffolk Borders PCG and Rugby 
PCG would not be able to extract the necessary data from their surgeries’ records. It was 
discovered that in most of their surgeries, some of the necessary data had not been 
collected. As a result, West Suffolk Borders PCG decided to withdraw from the 
research project.
However, Rugby PCG decided to undertake a process of prospective data collection 
over a six-month period, in order to perform a small-scale comparison between its 13 
surgeries. Unfortunately, this proved to be a rather complex and unrewarding exercise 
as only four surgeries collected the data according to the required methodology. The 
data collected from these four surgeries was not used in this study, but the exercise was 
useful as a learning process regarding some of the complexities involved in assessing 
performance in primary care.
At the end of this process, there were only two remaining PCTs: South Peterborough
PCT and Bedford PCT. During a workshop with Bedford PCT, it was suggested that
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contacting other PCTs in the region might increase the number of participating PCTs. 
From these contacts, several positive replies were received. However, after meetings 
with the information facilitators, we concluded that only Huntingdon PCT would be 
able to extract the necessary data. Huntingdon PCT agreed to the methodology and the 
framework previously developed, and became the third PCT taking part in this research 
project.
South Peterborough, Bedford and Huntingdon PCTs were able to extract the 
necessary data because they were engaged in a data improvement project called Primary 
Care Information System (PRIMIS). PRIMIS was set up in April 2000 by the NHS 
Information Authority as a training and support service to help surgeries make better 
use of their computer systems and to improve the quality of data in primary care. 
PRIMIS provides training to information facilitators employed by PCTs. These 
facilitators then educate the GPs, nurses and other staff in effective use of their clinical 
computer systems and in the extraction of meaningful information. Not all PCTs in 
England are involved in PRIMIS and those which are, may have joined the project at 
different points in time. South Peterborough PCT and Huntingdon PCT have been 
involved with PRIMIS since the beginning, while Bedford PCT only joined it in 2001.
5.3 Identifying the Participating Surgeries
After the two rounds of workshops, the research objectives, methodology and the
framework for evaluation had been clearly defined. The participating surgeries would
require the information facilitators to extract data regarding the local needs, inputs,
outputs and outcomes of diabetes care. Each participating surgery would also have to
post a questionnaire to a random sample of their diabetic patients. All participating
surgeries would receive a full report with the analyses and interpretation of the results.
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Despite the interest and full financial support o f  the PCTs, each surgery had to be 
contacted in order to ascertain their willingness to participate. A letter was sent to the 
practice manager of each surgery, and whenever requested, a meeting with the GPs and 
nurses in the surgery was arranged. In South Peterborough PCT, 13 out of 15 surgeries 
replied positively. In Huntingdon PCT, 9 out o f  25 surgeries replied positively. In 
Bedford PCT only one out of 25 surgeries replied positively. We were unable to 
ascertain why there was a very low response rate within Bedford PCT.
In April 2002, an invitation was received to present this research at a Diabetes 
Conference organised by Leicester Health Authority. The presentation focused on some 
of the drawbacks of the Government’s newly published National Service Framework 
(NSF) for diabetes; and the DEA framework we had developed for formative evaluation 
in primary diabetes care. It also highlighted some of the advantages of using DEA in 
primary care. At this stage, we had already developed a draft version of the patient 
questionnaire. This questionnaire was circulated during the conference for comments 
(please refer to Appendix B for a copy o f the patient questionnaire). After the 
presentation, two surgeries (one from Heartlands PCT and other from Melton and 
Rutland PCT) expressed an interest in taking part in this research project. A number of 
meetings with other health care professionals at each of these two surgeries were 
arranged and both surgeries agreed with the framework and methodology proposed for 
the project. Moreover, these two surgeries proved to have very good information 
systems, and became part of the sample of participating surgeries, which in total 
amounted to 25. Examination of the quality of the data extracted meant that two further 
surgeries had to be excluded, which resulted in a final sample of 23 surgeries.
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5.4 Research Ethics Approval
The fact that a questionnaire had to be sent to a sample of patients meant that research 
ethics approval had to be sought. As this research project involved several different 
regions, the necessary documentation was submitted to the West Midlands Multi-centre 
Research Ethics Committee. The research project was given full ethics approval on 24 
July 2002 (please refer to a copy of the letter in Appendix C). Following the new 
guidelines, all the relevant Local Research Ethics Committees were informed about the 
research project, and no objections were made.
5.5 Research Methodology
As we have discussed earlier, this research project aims to integrate performance 
assessment with evaluation research in order to develop a more comprehensive and 
useful performance assessment framework in primary care. In this respect, we have used 
a wide range of research methods to collect and analyse data, in order to gain a better 
understanding of the structures, practices and mechanisms behind successful primary 
diabetes care delivery. Additionally, we have used DEA in a practical context in order 
to assess its usefulness as a tool for formative evaluation.
5.5.1 The Combination of Qualitative and Quantitative Research Methods
We believe that the use of DEA in combination with other methods, such as surveys, 
interviews and workshops, enriches the performance assessment exercise and allows the 
researcher to perform a more meaningful, context-focused study. In particular, we 
believe that the use of qualitative methods in a quantitative performance assessment is 
essential for four main reasons:
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(1) it gives the providers an opportunity to have an active role in the performance 
assessment exercise, by contributing to the definition of the objectives, theories, 
models and the interpretation of the results;
(2) it gives the researcher an opportunity to have a better understanding of the 
context under evaluation and the complexities involved in attempting to give it a 
mathematical formalisation, as well as a better understanding of the abstraction 
process involved in so doing;
(3) it enhances the usefulness of the results in practice and should foster 
organisational learning, given that both the providers and the researcher have a 
better understanding of the assumptions behind the results and the challenges 
related to its context applicability.
(4) Smith (1995) emphasised the importance of involving the providers and paying 
attention to non-measurable outcomes of the program, as these are essential 
aspects in order to minimise the unintended consequences that can result from a 
performance assessment exercise.
The combined use of quantitative and qualitative methods has been criticised by
some authors, who believe that these two types of methods belong to opposing
philosophical views of the world (paradigms), and therefore should not be used together
(for example, Guba and Lincoln 1981). We believe that the debate over philosophical
views does not have to mirror the debate over the most appropriate methods in a
particular research context. It is our conviction that a research method per se does not
belong to a particular philosophical paradigm. However, the researcher’s philosophical
positions and implicit assumptions drive the way each method is applied and how the
results are interpreted. It is our conviction that all research methods have limitations and
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it is up to the researcher to be aware of them and to choose the most suitable methods 
for each research study. Cook and Reichardt (1979) recognised the importance of 
moving beyond the dichotomy between quantitative and qualitative methods. They 
urged researchers to use a combination of methods in order to best perform their 
specific evaluations.
We believe that the important question regarding methodology and methods is the 
need to have a clear conceptual framework that unifies and drives the research project. 
In this context, by conceptual framework we mean a set of theories about the 
organisations under evaluation, about what they are trying to achieve, how they are 
trying to achieve it, and whom they are trying to serve. We will now discuss the 
methodology used to develop the conceptual framework and to collect the data.
5.5.2 Methodology for Developing the Framework for Evaluation and for Data 
Collection
In order to develop a conceptual framework of primary diabetes care delivery, we 
started by performing a review of the literature and of the official documentation. This 
allowed the formulation of draft theories and frameworks, which provided a stepping- 
stone for discussion during the workshops with the PCG/Ts’ Boards. These workshops 
identified the issues that needed to be explored and the most adequate criteria for 
evaluation: equity, efficiency, clinical and patient-focused effectiveness and cost- 
effectiveness. Once the criteria for evaluation were established, we developed the 
framework for evaluation and identified the data that would be necessary. It was also 
during these workshops that we identified what data was available and what data still 
needed to be collected. Two questionnaires were designed to collect the data that was
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unavailable: the Diabetes Services Questionnaire (DSQ) and the Practice Profile 
Questionnaire (PPQ). These questionnaires are discussed in greater detail in section 5.6.
The data used in the performance assessment models was extracted by the 
information facilitator of each PCT. After extraction, all the data was fed back to each 
respective surgery and meetings between the information facilitator and one of the 
surgeries’ professionals took place in order to assess the data validity.
After the performance assessment framework was developed and validated, DEA 
was used to compare the sample of participating surgeries in terms of their 
transformation of inputs into services and services into outcomes. At the post-evaluation 
stage, we attempted to identify the effect of environmental variables in the performance 
results. Afterwards, another round of workshops with the participating PCTs and 
surgeries was arranged in order to validate and interpret the DEA results. This was 
followed by an in-depth investigation of some of the surgeries to identify how their 
diabetes services delivery could be improved. An assessment of the implications for 
primary health care delivery and primary health care policy was undertaken and is 
presented in chapter 10.
5.6 Questionnaire Design
We decided to use two questionnaires in order to collect data that was unavailable on 
the PRIMIS database. The first questionnaire was sent to a random sample of the 
diabetic patients registered at each surgery. The second questionnaire was sent to all 23 
participating surgeries. We will now discuss each one of these questionnaires in more 
detail.
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5.6.1 The Diabetes Service Questionnaire
When we consider that our objective was to develop a comprehensive framework for 
primary care evaluation, the inclusion o f patient-centred outcomes is essential. 
Performing patient interviews was not feasible due to limitations in time. Distributing a 
questionnaire at the surgery could bias the results, as we needed to include the views of 
patients who do not regularly attend the surgery, despite being registered. For these 
reasons, we decided to use a postal patient survey, which allows the inclusion of a large 
number of subjects. The patient survey had the following objectives:
(1) to provide data in terms of the services received by the patients during the 12- 
month period;
(2) to provide data regarding the patients’ perceived understanding of diabetes and 
its management;
(3) to provide data regarding patients’ confidence in taking good control of their 
diabetes;
(4) to provide data regarding the most useful types of information, the most 
appropriate settings for information delivery and the ‘best educators’ in diabetes 
care;
(5) to provide data regarding the patients’ evaluation of several aspects of diabetes 
care delivery, as well as patients’ ratings regarding the importance of each 
aspect;
(6) to provide data regarding patients’ assessment of the quality of other primary 
care services;
(7) to provide data regarding patients characteristics, such as age, age of diabetes 
diagnosis, socio-economic group, qualifications, professional position and type
of diabetes treatment;
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(8) to provide data regarding patients’ evaluations concerning the best and the worst 
aspects in diabetes care delivery.
The patient questionnaire was developed in collaboration with the participating PCTs 
and with a number of the health care professionals at the participating surgeries. The 
questionnaire used by the Audit Commission (2000b) in their audit of the quality of 
diabetes care in England was the starting point, but several modifications in terms of 
content and language were made. A draft version of the questionnaire was submitted for 
research ethics approval in July 2002. After ethics approval was received, we piloted the 
questionnaire face-to-face on a sample of 20 patients from one of the participating 
surgeries. The patients were firstly asked if they would object taking part of a 
questionnaire pilot and those who did not object were interviewed in one of the 
consultations rooms at the surgery. This pilot process aimed at establishing if the 
questionnaire covered all the relevant aspects in diabetes care delivery; if the questions 
actually measured what they were supposed to measure; if the wording and instructions 
were clear to all respondents; and if the respondents felt motivated to answer it. All the 
patients interviewed agreed upon the clarity of the questionnaire, as well as its 
comprehensiveness. A few alterations regarding wording of some questions were 
suggested and incorporated.
Before the final version of the questionnaire was sent for Ethics Approval, it was 
posted to all participating PCTs and surgeries for comments. All comments suggested 
were duly considered. The final version o f the DSQ is presented in Appendix B.
To guarantee patients’ confidentiality, each surgery posted the questionnaires to the
patients. Most surgeries sent out the questionnaires during October 2002. The financial
burden of this exercise was met by the PCTs. A total of 3,431 questionnaires were
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posted and 2,201 questionnaires were received. 12 questionnaires were returned by 
patients who were not diabetics. This meant a total of 2,189 filled questionnaires were 
returned, an average response rate of 63.80%.
5.6.1.1 Diabetes Service Questionnaire Design
In order to satisfy the objectives outlined above, the DSQ was divided into four distinct 
sections. Section A considered the diabetic services received by the patients in the 
previous 12 months. The list of services covered is consistent with the British Diabetic 
Association (2001) ‘What diabetes care to expect’ in terms o f the standards of diabetes 
care. All the registered patients should have received each of the services listed at least 
once over the previous 12 months. This first section also asks the patient to distinguish 
between the services received at the surgery and those received outside the surgery. An 
open question is included to allow for justifications and comments about the usefulness 
of the services.
Section B aimed to measure the perceived level of patients’ understanding of 
diabetes and its management. It included a multi-item question about patients’ perceived 
understanding of key issues in diabetes and its management, and five questions about 
the importance of having a good understanding of diabetes and about the most useful 
types and sources of diabetes information.
Section C aimed to measure patients’ satisfaction with the services received at the 
surgery in the past 12 months. It is a multi-item question, covering several distinct 
aspects of quality of care, identified both from the literature and with discussions with 
the health care professionals.
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Section D included some personal questions, such as age group, gender, ethnicity, 
profession, education level, age of diabetes diagnosis and type of diabetes treatment. 
The questionnaire ended with an open question regarding the best and worst aspects 
about the diabetes services provided by the surgery.
5.6.1.2 Methodology for Sample Size Calculation
The patient survey aimed at estimating measures of certain population proportions, such 
as: the proportion of diabetic patients who report having their blood pressure reviewed 
at least once during the previous 12 months; patients who report a high level of 
satisfaction with the diabetes services, and so on. Given the small numbers of diabetic 
patients registered with some of the surgeries, our initial intention was to undertake a 
census of all diabetic patients registered with each of the participating surgeries (5,950 
patients). However, during the review process, the West Midlands Multi-centre 
Research Ethics Committee felt that there would be no need to survey such a large 
number of patients and suggested the use of a random sample. In this respect, the 
following criteria were used to calculate the sample size for each participating surgery: 123
(1) the samples taken from each participating surgery were determined using random 
sampling;
(2) for surgeries with a number of diabetic patients smaller or equal than 100, the 
whole population of diabetic patients was studied;
(3) for surgeries with a number of patients larger than 100, the formula given below 
was used to calculate the minimum sample size. This formula is the standard
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formula used to determine the sample size of a random sample used to estimate 
the population proportion.
n > —-— ^  2 ^  ^ ------  (Source : Aiken 1997 :103)
d 2( N - \ )  + z 2p { \ - p )
Where: N = Population size, which varies from practice to practice.
p  = Proportion of the population for which the element under study 
is true. This value is unknown and varies for the different aspects 
under study. In this respect,/? = 0.5 was used to calculate the sample 
size, given that this value gives the largest possible sample sizes. 
d  = Half the desired width of the confidence intervals for the 
proportion.
z = Reliability factor, which for this study will be 1.96, given that we 
aim for a confidence level of 95%.
5.6.2 The Practice Profile Questionnaire
In order to ascertain some of the characteristics of the surgeries under evaluation, a 
questionnaire was sent to each participating surgery. A copy of the practice profile 
questionnaire (PPQ) is presented in Appendix D. The PPQ was modified from a 
questionnaire developed by Williams et al. (2000) to assess the structural provision of 
diabetes services in the UK. The main objectives of this questionnaire were:
(1) to provide information about the size of each surgery, its location and its 
characteristics;
(2) to provide information about the number of professionals it employs, including 
the number o f professionals that regularly visit the surgery;
(3) to provide information about the frequency of diabetes related consultations, as
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well as their duration;
(4) to provide information about the diabetes screening policy of each surgery;
(5) to provide information about the educational materials distributed to the diabetic 
patients;
(6) to provide information about the training of the health care professionals 
providing diabetes services at the surgery.
A PPQ was received from each surgery, despite the fact that some surgeries were unable 
to complete some of the sections of the questionnaire.
5.7 Conclusion
In this chapter we have discussed the methodology used to develop the framework for 
evaluation in primary diabetes care and the methodology used to collect the data. When 
we consider that this study aims to contribute to formative evaluation in primary care, 
an emphasis has been given to the participation of the providers and to the development 
of a framework that portrays alternative performance criteria. As a result, the data 
collection has been driven by theories in terms o f primary care delivery and by the 
values behind decision-making in primary care.
In order to obtain meaningful results that can be useful both for the health care 
professionals and the patients, we have complemented the data collection with the use 
of two questionnaires. The first was sent to a sample of patients to get the patients’ 
views regarding the delivery of primary diabetes care. The second was sent to all the 
surgeries to get information to characterise each one of the participating surgeries.
In the next chapter we will discuss the performance assessment framework for 
diabetes service delivery.
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6 The Fram ew ork for Form ative E valuation in Primary
Diabetes Care
6.1 Introduction
In this chapter we will provide the background for the use o f DEA for formative 
evaluation of primary diabetes care delivery. In Section 6.2 we justify the need to 
perform a formative evaluation in primary diabetes care. In section 6.3 we discuss the 
drawbacks of the National Service Framework (NSF) for diabetes developed by the 
Government. A definition and characterisation of this chronic condition is provided in 
section 6.4. In Section 6.5 we review the previous studies that have compared the 
performance of primary care providers in terms of diabetes care delivery. In section 6.6 
we discuss the framework developed for evaluation of primary diabetes care delivery, 
which entails a discussion o f the needs, objectives, inputs, outputs and outcomes that 
characterise primary diabetes care delivery in England.
6.2 Why do we need a Formative Evaluation of Primary Diabetes Care Providers?
“This is a crucial time for diabetes services. The numbers of people 
with diabetes are increasing, new evidence is emerging on the 
effectiveness of more intensive treatment, patient expectations are 
rising and services are being stretched to the absolute limit. The
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question is, how can services cope with this rising demand?”
(The Audit Commission 2000b: 8)
There are wide variations in the standard of the diabetes care provided across the 
country (The Audit Commission 2000b). However, to our knowledge, no published 
study has compared a sample of primary health care providers in terms of equity of 
access to services, efficiency and effectiveness; this is the objective of this case study. 
In order to identify the structures and mechanisms associated with best practice, we 
performed a comparative evaluation of the performance of 23 GP surgeries in terms of 
their delivery of primary diabetes care. Primary diabetes care refers to the 
comprehensive range of health services provided to patients in order to diagnose 
diabetes, give support to the diagnosed patients and minimise the consequences of 
diabetes. It excludes services that require patient hospitalisation.
With so many specialities to benchmark, it would be prudent to ask why we have 
chosen diabetes. The answer is simple, the rising prevalence and health care costs 
associated with this condition. In the UK, current diabetes prevalence amounts to over 
3% of the population, with another 3% of the population estimated to have undiagnosed 
diabetes (The Audit Commission 2000b). The total costs of diabetes care to the NHS are 
estimated to exceed 2 billion pounds a year (The Audit Commission 2000b), and are 
expected to increase significantly over the next decades.
Although diabetes care is currently at the top of Governments’ agenda, and is
receiving a great deal of attention in the literature, to our knowledge, no published study
has concentrated on the performance of primary diabetes delivery systems using a
comprehensive framework in a formative mode. Therefore, the identification of the
structures and mechanisms associated with an equitable, efficient and effective delivery
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provides essential information for both health care professionals and policy makers. 
Furthermore, we believe that this case study is very timely, because a new GP contract 
has been approved stipulating increased pay for the GP surgeries if certain performance 
targets are achieved (British Medical Association 2003). Diabetes care is one of the 
specialities subject to performance related pay. Each GP surgery will have to decide 
whether it is cost-effective to deliver diabetes care, and if  so, under what model. 
Structure, process and outcome targets have been defined, with greater weighting being 
given to outcomes achievement (British Medical Association 2003). Given the 
Government’s emphasis on clinical outcomes achievement, we believe that it is 
important to investigate what factors may be associated with clinical and cost 
effectiveness, as well as discuss the potential unintended consequences that may result 
from a target driven system of diabetes care delivery.
6.3 The Drawbacks of the National Service Framework for Diabetes
“The NSF aims to make best practice the norm: . . .  community-based 
diabetes clinics to bring together at one location and at one time specialist 
expertise and services, including foot care and eye screening. ... Alongside 
the real progress that has taken place in some areas and for some places, 
there remain significant variations in the quality o f  care. Excellent diabetes 
services in one place can exist cheek-by-jowl with diabetes care elsewhere 
that is inadequate and unimaginative. Recognition o f  these challenges led the 
Government to initiate the development o f this N ational Service Framework 
fo r  D iabetes."  (The Department o f Health 2001a: 2, 3)
123
The NSF for diabetes sets out the standards that must be achieved in diabetes care
delivery in the NHS. The strategy for delivery of these standards has also been outlined 
(The Department of Health 2003). The table presented in Appendix E provides the list 
o f standards outlined in the NSF for diabetes. To monitor the achievement of these 
standards a large set of Pis have been developed and targets have been set for these Pis. 
Each provider will have to implement the necessary changes in order to achieve these 
targets.
However, in our view, the NSF misses a crucial element in diabetes care: costs. The 
NSF does not include any indicator linking the resources used in diabetes care with the 
processes and the outcomes achieved. Without this crucial link, strategies to improve 
efficiency and cost effectiveness in diabetes care cannot be identified. To assess 
providers on the achievement of outcome targets for a particular speciality, like 
diabetes, without taking into account the delivery costs is problematic. It can lead to 
problems of affordability, as well as, lead to resource shifts away from specialities for 
which no targets have been imposed. In a context where resource rationing is 
unavoidable, it is of paramount importance to identify and investigate the systems of 
care delivery, which are able to produce more/ better outcomes, with the same (or 
lower) costs. It is this essential link between needs, resources used, processes of care, 
services delivered and outcomes achieved that we attempt to restore by using DEA. We 
discuss the results of our empirical study in chapter 7. We now provide a definition of 
diabetes.
6.4 Diabetes M ellitus -  Definition and Characterisation
Diabetes Mellitus is a progressive chronic condition in which the body is unable to
effectively control the amount of sugar in the blood, allowing it to rise to abnormal
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levels. It is commonly known as diabetes. This condition is currently incurable, and 
shows rising prevalence in the UK. The number of diagnosed diabetics is estimated to 
rise significantly during the next decades, partly due to better ways of screening for the 
condition, but mainly due to a widespread change in lifestyle towards a high fat, high- 
energy diet, combined with low physical activity.
There are two types of diabetes:
(1) Type-1 (formerly known as Insulin-Dependent-Diabetes), is caused by a 
deficiency of the pancreas to produce insulin. For type-1 diabetics the insulin 
producing cells ((3-cells) have been destroyed by the immune system. In this 
respect, type-1 patients depend upon the daily injection of insulin to survive. The 
symptoms of this form of the condition tend to develop very rapidly and its 
diagnosis is more common in children and young adults.
(2) Type-2 (formerly known as Non-Insulin-Dependent-Diabetes) is caused by the 
pancreas inability to produce enough insulin, associated in most cases with an 
inability of the cells to use the small quantities of insulin produced. In this case, 
the patient is treated with any combination of diet, medication and insulin. This 
type of diabetes is the most common form of the disease, representing around 
85% of the cases in the UK. Its symptoms tend to develop more slowly, and the 
diagnosis usually occurs in patients over 40 years of age. However, type-2 
diabetes has been increasingly reported in children and adolescents (American 
Diabetes Association 2000), coinciding with the increasing prevalence of obesity.
Although desirable, it was not possible to extract separate data based on which
condition afflicts the patient, because the coding of the two types of diabetes is still not
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standardised between surgeries. At a time when this type of data extraction is possible, 
we recommend that separate analyses should be made for type-1 patients and type-2 
patients, considering that they require slightly different types of treatment, and the 
progression of the condition is also slightly different. Based on the data from the patient 
questionnaire, we have estimated the proportion of patients with type-1 diabetes. The 
criterion used to classify type-1 patients was: age o f diagnosis < 41 years old and 
treatment with insulin. The estimated proportion of patients with type-1 diabetes for 
each surgery is later used as an environmental variable to explain the efficiency and 
effectiveness results obtained.
Both types of diabetes can lead to early death, poorer quality of life and the onset of 
serious health complications, such as: cardiovascular diseases, foot ulceration, kidney 
failure, eye diseases and blindness. Research suggests that an optimum metabolic 
control (blood glucose, blood pressure and cholesterol) can effectively prevent or delay 
these associated complications, both in patients with type-1 diabetes and in patients with 
type-2 diabetes (Wake et al. 2000). The outcome measures used in this study reflect this 
research evidence.
6.5 Previous Studies that have Compared Primary Care Providers in Terms of 
Diabetes Services Delivery
Most research in diabetes care has focused on the effects of different types of 
medication, on the development of complications and the associated health care costs. 
The standard method used in these studies is a randomised control trial, where a random 
sample of patients is subjected to a new type of medication and a control sample is 
subjected to a conventional type of medication. The costs and outcomes of the patients
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from both samples are compared in order to infer about the cost-effectiveness of the 
new therapy.
To date, four major studies have been published on this subject. The Diabetes 
Control and Complication Trial Study Group (DCCT) (1993) compared the costs and 
outcomes of type-1 patients under standard treatment and patients under insulin 
intensive treatment. This study found that intensive insulin therapy contributed to a 
reduction in the development and progression of microvascular complications in 
patients with type-1 diabetes. The comparison o f the costs involved in the two types of 
treatment suggested that intensive treatment is cost-effective in the long run.
The Stockholm Study (Reichard 1992) reported similar findings, although the cost 
figures were significatively lower. These findings have now been extended to patients 
with type-2 diabetes. Two major studies have been undertaken in the UK and Japan: 
The UK Prospective Diabetes Study Group (UKPDS) (1998a) and the Kumamoto study 
(Wake et al. 2000). These two studies found that better metabolic control by intensive 
insulin therapy can significantly reduce and delay diabetes related complications. 
Despite the increase in treatment costs due to the use of insulin, intensive therapy was 
found to be cost-effective in the long term due to a reduction in the costs associated with 
the treatment of complications. Smaller scale studies have investigated the effects of 
different types of medication on the cost-effectiveness of treatment. A full review of 
these studies is outside the scope of this thesis. The objective of this case study is to 
investigate other types of factors that can explain the efficiency and cost-effectiveness 
of primary diabetes care delivery. In particular, we are interested in investigating 
provider-related factors.
There are few studies that have investigated diabetes care performance at the
provider level. Most of the studies that have performed analyses at the provider level
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suffer from some limitations. In particular, to our knowledge, no published study has 
investigated the relationships between equity, efficiency and effectiveness of primary 
diabetes services providers. The research emphasis has been on the quality of care under 
different delivery systems without considering the delivery costs.
The Diabetes Integrated Care Team (1994) undertook a study involving the random 
allocation of 274 diabetic patients into conventional hospital care and integrated care3. 
The aim of the study was to investigate the effect of type of care on certain outcome 
measures, such as metabolic control, knowledge of diabetes, satisfaction with treatment, 
psychosocial status and costs to the patients and to the NHS. The study concluded that 
after two years, the outcomes of patients allocated to integrated care were as good as 
those allocated to conventional hospital care. The costs to the NHS were found to be 
similar, but integrated care imposed lower costs to the patients, particularly for patients 
living far from the hospital. This early study pointed towards the provision of diabetes 
care in primary care, given that it appears to be more convenient to patients, while 
maintaining cost-effectiveness. In recent years, there has been a shift from secondary to 
primary care in terms o f  the management of most chronic conditions, including diabetes 
(Goyderetal. 1998).
Griffin (1998) reviewed all published randomised control trials that evaluated 
outpatient hospital clinics versus general practice care for diabetes. He concluded that, if 
a computerised prompt system exists, general practice could be as effective as hospital 
outpatient clinics in the delivery of diabetes care. From another aspect, he concluded
3 Patients allocated to integrated care were seen annually at the hospital, and periodically at the GP 
surgery. Patients allocated to conventional hospital care were seen periodically at the hospital.
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that when a suitable organisation system of diabetes care is not in place, general practice 
care can lead to poorer services and outcomes.
More recently, Ovhed et al. (2000) investigated the importance of the role of the 
diabetes nurse in primary diabetes care in Sweden. The study compared two Primary 
Health Care Centres (PHCC) operating different models of diabetes care. PHCC A had 
implemented formal guidelines for diabetes care, establishing an independent role for 
the diabetes nurses. In this centre, the prerequisite o f  diabetes care was that patients 
should be seen three times a year with the nurse and once a year with the doctor. PHCC 
B had no formal guidelines for diabetes care and the doctor took the main role in 
diabetes care, seeing all patients twice a year. Diabetes nurses acted as assistants and the 
patients were only sporadically referred to a nurse when the doctor felt that it was 
necessary. The study concluded that PHCC A, where the nurses had an independent and 
more active role, presented better metabolic control. The authors recognised that this 
aspect needs to be further investigated particularly by comparing a larger number of 
primary care providers.
Glasgow and Strycker (2000) undertook a comparison of 47 physicians from two
different health care systems in the United States. They compared the physicians across
11 performance measures, which assessed the percentage of patients that had the
essential laboratory tests in the previous year, and the percentage of patients that had
received patient education of diabetes management in the previous year. A great deal of
variability in the performance measures across providers was found. In particular,
patient education was found to be quite unsatisfactory in most providers. In a second
stage, multiple regression analyses were used to identify the factors associated with the
performance variability. The results from the 11 performance measures for each
physician were regressed on a set of patient and provider characteristics. They
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concluded that several variables were associated with better performance, such as the 
number of patients treated and the use of guidelines. One interesting finding was that 
the level of community support for the patients (support from family, friends, work, and 
other community resources) was found to be the only significant predictor of better 
performance across both health care systems.
Despite the interesting findings of this study, it suffers from some limitations. Firstly, 
it would have been interesting to perform analyses at the practice level. Secondly, the 
authors used a simple average to aggregate all the performance measures. This is 
equivalent to giving equal weights to all the measures across all providers. An approach 
allowing some weight flexibility would be fairer, given that it would allow each 
provider to emphasise its specific strengths. Finally, and most importantly, no 
conclusions can be taken regarding the relative efficiency and cost-effectiveness of care 
because the authors did not link the outcome measures with any measure of cost.
Another study that fails to include an assessment of the costs involved in the delivery 
of diabetes care was that by Khunti et al. (2001). They compared a sample of 169 
practices in England in terms of some process and outcome measures in diabetes care. A 
wide variation across practices was found in both process and outcome measures. 
Additionally, most practices showed very poor levels in terms of outcomes 
achievement. The authors performed multiple regression analysis in order to identify the 
factors associated with the performance variations. Four factors explained a small part 
of the variability:
(1) the size of the practice (smaller practices performed better);
(2) fundholding status (fundholding practices performed better);
(3) the existence of a recall system (practices operating a recall system performed
better, but only in terms of the process measures);
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(4) the proportion of patients under hospital diabetes care (practices with a smaller 
proportion of patients under hospital care performed better).
Given the general poor quality of care identified, the authors suggested that the 
current payment for chronic disease management might be insufficient to guarantee 
high quality of diabetes care.
The isolated study of costs and outcomes of diabetes care has been one of the major 
limitations of most studies in this research area. The majority of studies of diabetes care 
performance have either focused on outcomes, whilst neglecting the costs, or focused on 
costs, without linking it to the outcomes achieved. We will now discuss the 
development o f our framework for formative evaluation in primary diabetes care.
6.6 Developing a New Framework for Formative Evaluation in Primary Diabetes 
Care
We now discuss the framework used for formative evaluation in primary diabetes care. 
This framework follows the generic conceptual framework presented in chapter 4. In 
this respect, we have used the following conceptual representation:
Needs ----- ► Objectives----- ► Resources----- ► Service delivery ----- ► Outcomes
By comparing the level of services delivered across surgeries to the essential services 
that the patients need, we get a measure of relative equity across surgeries. By 
comparing the quantity of appropriate services delivered to the amount of inputs used 
we get a measure of relative efficiency across surgeries. By comparing the amount of 
services delivered to the level of outcomes achieved we get a measure of relative
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effectiveness across surgeries. Finally, by comparing the level of outcomes achieved to 
the amount of inputs used we get a measure of relative cost effectiveness.
The period of analyses is 1 October 2001 to 30 September 2002. This was the most 
recent period for which data was available at the time of extraction. The final 
framework used for evaluation is presented in Figure 6.1. The final measures used in the 
models, resulted from a consideration of the following aspects:
(1) importance for the formative evaluation exercise, based on the literature and 
workshops with the health care professionals;
(2) fair attribution of the performance results. For example, to monitor the incidence 
of diabetes related complications would not be appropriate, when we consider that 
most of these complications are related to the diabetes care provided many years 
prior to the onset of the complications. The number of patients with optimal 
metabolic values is a better indicator o f the quality of diabetes care regarding the 
prevention of complications, because it captures the patient’s current risk of 
developing complications and is influenced by recent medical care or its absence;
(3) availability of reliable and consistent data across the surgeries, or possibility of 
collecting reliable data using the patient questionnaire;
We will now discuss in more detail each of the elements involved in this formative 
evaluation, in order to justify the measures used.
6.6.1 Local Needs of Primary Diabetes Care
In Chapter 4 we have discussed the concept of need. As suggested by Williams (1974)
and Culyer (1976), we have equated need for health care with the patients’ capacity to
benefit from the consumption of health care. The fact that we have narrowed our focus
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from primary care as a whole to primary diabetes care facilitates the assessment of need. 
For our empirical analysis, we have defined two groups of patients with need for 
primary diabetes care:
(1) Patients most at risk of developing diabetes, who can benefit from a screening 
exercise;
(2) Patients already diagnosed with diabetes, who can benefit from a comprehensive 
annual review and appropriate diabetes medication;
Most of the participating surgeries do not follow a regular programme of diabetes 
screening. As a consequence, we have focused solely on the delivery of diabetes care to 
patients already diagnosed with diabetes. The number of diabetic patients registered 
with each surgery is therefore our proxy measure for local need. We recognise that this 
is a crude measure of need given that it does not discriminate between patients with 
different levels of severity, nor does it distinguish between type-1 and type-2 diabetics. 
Nevertheless, there is a range of essential services that all diabetics should receive at 
least once a year (British Diabetic Association 2001). Therefore, we believe that it is 
useful to investigate if  the proportion of patients who receive these essential services 
varies significantly between surgeries.
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The main objectives identified in the literature (St Vincent UK Working Group 1996 
and Home et al. 1999) and corroborated in the workshops with the PCTs were:
(1) To reduce the incidence of diabetes, through preventive action.
It is not thought to be possible to prevent the onset of type-1 diabetes. However, 
given that obesity triggers the onset of type-2 diabetes, it is thought that the use of 
measures aimed at reducing obesity and increasing physical activity could contribute 
towards a reduction in the incidence of type-2 diabetes. It would also be an effective 
measure of heart disease prevention.
Despite the importance of diabetes prevention, this study will not focus on this type 
of service, because at the time of this study, most surgeries were not actively involved 
in diabetes preventive care. Once this becomes an integral part o f the regular activities 
of GP surgeries, we recommend that the costs, services and outcomes associated with 
preventive care are also included in a new performance study. An analysis of the 
observed trade-offs between preventive care and disease management care could 
provide interesting insights into the optimal balance between these two areas.
(2) To detect diabetes as early as possible, through community education on 
symptom recognition and through regular screening.
Type-2 diabetes screening is recommended by the World Heath Organisation (1994). 
In the UK, Wareham and Griffin (2001) review the evidence and suggest that although 
universal screening is not recommended, targeted screening appears to be cost-effective. 
It is possible to provide patients with urine test sticks to screen at home for diabetes. 
This test, if accompanied by clear instructions, could be a cheap and effective method to
6 .6 .2  O b je c t iv e s  o f  P r i m a r y  D ia b e te s  C a r e  D e liv e ry
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screen most at risk patients. However, any type of systematic screening would 
obviously identify a large amount of unmet need, for which the primary care system 
may not be prepared.
Despite this important short-term problem of insufficient capacity, an early diagnosis 
is essential both in terms of patients’ expected quality of life and long-term cost savings 
to the NHS. It is believed that half of the patients diagnosed with type-2 diabetes 
already have complications at diagnosis (UKPDS 1990).
(3) To reduce the risk of complications of diabetes, through regular monitoring and 
by using adequate medication.
In order to reduce the risk of complications in diabetes, the blood glucose concentration 
has to be tightly controlled. Moreover, given the fact that diabetes tends to lead to the 
development of cardiovascular diseases, it is important to control the cardiovascular risk 
factors, such as smoking, obesity, blood pressure (BP) and cholesterol levels.
(4) Effective patient education in diabetes and its management, through regular 
consultations with health care professionals, and the provision of adequate 
education materials.
It is essential to recognise that patient education and patient compliance are essential in 
achieving good metabolic control. It is also very important to recognise that patients 
with chronic conditions often have a wealth of knowledge and understanding about the 
optimal day-to-day management of their condition. Enhancing this practical wisdom 
and supplementing it with clinical knowledge is supposed to make the patient a key 
element in the achievement of good outcomes of care (The Department o f Health 
2001b). Obviously, this discourse regarding the benefits of patient education and patient
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empowerment assumes that the patient both wants and has the capability to take 
responsibility for disease management.
(5) To reduce the impact of diabetes and its complications once developed, 
through appropriate patient support and effective treatment.
Diabetes is the leading cause of kidney failure, blindness and one of the biggest causes 
of lower limb amputation. Diabetes pre-disposes to cardiovascular diseases. A 
significant proportion of diabetic patients require psychological support in order to 
overcome depression and anxiety (Lloyd, Dyer and Barnett 2000). It is essential that a 
regular and effective programme of care be in place to prevent these health problems, or 
to minimise its consequences.
6.6.3 Inputs -  Resources used in the Delivery of Primary Diabetes Care
In this study we have used a combination of methods in order to arrive at estimates for 
the resources used by the GP surgeries in their delivery of diabetes care. From one side, 
we collected data from the GP surgeries in terms of the resources used at the surgery in 
diabetes care. These include the Whole Time Equivalent (WTE) GP, the WTE nurse 
and the number of medication items prescribed. A questionnaire was sent to a large 
random sample of patients with questions about the use of resources outside the surgery. 
We used the answers to the patient questionnaire to estimate the number of 
consultations with a diabetologist, an ophthalmologist and a dietician.
The input data extraction from the surgeries’ registers proved to be one of the most 
difficult aspects of this case study, because the surgeries do not operate a speciality- 
based-costing. In order to identify the costs attributable to primary diabetes care, new 
extraction queries had to be written and the data for most inputs had to be extracted for
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the first time. Additionally, a number of assumptions had to be made regarding the 
number of consultations with health care professionals. The difficulty arises because 
most patient consultations have more than one topic of discussion, and that health care 
professionals do not yet code consultations detailing the main topic of discussion. 
Therefore, we had to assume for all the surgeries that any diabetic patient consultation 
was an opportunity for ongoing diabetes monitoring, patient education and support. This 
was considered to be the most appropriate assumption after discussions with the health 
care professionals. It was their opinion that most consultations cover several topics and 
that diabetes is often a topic of discussion in any consultation with a diabetic.
The data regarding the costs with diabetic medication was obtained from the 
Prescribing Analysis and Cost (PACT) system published electronically by the 
Prescribing Price Authority (PPA). We now discuss in more detail each one of the 
inputs involved in primary diabetes care delivery.
6.6.3.1 Diabetes Screening
The early detection of diabetes is an important objective of primary diabetes care. As 
previously discussed, it is estimated that around half o f the type-2 patients already have 
complications at the stage of diagnosis. If an earlier diagnosis can be made, significant 
savings can result. Therefore, regular screening is one of the policies recommended in 
the diabetes NSF. However, at the time of study, regular screening was not yet policy. 
We have decided to exclude this information from our analyses. Once active screening 
becomes common practice, its inclusion in a performance assessment exercise is 
recommended.
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6.6.3.2 Medication Related to Diabetes Treatment
In order to measure technical and allocative efficiency, we have collected data in terms 
of quantities and unit costs for the different medications related to diabetes treatment.
The data for the diabetic medication is provided directly from the PACT system 
because these items relate to drugs and materials only prescribed to diabetics. The costs 
in these categories can be attributed in full to the registered diabetics. However, the data 
for the cardiovascular risk reduction medication is not as straightforward to extract. 
Both lipid-lowering drugs (for example, statins) and Angiotensin-converting Enzyme 
Inhibitors (ACEI)4 are items that can also be prescribed to non-diabetics. In this respect, 
given that we intend to identify the prescribing costs solely attributable to diabetes, a 
different method of data extraction had to be used. Firstly, we extracted the number of 
diabetic patients on Lipid-lowering drugs and the number o f diabetics on ACEI. Each 
28 days o f treatment for each patient counts as one item o f  medication. We then used 
the PPA (2002) average cost estimates for each one of these items5.
6.6.3.3 Laboratory Tests
A large number of regular blood, urine and other tests have to be done with diabetic 
patients. This represents a significant proportion of the resources used in primary 
diabetes care. However, despite our efforts, no reliable estimates could be obtained for
4 Angiotensin-converting enzyme inhibitors are medicines that block the conversion of the chemical 
‘angiotensin I' to a substance that increases salt and water retention in the body.
5 These average costs represent the costs of treating a patient for 28 days on the adult recommended dose 
of the most frequently prescribed drug for the purpose.
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the number of tests carried out by each surgery, given that the surgeries are not charged 
per volume of laboratory tests. A block contract exists between the PCTs and the 
laboratories and the payment is independent of the number of tests requested. Therefore, 
this aspect does not constitute a performance incentive. Unfortunately, duplication of 
tests and procedures can be one of the causes of technical inefficiency. We recommend 
that this component is included as soon as reliable information can be extracted.
6.6.3.4 Consultations with the GP, Diabetologist and Nurse
The extraction of data regarding the number of consultations requires the surgeries to 
keep an accurate record of all consultations, by patient number. Therefore, we had to 
restrict our sample of surgeries to those that operated a fully computerised recording 
system. We extracted data regarding all the consultations with diabetics that took place 
during the period of study. These consultations were then disaggregated by place of 
consultation (surgery consultation, home visit, telephone consultation) and by 
consultant (GP and nurse).
The number of consultations with a diabetologist could not be extracted directly 
from the surgeries’ records. Furthermore, some of the surgeries were not able to provide 
an estimate of the proportion of patients under diabetes hospital care and under diabetes 
shared care6. Therefore, we decided to use the data collected from the patient survey to 
estimate the average number of consultations with a consultant at the hospital during the 
period o f study7.
6 Patients under shared diabetes care are regularly consulted both at the GP surgery and the hospital.
7 We used the average number of times that patients reported to have had a consultation with a doctor 
outside the surgery to estimate this value.
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In order to obtain information regarding the average duration of the consultations 
with a GP and a nurse, a questionnaire was sent to each surgery (Practice Profile 
Questionnaire -  Appendix D). We intended to use this information to calculate the WTE 
GP and WTE nurse. However, not all surgeries completed this section of the 
questionnaire. Therefore, we used ‘a national average duration of consultations’ based 
on the figures published by Netten, Rees and Harrison (2001). The unit costs of one 
hour of patient contact with a nurse and a GP are also based on the estimates obtained 
by Netten, Rees and Harrison (2001). Table 6.1 presents the average duration of each 
type of consultation and the costs per WTE hour, as used in this study.
6.6.3.5 Consultations with other Diabetes Related Specialists
We wanted to include data regarding the number of times each diabetic patient had been 
seen by a diabetes-related specialist. However, due to a lack of coordination in the data 
register systems, reliable figures could not be obtained. We have used the responses 
from the patient questionnaire (Appendix B, section A) to estimate the average number 
of times that patients had a consultation with an ophthalmologist and a dietician.
Unfortunately, we could not estimate the number of times patients had a consultation 
with a chiropodist because some patients mention that they regularly consulted a private 
chiropodist (this is a common feature in terms o f foot care, given the long waiting times 
under the NHS). Therefore, we have decided to exclude the costs with the chiropodist 
from the models. We recommend that this input is included in future studies, once 
reliable data can be extracted. Table 6.1 presents the unit costs used for a consultation 
with an ophthalmologist and a dietician.
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Table 6.1: Average duration of consultations and costs per WTE hour
Average duration of consultations in minutes" Cost per WTE
____________________________________________________ hour’
Clinic Home visit Telephone (2000/2001 prices)
consultation (Includes travelling consultation 
time and travelling
____________________ expenses)________________________________________
GP 12.56 29.30 10.47 £86
Practice Nurse 18.26 26.09 10.47 £23
Diabetologist - - - £ 74 per outpatient 
appointment
Ophthalmologist “ £ 74 per outpatient 
appointment
Dietician 30 " £27
6.6.3.6 Smoking Cessation Therapy
Smoking is a cardiovascular risk factor to the general population. A number of research 
studies have suggested that the combination of smoking and diabetes leads to the 
premature development of a range of health complications, because smoking increases 
insulin resistance and interferes negatively with insulin action. Haire-Joshu, Glasgow 
and Tibbs (1999) review this literature and suggest that effective smoking cessation 
therapy should be a routine component of primary diabetes care. In the UK, smoking 
cessation is a major priority in primary diabetes care delivery and smoking cessation
8 The average duration of the consultations for GPs was obtained by dividing the cost of that type of 
consultation by the cost of one minute of GP contact with patients. The average duration of a nurse home 
visit and a nurse clinic consultation were calculated in the same way. The average duration of a nurse 
telephone consultation was assumed to be the same as for a GP. 9
9 The unit cost for the GP consultations includes overhead costs. The unit cost of an outpatient visit refers 
to the cost o f a generic visit, which is an average of the costs of a wide rage of specialities (Netten, Rees 
and Harrison 2001: 83). We used this estimate because specific estimates for diabetologist and 
ophthalmologist consultations could not be obtained.
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services are currently being developed in most GP surgeries. However, at the time of 
data extraction, reliable data regarding the costs and outcomes of these programmes 
could not be obtained. Therefore, we have decided to exclude this item from the models. 
We do recommend the inclusion of smoking cessation measures once reliable data 
becomes available.
6.6.4 Outputs -  Services Delivered in Primary Diabetes Care
The common output measure in studies of efficiency in health care provision is the age- 
standardised number of registered patients. We argue that this is a poor output measure, 
when we consider that a registered patient who has not received any service during the 
year of study should not be counted as an output. Therefore, we suggest the use of an 
activity measure. In this study, the outputs used reflect ‘services delivered in the year of 
study’. We now discuss in detail each of the outputs used in this study.
6.6.4.1 Diabetes Annual Review
Measure: Proportion of patients who attended a diabetes annual review (or initial 
review) during the period of study.
A full annual review is the most basic service that surgeries should deliver to their 
diabetic patients. This review should include a range of tests and diagnostic procedures, 
a review of the patient’s diet and/or medication, a discussion with the patient regarding 
his/her wellbeing and a discussion of the results of the tests. It is essential that all the 
information of the annual review be electronically recorded, as this is the basis for an 
automated system of patient call and re-call. Automatic letters can be produced and sent 
to the patients before the 12-month period is completed, and the system can be designed
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to give warning messages whenever a patient has not been seen for more than a pre­
defined period. The proportion of registered diabetic patients who are annually reviewed 
either at the surgery or at the hospital should therefore be very high10 1. The records of the 
patients who are not annually reviewed should be closely inspected, and these patients 
should either be invited for a review, or removed from the records if they are no longer 
registered with the surgery or if  they are found not to be diabetics. However, most 
surgeries fall very short of this performance measure (The Audit Commission 2000b), 
either because they are not reviewing their patients often enough, or because they are 
not recording it.
There is a standard register code to be entered into the patient’s medical records each 
time he/she is fully reviewed. However, some health care professionals either use their 
own codes or do not insert this information electronically. In this study, an effort was 
made to extract data including all the codes in use at each surgery. We have assumed for 
all the surgeries that a recorded annual review includes all the tests that are 
recommended as well as a review of medication and education. There was no way of 
verifying this from the surgeries records. The proportion of registered diabetic patients 
who have had a full annual review is, therefore, the first, and most important, output 
measure in primary diabetes care delivery. The number of patients who have had an 
annual review includes the newly diagnosed patients" who have had a full initial 
diabetes review.
10 The new GP contract (British Medical Association 2003) establishes a target of 90% for this measure.
11 Newly diagnosed patients are those patients who were diagnosed as diabetics during the period of 
study, that is, between October 2001 and September 2002.
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6.6.4.2 Cardiovascular Risk Reduction
Measure 1: Proportion of patients with cardiovascular diseases or at risk of developing 
cardiovascular diseases, who are on lipid lowering medication.
Measure 2: Proportion of patients aged 40 years old or more who are on anti­
hypertensive medication.
In order to account for the services related to cardiovascular risk reduction, we have 
decided to include two outputs regarding the proportion of high-risk diabetic patients 
who are under adequate medication.
The first of these output measures represents the proportion of patients with 
Ischaemic Heart Disease (IHD), or at risk of developing IHD (that is, diabetic patients 
aged between 35-70 years old, with total cholesterol > 5 mmol/112), who are on regular 
treatment with lipid lowering medication. The most common type of medication for 
lipid lowering is statins. The prescription of statins to diabetic patients has been showed 
to lead to significant reductions in coronary events, revascularisation and stroke (Heart 
Protection Study Collaborative Group 2003).
The last output measure represents the proportion of diabetic patients aged over 40 
years old who are on anti-hypertensive medication. The most common type of 
medication used is ACEI. Regular treatment with ACEI is recommended in all diabetics 
over 40 years old, independently of their BP value, because ACEI have been shown to 
have other major health benefits in diabetics (cardiovascular and renal protection), 
independently of BP reduction (The Heart Outcome Prevention Evaluation Study 
Investigators 2000).
12 Mmol/1 is the standard unit of measurement of concentration of cholesterol in the blood.
6.6.5 Outcomes: Impact of Primary Diabetes Care
The most important outcomes of primary diabetes care relate to the achievement of 
near-normal metabolic values, the improvement of patient understanding of diabetes 
and the improvement of patients well being. The specific outcome measures chosen for 
this study, as well as the specific threshold levels for the clinical measures resulted from 
the literature review and the discussions with the health care professionals. Measures of 
outcome achievement were chosen instead of outcome improvement because these were 
believed to better reflect how close each surgery is to the achievement o f  its objectives. 
Furthermore, the new GP contract (British Medical Association 2003) also uses 
measures of outcome achievement for target setting. We provide a brief justification for 
the specific measures used, as well as the specific threshold levels chosen.
6.6.5.1 Blood Glucose Level
Measure: Proportion of patients with the latest Glycated Haemoglobin (HbAlc) < 7% 
(it requires the patients to have at least one HbAlc measurement during the 12-month 
period of study).
Glycated Haemoglobin (HbAlc) measures the average blood glucose level of the 
previous 120 days, with a greater weight given to the 30 days preceding the 
measurement. This is a standardised measure of ‘long-term’ blood glucose, used by 
researchers, health professionals and patients to identify targets of diabetes control.
The generic aim is to reduce the levels of blood glucose to as near normal levels as 
possible. The normal level o f HbAlc in non-diabetics is between 5.5% and 6.5%. The 
results of the UK Prospective Diabetes Study Group (UKPDS) (1998a) suggest that
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diabetes related complications and diabetes related death can be prevented by lowering 
blood glucose levels in patients with type-2 diabetes.
Using the UKPDS (1998a) recommendation as a template, it was agreed that a 7% 
measure should be used as the cut-off point, despite the use of a 7.5% cut-off point in 
the NSF for diabetes. An HbAlc of less than 7% is considered a good outcome, whilst 
an HbAlc between 7% and 7.5% is only considered as an acceptable outcome.
6.6.5.2 Blood Pressure Level
Measure: Proportion o f  patients with the most recent reading of Blood Pressure (BP) 
<140/80 mm Hg (it requires the patients to have at least one BP reading during the 12- 
month period of study).
The inclusion of this outcome results from strong research evidence supporting a 
tight control of BP in diabetic patients. There are two major studies supporting a tight 
control of BP in diabetic patients. The UKPDS hypertension study (1998b) involved a 
randomisation of a sample of diabetics with hypertension into conventional treatment 
and intensive treatment. A significant reduction in diabetes related complications and 
death was observed in patients subject to intensive BP control. The second study was 
the Hypertension Outcomes Trial (Hansson et al. 1998), which involved the 
randomisation of a large number of hypertensive patients into three groups (aiming for 
diastolic BP under 90, under 85 and under 80). This study showed a 50% reduction of 
cardiovascular morbidity and mortality in the diabetic patients achieving diastolic BP 
under 80 mm Hg.
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6.6.5.3 Blood Cholesterol Level
Measure: Proportion of diabetic patients with the most recent measurement of total 
cholesterol < 5 mmol/1 (it requires the patients to have at least one total cholesterol 
measurement during the 12-month period of study).
Total cholesterol concentration is a risk factor for the development of CHD within 
the general population. The results of the UKPDS (1998a) suggest that an increased 
concentration o f total cholesterol is a major risk factor in the development of CHD in 
patients with diabetes type-2. As secondary prevention, therapy is recommended to 
reduce the total cholesterol level in all patients with history of CHD. It is also 
recommended as primary prevention in diabetic patients who are at risk o f developing 
cardiovascular complications. The threshold of total cholesterol 5 5 mmol/1 reflects the 
research evidence and the views of the clinicians as to what level is desirable.
6.6.S.4 Patient Understanding of the Condition and its Management
Measure: Average proportion of patients who reported to have a good understanding in
terms of diabetes and its management13.
Patients’ motivation and ability to effectively manage the condition is crucial to 
achieve optimum metabolic control and to prevent the development of complications 
(Home et al. 1999). Health care professionals play a crucial role in terms of patient 
education and empowerment. Therefore, we believe that the level of patient 
understanding of diabetes and its management is an important outcome of primary 1
11 This measure was estimated by calculating the average o f the proportions of patients who answered ‘I 
understand enough' to items a-i included in Section B of the questionnaire (Appendix B).
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diabetes care. In this study we have used a multi-item question to assess this outcome. 
This question assesses the patients’ perceived understanding of the essential aspects of 
diabetes and its management. These are essential aspects related to diabetes, its 
management and its effects on a patient’s health. Any patient with diabetes should have 
a reasonable understanding o f all these aspects. For the list of questions used, please 
refer to the patient questionnaire (Appendix B, section B).
6.6.5.5 Patient Perceived Quality of Diabetes Care
Measure: Average estimated proportion of patients who answered ‘Always’ or ‘Most 
Times’ regarding the quality of diabetes services provided at the surgery14.
The fifth objective of diabetes care relates to the reduction of the impact of diabetes 
on patients. In this study we have attempted to capture this element by assessing the 
patient perceived quality o f services delivery. A multi-item question was developed to 
capture the elements of primary diabetes care that can impact upon the quality of 
patients’ lives. These elements include easiness and convenience of access to services; 
clinicians’ efforts to involve the patients in the decisions of care; clinicians’ time to 
listen and talk to the patients; the support clinicians give to the patients; consistency of 
advice given and usefulness of education materials given15. For the specific questions 
used, please refer to the patient questionnaire (Appendix B, section C).
14 This measure was estimated by calculating the average of the proportions of patients who answered 
‘Always’ or ‘Most times’ to items a-m of Section C of the questionnaire (Appendix B).
15 Items regarding the comfort o f the waiting areas in the surgery and other logistic aspects have not been 
included because they were not seen as having a significant impact on patients' Quality of life.
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6.6.5.8 Patient Confidence
Measure: Proportion of patients who report feeling ‘Very Confident’ or ‘Confident’ in 
taking good control over their diabetes.
In order to be able to actively control their diabetes, patients need to feel confident 
regarding the usefulness of continuous treatment and lifestyle changes. In a chronic 
condition, such as diabetes, where the effects of good control are only visible in the long 
term, having full confidence in being able to control the condition is essential. The role 
of the health care professionals is very important in building this confidence. Therefore, 
we believe that an assessment of how confident patients feel in taking good control of 
their diabetes is essential to evaluate the quality of care provided. The data for this 
outcome was extracted from the answers to question 3 o f section B of the patient 
questionnaire (Appendix B).
6.7 The Use of Proportions as Outputs in DEA
In our models of efficiency and effectiveness, we have used proportions as outputs, as it 
was believed that these were the measures that better represented the objectives related 
to diabetes management. We must stress that the proportion of patients with BP under 
control is more important than the actual number of patients with BP under control. By 
using a proportion measure we simultaneously account for service delivery and need. 
Proportion measures are also the measures used by the Government both in the 
definition of the NSF Pis and in the performance related pay targets stipulated in the 
new GP contract. Therefore, it was believed that it is important to use proportions in 
order to evaluate the performance of the surgeries in these terms and to evaluate the 
impact on costs o f using this type of measures.
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However, as pointed out by Femandez-Castro and Smith (1994), using proportions in 
DEA can lead to incorrect inferences. The problem is that DEA calculates an 
approximate weighted average with the proportions, which can be different from the 
correct weighted average that would be obtained if  the ratios were used. However, as 
suggested by Salinas-Jimenez and Smith (1996), this approximation is often used and it 
does not lead to serious problems in most studies.
In our case study, we also ran the models using volume measures and the number of 
surgeries deemed efficient and cost-effective was in fact smaller. This results from the 
fact that a DEA model that uses proportions as outputs implicitly has more variables 
than a DEA model that uses volume measures. For example, if the proportion of 
diabetics with BP under control is used as an output, this is equivalent to using a model 
where the number of diabetics has been used as a non-controllable input and the number 
of diabetics with BP under control has been used as an output, and where the weights of 
these two variables have been restricted to be the same. Whilst the use of volume 
measures might be considered advantageous given the greater discrimination that it 
provides, we believe that the use of proportions provides fairer estimates of efficiency 
and cost effectiveness by taking into account the level of need in each surgery.
However, when the outputs are represented in proportions, we need to represent the 
inputs as the average amount of resources spent per patient in order to establish that an 
increase in the inputs should lead to an increase in the outputs. Once this has been done, 
we can use the CCR model to compare the efficiencies of different units (Cooper, 
Seiford and Tone 1999).
One further concern regarding the use of proportions as outputs relates to the 
possibility o f obtaining meaningless targets (projections to an output level beyond 
100%), if an output oriented model is used. In our case study, whenever proportions
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were used as outputs, we used input oriented models, which means that meaningful 
targets can be calculated. Furthermore, as discussed by Dyson et al. (2002), it is 
important not to combine measures of volume with proportion measures in the same 
model, as this leads to a break down in terms of proportionality.
6.8 Conclusion
In this chapter we have provided the background for the case study in primary diabetes 
care. We have justified the need for a formative evaluation in primary diabetes care. The 
drawbacks of the newly developed National Service Framework for diabetes were also 
discussed. We have provided a brief characterisation of diabetes in order to facilitate the 
discussion of the framework for evaluation in primary diabetes care. The needs, 
objectives, resources, outputs and outcomes of primary diabetes care were also 
discussed in some detail, in order to justify the performance assessment models used in 
the next chapter. We will discuss the data available from the participating GP surgeries 
and report on the results obtained from the data analyses in chapter 7.
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7 Data, M odels and Results
7.1 Introduction
In this chapter we present the results from the formative evaluation undertaken for a 
sample of surgeries in terms of their diabetes service delivery. In Section 7.2 we make a 
brief characterisation of these surgeries in order to familiarise the reader with the 
providers under comparison and discuss the data limitations. In Section 7.3, we discus 
the data used and its limitations. In Section 7.4 we detail the analyses based on the 
performance assessment framework outlined in Chapter 6. In this respect, we present 
and discuss the results in terms of equity, efficiency and effectiveness. Section 7.5 
concludes this chapter.
7.2 A Brief Characterisation of the Surgeries Under Comparison
In the course of this project, we collected data from 23 surgeries, including data from 
the patient questionnaire and the practice profile questionnaire. At this stage we have 
decided to perform a detailed analysis of the results o f 14 surgeries only, as we are 
concerned over the quality of the data extracted from the remaining surgeries. For the 
14 surgeries studied we are certain that the data has been extracted using consistent 
methods, and that the data is of reliable quality. This chapter presents the results for this 
sample of 14 surgeries. The data extracted for the remaining 9 surgeries was then used 
at a second stage to evaluate the robustness of the results obtained for the performance 
of the 14 surgeries studied.
In terms of the surgeries included in the analyses, 12 belong to South Peterborough 
PCT, one belongs to Melton and Rutland PCT and the other belongs to Heartlands PCT.
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To maintain anonymity, the surgeries have been given an identification number. Table
7.1 provides an overview of these surgeries regarding their location and size.
Table 7.1: Characteristics of the surgeries
Surgeries Number of 
registered 
patients
Number of 
diabetics
Location Total 
number 
of GPs 
(WTE)
Average list 
size per 
WTE GP
Total
number
of
Nurses
(WTE)
Diabetes
clinics
1
2
11,506
12,843
426 (3.70%) 
346 (2.69%)
Mixed
Mixed
5.5
7.75“
2,092
1,675“
3.075
3.6
GP/Nurse-led 
twice weekly 
Nurse-led 
twice weekly
3 8,654 211 (3.44%) Suburban 5.5 1,573 3 Nurse-led five 
times a week
4 10,352 286 (2.76%) Rural 5.75 1,800 1.5 Nurse-led 
twice weekly
5 6,958 214(3.08%) Rural 3.5° 1,988 3 Nurse-ledmonthly
6 13,722 461 (3.36%) Mixed 7.75°
CO1,771 6 GP/Nurse-ledweekly
7 5,760 145 (2.52%) Rural 3“
(01,920 3 No diabetes clinic
8 3,869 114(2.95%) Inner city 2 1,935 1 GP/Nurse-led
weekly
9 8,758 239 (2.73%) Mixed 4E 2,190 1.5 No diabetes clinic
11 1,334 25(1.87%) Rural i 1,334 0.875 Nurse-led
monthly
12 2,045 51 (2.49%) Suburban 1.5625 1,309 1 Nurse-led
weekly
13 3,849 88 (2.29%) Inner city 1£ 3,849 1.13 No diabetes clinic
23 16,528 471 (2.85%) Suburban 7P 2,361“ 3.5 GP/Nurse-leddaily
24 34,340 972 (2.83%) Mixed 16.5Y 2,081“ 15 GP/Nurse-lcddaily
Key
WTE Whole Time Equivalent 
Ct One GP trainee
P Two GP trainees
y  Three GP trainees
£ One vacancy
(0 Excluding GP trainees
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Most surgeries operate from a single location. However, Surgery 5 operates from 
three separate locations; Surgery 6 and Surgery 7 operate from two locations. After 
discussions with the Practice Managers at each one of these three surgeries, it was 
decided that it would not be relevant to separate the analyses for each one of the 
locations, as they were said to operate as a whole.
From Table 7.1, we note that the 14 surgeries included in this study vary 
considerably in size with the smallest surgery (Surgery 11) managing only 1,334 
patients, and the largest surgery (Surgery 24) managing 34,340 patients. Furthermore, 
they vary in terms of the average number of patients per GP. Surgery 11, again, has the 
smallest list per GP (1,334 patients) and Surgery 13, currently with a GP vacancy 
managing an average of 3,849 patients per GP. Arguably, this would compromise 
homogeneity if the objective were one of classification and target setting. However, 
given that the purpose of this study is exploratory and formative, we believe that this 
may contribute to the discussion regarding the association between list size and the 
quality of the services provided. Wilkin et at. (1987) in their study of General Practice 
in Manchester concluded that the ideal list size appears to be between 2,000 and 2,500 
patients per WTE GP, and found no evidence that that a list size smaller than 2,000 
patients brings additional benefits to the patients.
We can also notice that the diabetes prevalence varies from surgery to surgery. This 
is partly explained as a result of population characteristics, but it may also be a result of 
different screening policies. Furthermore, the number of diabetics registered with each 
surgery varies from 25 to 972, which indicates that different surgeries may have 
different incentives to implement an effective diabetes management system. One of the 
possibilities introduced by the new GP contract is that surgeries can ‘opt out’ of diabetes 
provision if they feel that its management is not cost-effective (British Medical
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Association 2003). In this case, the PCTs will have to provide diabetes services to the 
patients. Despite the different number of diabetics, all 14 surgeries provide diabetes 
services to their patients and all of them have a formal lead person for diabetes (a person 
with a special interest in diabetes). Furthermore, all of the surgeries wanted to be 
included in the study in order to evaluate their performance in relation to the others.
This leads us to the next issue. It is important to repeat that all 14 surgeries agreed to 
take part in this research project and were involved in the development of the 
framework for evaluation and the development of the patient questionnaire. A long 
process of consultation took place with each surgery prior to the data extraction and the 
patient survey. In this respect, all these 14 surgeries volunteered to take part in this 
research study. We feel that this is very important in order to obtain meaningful results, 
which may be of use in practice. However, considering this process of self-selection, it 
is possible that the results presented here portray a biased picture in terms of equity, 
efficiency and effectiveness in primary diabetes care delivery in England. It is natural to 
expect that these 14 surgeries are already trying to do their best and are all engaged in 
improving their diabetes care. Our intention is to use the results from this sample to 
assess the potential of DEA as a tool for formative evaluation in primary heath care; and 
to identify some of the structures and mechanisms behind successful performance 
within this small sample. However, when we consider the fact that a small self-selected 
sample was analysed, care needs to be taken in terms of the interpretation of the results 
and of its generalisation.
As previously discussed, the data collection was the most difficult part in this case 
study. Firstly, most of the data had never been extracted before. Several discussions 
with the information facilitators of each PCT took place in order to identify the 
variables for which there would be reliable data. Extraction queries were then written in
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order to extract data in a comparable format from all the surgeries. Secondly, this 
research project coincided with a very busy period both to the PCTs and to the 
surgeries; as a result, the data collection process was longer than expected. The data 
used in this case study is presented in Appendix F. Further to the discussion in Chapter 
6, there are some specific observations about the data quality that we should make 
before proceeding to the data analysis.
7.3 The Data and its Limitations
The prescribing data was obtained from the Prescribing Price Authority and the data 
regarding the number of consultations was extracted from the surgeries’ computer 
register systems. When we consider that all the surgeries included in the analyses 
operate a computerised appointments system, the data for these inputs should be of 
reliable quality.
The data for the outputs and the outcomes was extracted from the surgeries’ clinical 
systems, using for each variable all the codes in use at each surgery. For example, with 
regards to the main output, which is the ‘proportion of patients who have had a full 
diabetes annual review’, an effort was made to identify all the codes used in each 
surgery for this procedure. Despite the fact that there is a standard code for this 
procedure, this code is not used by all professionals in all surgeries. Some surgeries 
have created their own codes. Furthermore, it is conceivable that in certain cases, the 
procedure is carried out but it is not recorded in the computer. Naturally, the data 
extraction cannot identify cases where procedures were not recorded or where the
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procedures were wrongly coded16. For this reason, the results may be bias against 
surgeries that are not recording or correctly coding all their activities.
We are convinced that, within our sample, the number of cases that have not been 
recorded or correctly coded, should be low, because the surgeries have undergone a 
long period of training regarding clinical coding and recording. This is one of the 
reasons why we are working with a small sample. Surgeries where the electronic 
recording was poor had to be excluded. It is expected that with the implementation of 
the National Service Framework for diabetes, the standard of data in primary diabetes 
care will improve significantly across all surgeries in England. This should facilitate 
future implementation of a process o f regular formative evaluation in primary care.
7.4 Performance Results
We will now present the results obtained from our comparison of the 14 surgeries in 
terms of geographical equity, efficiency and effectiveness. Our DEA measures follow 
the methodology outlined in chapter 2 and the variables included in the different models 
follow the discussion carried out in chapter 6.
7.4.1 Equity of Service Utilisation
We are interested in measuring equity of utilisation at an aggregated level, in particular, 
on a geographical level. We must now clarify how we have measured equity of 
utilisation.
16 It is interesting to note that most clinical computer systems can lead to coding errors when the ‘search’ 
facility is used. For example, if the term ‘diabetes review’ is typed several different codes are suggested, 
and it is up to the professional to choose the one to use. Obviously, this can cause some problems in terms 
of standardization.
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In Chapter 4, we defined horizontal equity as the assessment of whether groups of 
patients with a similar level of need receive consistent treatment. Three ways to assess 
the level of treatment received were discussed: (1) level of resources used, (2) level of 
services utilisation and (3) level of outcomes achieved. To assess equity based on the 
level of resources used is problematic because it is influenced by the level of efficiency 
of each provider. To assess equity based on the level of outcomes achievement requires 
careful consideration given the strong impact of patients’ characteristics on the 
outcomes. For these reasons, we investigate whether diabetic patients registered with 
different surgeries show, on average, similar utilisation rates of the services they equally 
need. We assume that there are a number of services that are essential in diabetes care 
and that all diabetic patients have an equal need to receive those services. According to 
British Diabetic Association (2001) there are seven essential services that all diabetics 
should receive at least once a year (please refer to Model 7.1 below).
We used the patient questionnaire to obtain this data because the surgery records 
were incomplete regarding the procedures or tests that had been undertaken outside the 
surgery, as a result of poor coordination with other local providers. We have asked the 
representative sample of patients from each surgery to indicate the number of times they 
had certain services over the previous 12 months (please refer to Section 1 of the 
questionnaire in Appendix B).
Model 7.1: Variables used for the measurement of Equity
Estimated proportion of diabetics who have had these essential services in the previous 12 
months 1
(1) A detailed eye examination, with dilated pupils
(2) A detailed examination of feet and legs
(3) A review of the blood pressure (BP)
(4) A review of blood cholesterol
(5) A review of the blood glucose by means of a HbAlc test
(6) A review of the kidney function, by urine and blood tests to check for protein
(7) A review of the medication, diet and any other relevant matters, with a doctor or a nurse
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For an assessment of equity, we are not concerned whether the patients have had the 
essential diabetes services at the surgery or outside the surgery. Our objective is to 
assess whether particular groups of patients have systematically not received certain 
services, for reasons outside their control. This leads us to an essential point in the 
assessment of equity of utilisation: the fact that different patients may have different 
propensities to utilise health services. Inequality in utilisation rates does not necessarily 
mean inequality in access. To account for this problem, we have included an open 
question in the questionnaire, asking the patients to justify why they have not received 
particular services. We hope that patients would acknowledge when it was their 
decision not to attend a consultation or test offered. Examples where the patient 
acknowledges being offered a service and refusing to take it were excluded from the 
assessment of equity. For example, we have found that many patients who did not have 
any consultation with a dietician provided a suitable justification. These patients state 
that despite being offered an appointment with a dietician, they refused to take it, 
because they did not find such consultation necessary or useful. For this reason, we 
decided not to include ‘a consultation with a dietician’ in the measurement of equity.
To conclude, our measure o f service utilisation for the measurement of equity is 
defined as the proportion of diabetics within each surgery who report having received 
all the essential diabetes services during the 12-month period of this study. This 
proportion was analysed across our sample of surgeries for the whole set of diabetics. 
The list of essential services considered is presented in Model 7.1 and the results o f this 
assessment are presented in Table 7.2 below.
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Table 7.2: Equity results
Results Equity Equity Equity
Surgeries Model 7.1 Model 7.1 Model 7.1
Mean proportion of diabetics 
who received all services
95% Confidence interval 
lower limit
95% Confidence interval 
upper limit
1 84.73% 79.60% 89.86%
2 88.98% 84.39% 93.58%
3 84.88% 79.04% 90.72%
4 90.20% 86.98% 93.41%
5 78.64% 72.93% 84.35%
6 80.54% 75.30% 85.77%
7 72.00% 64.92% 79.08%
8 75.00% 66.28% 83.72%
9 71.56% 65.30% 77.82%
11 64.29% 47.29% 81.28%
12 59.09% 43.44% 74.74%
13 78.38% 68.22% 88.53%
23 77.50% 71.04% 83.96%
24 67.89% 62.43% 73.35%
Average 76.69% 69.08% 84.30%
The average proportion o f patients who have received all the essential diabetes 
services across the 14 surgeries is 76.69%. Therefore, we can conclude that, on average, 
23% of the patients have not received some of the essential services in the 12-month 
period of this study. There may be several reasons for this:
(1) random variability in the data, given that only a sample of patients was 
surveyed;
(2) patients may have forgotten about a particular check they had, or may have been 
confused about when they had that check. However, it is reasonable to expect 
that on average, surgeries will be equally penalised by inaccuracies of patients’ 
memories, and therefore a relative comparison is meaningful;
(3) certain surgeries operate a late ‘call and re-call system’ for the essential diabetes 
services, which means that some patients are not reviewed within the 
recommended 12-month period;
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(4) certain surgeries have relatively poor coordination with the local hospital and 
local opticians, and this means that a proportion of their patients have not had an 
annual eye check, for example;
(5) certain surgeries have not invited some of their diabetic patients for some of the 
annual checks.
Once all these factors have been considered, if, for example, one surgery presents a 
significantly lower proportion of patients who have not received all the essential 
services, this can be an indication of relatively ‘poorer access’ in that surgery. Surgery 
12 presents the lowest score (59.09%). This score is significantly lower than the average 
at the 95% confidence level. However, Surgery 4 presents the highest score in terms of 
equity, given that more than 90% of its patients report having received all the essential 
services in the 12 month-period o f this study. This score is significantly higher than the 
average at the 95% confidence level. Therefore, we can state that a diabetic patient 
registered with Surgery 12 has a significantly lower probability of receiving all the 
essential diabetes services when compared to a patient registered with Surgery 4. 
Further investigation regarding which particular service is being missed at each surgery 
should lead towards corrective action.
7.4.2 Technical Efficiency
Technical efficiency refers to the optimal use of resources in the delivery of services. 
The model used for technical efficiency is Model 7.2 below. We used three inputs and 
three outputs to measure technical efficiency. It must be remembered that we only have 
a small sample of surgeries to compare and, as a result, we had to reduce the number of 
variables, in order to obtain some discrimination between the surgeries. Instead of using
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the quantities for all the individual medication items prescribed, we have used an 
average number of medication items prescribed to each diabetic. We previously defined 
that an item of medication is the average dosage necessary for 28 days of treatment. The 
two other inputs used were the WTE GP and the WTE nurse per diabetic. The first 
output represents the proportion of patients who have had a diabetes annual review in 
the previous 12 months. The second output measures the proportion of patients who are 
receiving anti-hypertensive medication (ACEI). The third output measures the 
proportion of patients under regular treatment with lipid-lowering medication (statins).
An input-oriented model was used in order to calculate the minimum quantities of 
resources that allow the current delivery of diabetes services. We have assumed 
constant returns to scale as Model 7.2 only uses variable inputs that should be 
proportional to the number of registered diabetic patients. Any diseconomies of scale 
that might have existed have been reduced by the fact that the PCT contracts specialist 
professionals, which go to each surgery to provide extra diabetes care, if needed. 
Therefore, as we could not find any evidence of economies or diseconomies o f scale, we 
have decided to use a CRS model.
We have decided not to introduce any weight restrictions in the models because we 
want to decompose overall efficiency into its technical and allocative components. For 
this reason the input weights should be unrestricted so that the input mix effect is 
captured by comparing the results of a model with total flexibility of input weights and 
a model which uses the input unit prices as the weights. The software used to run the 
DEA models was Onfront 2 developed by the Economic Measurement and Quality in 
Lund Corporation (1998-2000) and EMS 1.3 developed by Holger Scheel. Table 7.3 
presents the results of technical efficiency.
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Model 7.2: Variables used for the measurement of Technical Efficiency -  input
oriented
Inputs Outputs
(1) WTE GP per diabetic
(2) WTE Nurse per diabetic
(3) Average number of medication items 
prescribed per diabetic
(1) Proportion of diabetics who have had a 
complete diabetes Annual Review
(2) Proportion of diabetics on targeted 
ACEI
(3) Proportion of diabetics on targeted 
statins
Table 7.3: Technical efficiency results
Results Technical Efficiency Peers
Surgeries Model B Model B
Fi(y,x) | CRS) Fi(y,x) | CRS)
1 85.52% 6(0.10) 9(0.14) 23(0.66)
2 100.00% 2
3 83.00% 6(0.18) 9(0.03) 23(0.62)
4 98.29% 6(0.34) 8(0.39) 23(0.34)
5 86.72% 2(0.22) 6(0.53) 23(0.04)
6 100.00% 6
7 93.81% 2(0.34) 6(0.47) 23(0.21)
8 100.00% 1
9 100.00% 3
11 100.00% 0
12 71.20% 9(0.53) 23(0.25)
13 100.00% 1
23 100.00% 7
24 86.09% 6(0.47) 13(0.14) 23(0.38)
Average 93.19%
From Table 7.3 we can see that Model 7.2 results in 7 out of the 14 surgeries being 
classified as technically efficient. The average efficiency score is 93.19%. For the 
efficient surgeries it is of interest to investigate the number of times that each surgery 
appears as a peer to non-efficient surgeries. This provides us with an indication 
regarding the comparison group that each surgery used to classify itself, and an 
indication regarding the robustness of its score.
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For example, Surgery 23 is peer to 7 surgeries, Surgery 6 is peer to 6 surgeries and 
Surgery 9 is peer to 3 surgeries. From another side, Surgery 11 is only peer to itself. 
This means that Surgery 11 is able to appear efficient by choosing a unique weight 
structure. In particular, in order to appear efficient, Surgery 11 puts most of its input 
weights on the WTE nurse per patient, and all of its output weights on the proportion of 
patients under regular treatment with ACEI. When we consider that no other surgery 
benefits from this weight structure, Surgery 11 does not have a comparison group and 
appears efficient as a result. Surgery 11 can then be defined as a self-evaluator DMU.
Surgery 12 presents the lowest score in terms of technical efficiency. An analysis of 
the optimal values for the intensity variables reveals that Surgery 9 and Surgery 23 are 
the peers for Surgery 12.
This means that a virtual surgery can be created by using the following convex 
combination:
(0.53 x Surgery, + 0.25 x Surgery2J).
This virtual surgery delivers at least the same quantities of outputs as Surgery 12, but 
uses only 71.20% of the inputs used by Surgery 12. Further investigation reveals that 
with this reduced set of inputs is possible to achieve greater levels o f outputs, as there is 
a 7.29% slack on the proportion of patients under regular treatment with ACEI; and 
7.03% slack on the proportion of patients under regular treatment with statins.
7.4.3 Cost Efficiency - Introducing Information about Input Prices
Some of the surgeries have used a non-economical weight structure in order to increase 
their efficiency score. For example, Surgery 11 was classified as technically efficient by 
placing all its input weight on the WTE nurse whilst ignoring the other two inputs. This 
reflects an input mix that is sub-optimal in terms of allocative efficiency. Furthermore,
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it leads to unrealistic marginal rates of input substitution. When we consider that we 
have estimates for the input prices, it is beneficial to use this information in order to 
calculate cost efficiency. This type of efficiency aims to minimise the costs, whilst 
maintaining the current level of outputs. Cost efficiency is the most demanding of all 
efficiency measures. It requires an optimisation in terms of quantities of inputs used to 
produce the outputs, but also it requires that the input mix is optimal given the current 
input prices. Once an estimate of cost or overall efficiency is obtained it is of interest to 
decompose it into its constituent components, as discussed in chapter 2.
To calculate cost efficiency we have used Model 7.2, together with the following 
labour unit costs: £86 per hour of WTE GP; £23 per hour of WTE nurse. The average 
unit cost for the medication varies between surgeries, and the figures are presented in 
Appendix F (Table F5).
7.4.3.1 Decomposition of Cost Efficiency
We have decomposed our measure of cost efficiency into allocative efficiency and pure 
technical efficiency, in order to obtain some insights regarding the sources of 
inefficiency in each surgery.
Allocative efficiency is calculated by comparing the score of cost efficiency with the 
score of technical efficiency. It is worth noting that if a certain surgery is not using the 
most adequate input mix, its score of cost efficiency will be inferior to its score of 
technical efficiency.
Table 7.4 presents the results for cost efficiency, allocative efficiency and technical 
efficiency. The mean level of cost efficiency is 85.28%, which indicates that on average 
savings of 14.72% could be made on the costs, whilst maintaining the current level of 
service delivery. Further investigation of the optimal input values for each surgery will
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pin point which inputs need to be reduced and which inputs need to be increased in 
order to obtain cost efficiency. We have two surgeries that are cost efficient: Surgery 2 
and Surgery 23. Once again, surgery 12 presents the lowest efficiency score. In order to 
understand the sources of the inefficiency in each one of the inefficient surgeries, we 
need to analyse the results from the decomposition into allocative and technical 
efficiency.
Table 7.4: Decomposition of cost efficiency
Results Cost efficiency Allocative efficiency Technical efficiency
Surgeries Model B Model B Model B
Oi(y,x,w) | CRS) Ai(y,x,w) | CRS) Fi(y,x) | CRS)
1 80.64% 94.29% 85.52%
2 100.00% 100.00% 100.00%
3 74.38% 89.61% 83.00%
4 88.75% 90.29% 98.29%
5 76.77% 88.53% 86.72%
6 89.18% 89.18% 100.00%
7 84.09% 89.64% 93.81%
8 94.70% 94.70% 100.00%
9 94.86% 94.86% 100.00%
11 71.64% 71.64% 100.00%
12 68.63% 96.40% 71.19%
13 91.69% 91.69% 100.00%
23 100.00% 100.00% 100.00%
24 78.55% 91.24% 86.09%
Average 85.28% 91.51% 93.19%
7.4.3.2 Allocative Efficiency and Input Mix
In terms of allocative efficiency, which strictly measures how the current input mix fits 
the input prices, we have an average score of 91.51%. Surgery 12 is no longer the worst 
performer using this criterion, presenting a score o f 96.40%. This means that its low 
cost efficiency results primarily from technical efficiency. Its technical efficiency score 
is 71.20%. After radially reducing all its inputs to 71.20% of their current value, 
Surgery 12 removes most of its inefficiency.
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On the contrary, Surgery 11, which was classified as technically efficient, presents a 
score of 71.64% in terms of allocative efficiency. As we have suggested before, its input 
mix does not fit the current input prices. We can recall that this surgery was a self­
evaluator and was classified as efficient by assigning all its input weights to WTE 
nurse, which is economically unreasonable. We can further investigate the problem with 
the input structure of Surgery 11 by comparing its current input mix with its optimal 
input mix. Table 7.5 presents the values for the current input quantities for each surgery. 
For example, Surgery 11 ’s current ratio of WTE GP to WTE nurse is 2.53. This is a 
very costly input mix, given that one hour of WTE GP is nearly 4 times more expensive 
than that of WTE nurse. To further this situation, Surgery 11 presents the highest figure 
in terms of the number of medication items prescribed per patient. This surgery is 
classified as cost inefficient, because its costly use of resources is not compensated by a 
high enough level of service delivery.
We can recall that Surgery 11 is the smallest surgery working with a single GP. It 
has the smallest number of registered patients (1,334), which means that this GP has 
more time to spend with its patients than GPs in other surgeries. Whilst this is a positive 
aspect from the patients’ point of view, there is certainly an opportunity cost associated 
with its relatively small list size. It is of interest to investigate whether this extra time 
brings additional benefits in terms of outcomes achievement and we will investigate that 
later.
Surgery 23 is cost efficient, despite having a high ratio o f WTE GP to WTE Nurse. 
This is because Surgery 23 prescribes a lower than average number of medication items, 
and is able to deliver a large enough number of services to compensate for the 
expensive labour mix chosen. For example, this surgery presents the highest figure in
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terms of the proportion of patients that have had an annual review in the 12-month 
period (83.23%).
Table 7.5: Current and optimal input mix
Results Current input quantities Optimal input quantities -  Model B
Surgeries W T E  GP W TE Nurse 
Hours Hours 
per patient per patient
Number of medication 
items prescribed 
per patient (average)
W TE GP 
Hours 
per patient
W TE Nurse 
Hours 
per patient
Number of medication 
items prescribed 
per patient (average)
1 1.85 1.18 21.32 1.63 0.76 16.84
2 1.77 2.08 22.28 1.77 2.08 22.28
3 1.74 2.16 20.67 1.49 0.75 15.55
4 1.65 1.70 23.59 1.77 1.30 19.78
5 1.32 1.61 21.80 1.42 0.85 15.33
6 1.27 1.5 24.81 1.84 0.86 19.06
7 1.70 1.7 24.86 1.66 1.54 19.55
8 1.43 1.82 21.06 1.59 1.55 19.02
9 1.53 1.23 20.53 1.79 0.84 18.48
11 2.23 0.88 31.17 1.77 1.52 20.51
12 1.80 1.27 22.12 1.42 0.66 14.66
13 1.25 1.59 17.43 1.49 0.70 15.37
23 1.88 0.88 19.45 1.88 0.88 19.45
24 1.73 2.05 25.01 1.79 0.84 18.54
Average 1 .65 1.55 22.58 1.67 1.08 18.17
Min. 1 .25 0.88 17.43 1.42 0 .6 6 15.33
Max. 2 .2 3 2.16 31 .17 1.88 2.08 22 .28
7.3.3.3 Including Information about Consultations with Specialists in the 
Measurement of Efficiency
In all the models used until now, we have ignored the number of consultations with 
diabetes related specialists. We are referring to the number of consultations with an 
ophthalmologist, a diabetologist and a dietician, which should be included in the model 
in order to make a fairer evaluation of a surgery’s efficiency. We have excluded this 
information in most of our performance models, as the data extracted from the surgeries 
for these variables is not reliable. This type of data tends to be kept in the form of 
letters, which are not always entered in the computer. The extraction of this data is 
therefore very difficult.
169
The Diabetes Services Questionnaire was designed to obtain estimates for this data. 
We asked the patients how many times in the previous 12 months they had had each 
type of consultation. Using their responses we were able to estimate data for the average 
number of consultations with an ophthalmologist, a diabetologist and a dietician. We 
must remember that this data was estimated using the responses from the patient 
questionnaire, and as a result we need to take heed regarding its interpretation. Model
7.3 includes the estimates for the average number of consultations with an 
ophthalmologist, a diabetologist and a dietician. The efficiency results from this model 
are presented in Table 7.6.
The results for technical efficiency increase significantly after the inclusion of this 
information. Three new inputs are included, and considering that no weight restrictions 
have been introduced, each surgery now has three new variables to distinguish itself. 
Only three surgeries are classified as technically inefficient after the inclusion of data 
about consultations with the specialists. These are surgeries 4, 5 and 12.
Model 7.3: Variables used for the measurement of cost efficiency (including 
estimates for consultations with specialists)
Inputs
(1) WTE GP per registered diabetic
(2) WTE Nurse per registered diabetic
(3) Average number of medication items 
prescribed per diabetic
(4) Estimated average number of 
Ophthalmologist consultations per diabetic 
(3) Estimated average number of 
Diabetologist consultations per diabetic 
(6) Estimated average number of dietician 
consultations per diabetic
Outputs
(1) Proportion of diabetics who have had a 
complete diabetes annual review
(2) Proportion of diabetics on targeted 
ACEI
(3) Proportion of diabetics on targeted 
statins
We have also calculated cost efficiency in order to take into account the unit prices of 
these inputs. The average cost efficiency score, after the inclusion of information about
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the consultations with specialists is 86.24%, which is only slightly higher than the 
average cost efficiency score of Model 7.2. We note that some surgeries benefit from 
the inclusion of this data, whilst others see their cost efficiency scores drop. For 
example, Surgery 4 sees its cost efficiency score drop from 88.75% to 87.27%. 
However, Surgery 6 is the surgery that most benefits from the inclusion of this 
information. Surgery 6 has the lowest referral rates to a dietician and a diabetologist 
and, for this reason, sees its cost efficiency score increase from 89.18% to 95.63%.
We know that most surgeries appear to be over-prescribing (Table 7.5), when we 
consider their current service delivery. For example, Surgery 24 currently prescribes an 
average of 25.01 medication items per patient, whilst its optimal amount of medication 
items prescribed should be 18.54. If we wanted to identify exactly which items of 
medication ought to be reduced, a different model discriminating between the nine types 
of medication should be used (Model 7.4).
Table 7.6: Efficiency results including costs with specialists
Results Cost Efficiency Allocative Efficiency Technical Efficiency
Surgeries Model C Model C Model C
Oi(y,x,w) | CRS) Al(y,x,w) | CRS) Fi(y,x 1 CRS)
1 80.63% 80.63% 100.00%
2 100.00% 100.00% 100.00%
3 73.61% 73.61% 100.00%
4 87.27% 88.15% 99.00%
5 76.66% 88.12% 87.00%
6 95.63% 95.63% 100.00%
7 86.29% 86.29% 100.00%
8 94.69% 94.69% 100.00%
9 96.24% 96.24% 100.00%
11 72.02% 72.02% 100.00%
12 70.61% 82.10% 86.00%
13 93.52% 93.52% 100.00%
23 100.00% 100.00% 100.00%
24 80.18% 80.18% 100.00%
Average 86.24% 87.94% 98.00%
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M o d e l 7 .4 : V a r ia b le s  u se d  fo r  th e  m e a s u r e m e n t  o f  c o s t e f f ic ie n c y , u s in g  d e ta i le d
m e a s u r e s  fo r  th e  m e d ic a t io n  p r e s c r ib e d  ( i n p u t  o r ie n te d )
Inputs
(1) WTE GP per registered diabetic
(2) WTE Nurse per registered diabetic
(3) Average number of Biguanides 
prescribed per diabetic
(4) Average number of Sulphonylureas 
prescribed per diabetic
(5) Average number of other anti-diabetic 
drugs prescribed per diabetic
(6) Average number of items of screening 
and monitoring prescribed per diabetic
(7) Average number of hypoglycaemic 
drugs prescribed per diabetic
(8) Average number of short-acting insulin 
items prescribed per diabetic
(9) Average number of intermediate/long- 
acting insulin items prescribed per diabetic
(10) Number of ACE1 items prescribed per 
diabetic
(11) Number of Statins prescribed per 
diabetic
(12) Estimated average number of 
Ophthalmologist consultations per diabetic
(13) Estimated average number of 
Diabetologist consultations per diabetic
(14) Estimated average number of Dietician
consultations per diabetic_______________
Outputs
(1) Proportion of diabetics who have had a 
complete diabetes annual review
(2) Proportion of diabetics on targeted 
ACE1
(3) Proportion of diabetics on targeted 
statins
Given that a large number of variables are used in this model, we have not calculated 
technical efficiency using Model 7.4. Nevertheless, by applying the individual prices to 
each one of the inputs, the minimum feasible cost can be estimated and we can compare 
the surgeries in terms of their cost efficiency. In this respect, Model 7.4 is our most 
complete model of cost efficiency, as it includes the costs with the specialists and 
discriminates between the individual types of medication. The results for this model are 
presented below in Table 7.7.
Using the results of Model 7.4, we note that the actual average annual unit cost per 
diabetic varies from £535.5 to £831.35. When we consider the level o f service delivery, 
our cost efficiency comparison suggests that some of this variation appears to be
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unjustified. However, we need to analyse effectiveness in order to understand the effects 
of different cost levels on outcomes achievement, as detailed in the next section.
Table 7.7: Cost efficiency results, based on the decomposition of the medication
Results Actual average cost per Minimum average cost per Cost efficiency
diabetic (£) diabetic (£)
Surgeries Model D Model D Model D
WX -  Actual cost C(y, x, w) | CRS) - Minimum cost Oi(y,x,w) | CRS)
1 631.77 529.63 83.83%
2 657.01 657.01 100.00%
3 641.97 480.32 74.82%
4 711.39 601.96 84.62%
5 599.60 483.13 80.58%
6 580.13 575.15 99.14%
7 668.80 578.90 86.56%
8 592.73 580.01 97.85%
9 589.14 589.14 100.00%
11 831.35 610.52 73.44%
12 648.11 447.44 69.04%
13 535.50 511.36 95.49%
23 622.44 622.44 100.00%
24 720.13 576.20 80.01%
Average 645.01 560.23 87.53%
7.4.4 Clinical Effectiveness
Model 7.5 uses the outputs from the efficiency models as inputs and uses three clinical 
outcomes as outputs. This model does not consider the delivery costs; it evaluates the 
impact of the services delivered on the clinical well being of the patients. The three 
clinical outcomes chosen assess the proportion of patients with the three essential 
biomedical indicators under control. This model assesses the ‘added value’ of the health 
care professionals’ time and medication in terms of these three essential clinical 
outcomes. We have applied an output-orientation to Model 7.5, as the objective is to 
maximise the outcomes, given the level of services delivered.
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M o d e l 7 .5 : V a r ia b le s  u s e d  f o r  th e  m e a s u r e m e n t  o f  c lin ic a l  e f fe c tiv e n e s s  ( o u tp u t
o r ie n te d )
Inputs
(1) Number of diabetics who have had a 
complete diabetes annual review
(2) Number of diabetics on targeted 
ACEI
(3) Number of diabetics on targeted 
statins
Outcomes
(1) Number of diabetics with BP under 
control
(2) Number of diabetics with blood 
glucose under control
(3) Number of diabetics with blood 
cholesterol under control
Weight Restrictions (WR)
-  v, + v2 < 0
-  v, + v3 < 0
We have included two weight restrictions in this model in order to guarantee that no 
surgery would be classified as effective simply because it had the lowest number of 
patients under regular treatment with statins, for example. We have developed these two 
weight restrictions based on the identification of technologically realistic trade-offs 
between the different inputs. The restrictions introduced and their interpretation is 
presented below.
7.4.5 Weight Restrictions and their Economic Interpretation
As defined in chapter 2, the weight associated with input i is denoted by v, and the 
weight associated with output r is denoted by ur. The general formula for the 
introduction of homogeneous weight restrictions according to the trade-offs approach is 
given by the following equation (Podinovski 2002):
a,u, +a2u2 + ... + a,u, -¿>,V| - b 2v2 - . . . - b mvm £0.
7.4.5.1 Annual Review and Regular Treatment with ACEI
If the number of patients under regular treatment with ACEI (x 2) decreases by one and
the number of patients with a full annual review (x/) increases by one, there should be
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no impact on the level of outcomes achievement. The justification for this restriction is 
that the annual review is the most basic service delivered to all diabetics and, per se, is 
the service that can lead to greater improvements in the outcomes. Regular treatment 
with medication can only lead to outcomes improvement if the patient is also annually 
reviewed to ascertain if the medication is working as expected. Symbolically, this can 
be represented by the following trade-off coefficients:
(a,, a2, a 3) = (0, 0, O) and (ft,, ft2, ft3) = (l, -1 , O).
Applying these coefficients to the general formula results in the following weight 
restriction:
-  v, + v2 < 0
7.4.5.2 Annual Review and Regular Treatment with Statins
If the number of patients under regular treatment with statins (xj) decreases by one and 
the number of patients with a full annual review (x /) increases by one, there should be 
no impact on the level o f  outcomes achievement. The same justification applies. 
Symbolically, this can be represented by the following trade-off coefficients:
(a„ a2, a }) = (0, 0, 0) and (ft,, ft2, ft3) = (l, 0 ,-l).
Applying these coefficients to the general formula results in the following weight 
restriction:
-  v, + v3 <0
The imposition of weight restrictions cannot improve the effectiveness score. However, 
it will reduce the score, unless the restriction is redundant for a particular surgery, in 
such an example it would have no effect on its score.
For this reason, it is very important to evaluate the appropriateness of the restrictions 
introduced. If the process that transforms inputs into outputs is complex, and we cannot
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be certain of the type of trade-offs that can occur, it is prudent to allow weight 
flexibility. We have chosen not to introduce weight restrictions between the outcomes 
for this reason. The establishment of realistic causal links between the level of services 
delivered and the achievement of outcomes is tentative. As a result, we chose to allow 
full flexibility regarding outcome trade-offs in order to determine conservative 
effectiveness scores. Table 7.8 presents the results of clinical effectiveness.
The average score in terms of clinical effectiveness is 68.63%, which is relatively 
low. There are a group of surgeries that appear to be suffering from very low clinical 
effectiveness. It is worth further investigation to determine why surgeries 1, 3, 7, 8 and 
13 have clinical effectiveness scores below average. Could it be population 
demographics, lack of professional training, or a combination of factors? An alternative 
explanation is that these surgeries might be focusing on other outcomes such as 
patients’ satisfaction at the expense of the achievement of the clinical outcomes. These 
are important questions that we will try to address.
There are five surgeries that have been deemed clinically effective. There is no 
evidence that these surgeries could achieve a higher level of outcomes from the services 
that they deliver. However, some surgeries have been classified as clinically effective 
by choosing a unique weight structure. For example, Surgery 24 is clinically effective, 
but is not peer to any other surgery. This is also the largest surgery in the sample and 
employs a F/T specialist diabetes nurse. Furthermore, the nurse’s availability onsite 
results in a system of very frequent consultations and intensive use of diabetes related 
medication. This model o f care is relatively unique, but nevertheless appears to 
compensate in terms of clinical effectiveness.
Surgeries 4, 5 and 12, which scored below average in terms of cost efficiency, are 
clinically effective. Surgery 12 is peer to 9 other surgeries and can therefore be
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considered one of the role models in terms of clinical effectiveness. However, it is 
important to note that this is a small surgery working with a single GP, who delivers the 
majority of the diabetes consultations. The application of this model of care to some of 
the other surgeries may therefore be difficult. Furthermore, the fact that this surgery 
presents the lowest score in terms of equity may suggest some caution regarding its use 
as best practice role model in diabetes care delivery. On the contrary, Surgery 4 is able 
to deliver effective services, whilst reviewing a very large proportion of the patients 
(surgery 4 achieved the highest score in terms of equity). Further investigation of the 
structures and mechanisms used in this surgery can therefore be of significant value for 
diabetes care delivery.
Table 7.8: Clinical effectiveness results
Results Clinical Effectiveness Peers
Surgeries Model 7.5 with WR Model 7.5 with WR
l/Fo(x,y)
1 30.26% 5(0.39) 12(8.41)
2 66.97% 12(6.50)
3 46.72% 12(4.28)
4 100.00% 3
5 100.00% 2
6 100.00% 1
7 44.52% 4(0.22) 12(1.29)
8 12.64% 12(2.09)
9 90.27% 4(0.51) 12(2.62)
11 70.59% 12(0.25)
12 100.00% 9
13 19.25% 12(1.37)
23 79.60% 4(1.47) 5(0.19) 6(0.04) 12(1.93)
24 100.00% 0
Average 68.63%
Surgery 23, which was cost efficient, scores 79.60% in terms of clinical 
effectiveness. We have measured efficiency and clinical effectiveness using a method 
that implies a trade-off between these two criteria because the outputs in the cost 
efficiency models are now inputs to the clinical effectiveness models. The professionals
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present in the workshops believe that there is a trade-off between these measures and 
therefore the framework had to represent it. Nevertheless, the results suggest that this 
trade-off is not inescapable. It is possible for a surgery to score very highly in both these 
criteria. For example, surgery 6 is clinically effective and scored 99.14% in terms of 
cost efficiency. Whether this balance achieved by surgery 6 comes at a price in terms of 
patient satisfaction is worth further investigation. We now discuss the evaluation of 
effectiveness from the patients’ perspective, by including patient-centred outcomes.
7.4.6 Patient-focused Effectiveness
The outcomes that have been included in the prior analyses reflect clinical outcomes 
only. Although these are important types of outcomes to evaluate, there are other 
outcomes that must be considered. In any study of patient care, the patients’ perspective 
must be given high priority. In order to evaluate the quality of the diabetes services from 
the patients’ perspective; we have defined three patient-focused outcomes. The first 
outcome aims to measure the effectiveness of patient education and represents the 
number of patients who report a good understanding about diabetes and its 
management17. Patient understanding represents an important outcome to patients 
because 99.2% of the patients who answered the patient questionnaire said that having a 
good understanding of their diabetes and its management is important or very important 
to them.
17 Given that several items regarding diabetes management were included in the questionnaire, we 
calculated the number of patients who answered ‘I understand enough’ to each item, and then used the 
average between the results obtained for items a-i. Please refer to Section B of the questionnaire 
(Appendix B) for the specific items included in this outcome measure.
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The second outcome aims to measure the quality of diabetes care, and represents the 
number of patients who answered ‘Always’ or ‘Most times’ regarding the quality of the 
diabetes services delivered at the surgery18.
The third outcome aims to measure the extent of patient empowerment, and 
represents the number o f patients that reported being confident or very confident in 
taking good control of their diabetes. We used an output oriented DEA model (Model 
7.6) in order to maximise these patient-focused outcomes. The results obtained are 
presented below in Table 7.9.
Model 7.6: Variables used for the measurement of Patient-focused Effectiveness
(output oriented)
Inputs Patient centred outcomes
( 1 ) Number of diabetics who answered the ( 1 ) Average number of diabetics who
diabetes service questionnaire report that they understand enough about
diabetes and its management
(2) Average number of diabetics who 
answered ‘Always’ or ‘Most times' 
regarding the quality of the diabetes 
services delivered at the surgery
(3) Average number of diabetics who 
report being ‘confident’ or ‘very 
confident’ in talcing good control over 
their diabetes
IB An average measure was calculated regarding the number of patients who answered ‘Always’ or 'Most 
times' for the items included in Section C of the questionnaire (Appendix B).
17‘)
T a b le  7.9 : P a t ie n t - f o c u s e d  E f fe c t iv e n e s s  r e s u l ts
Results Patient-focused Effectiveness
Surgeries Model 7.6
l/Fo(x,y)
1 95.24%
2 97.80%
3 95.48%
4 100.00%
5 96.31%
6 92.54%
7 98.63%
8 92.33%
9 91.26%
11 100.00%
12 97.33%
13 94.44%
23 92.35%
24 95.80%
Average 95.68%
In terms of patient-focused outcomes, we only have two surgeries that are classified 
as effective, which are surgeries 4 and 11. Surgery 4 is a medium size surgery, which 
employs a P/T specialist nurse, who performs all the annual reviews and undertakes 
most of the diabetic consultations. Surgery 11 has a single GP who undertakes most of 
the diabetes consultations.
The scores for the remaining surgeries are generally high, but surgeries 6, 9 and 23, 
which were classified as efficient, score below average in terms of patient-focused 
effectiveness.
It is important to emphasise that some of the outcomes included in this model may be 
highly influenced by population demographics. In particular, surgeries located in highly 
deprived areas may face more difficulties in achieving a good level of patient 
understanding and patient confidence (in chapter 9 we return to this issue and analyse 
the impact of environmental variables on the performance results). We will now 
compare the level of resources expenditure with the level of outcomes achievement 
across the surgeries.
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7 .4 .7  C o s t  e f fe c tiv e n e s s
Whilst clinical effectiveness measures whether a surgery is doing the ‘right things’, cost 
efficiency measures whether a surgery is doing things in the ‘right way’. In this respect, 
considering the scarcity of resources, it is essential to identify models of care that 
achieve the best outcomes at the lowest possible cost. In order to evaluate this, we turn 
to Models 7.7 and 7.8. These two models use the resources as the inputs (the same 
inputs as used to measure cost efficiency in model 7.4) and use the different outcome 
measures as the outputs. Model 7.7 takes into account the three clinical outcomes and 
Model 7.8 takes into account the patient-focused outcomes.
Model 7.7: Variables used for the measurement of Cost Effectiveness -  clinical
focus (input oriented)
Inputs Clinical outcomes
(1) WTE GP per registered diabetic
(2) WTE Nurse per registered diabetic
(3) Average number of Biguanides 
prescribed per diabetic
(4) Average number of Sulphonylureas 
prescribed per diabetic
(5) Average number of other anti-diabetic 
drugs prescribed per diabetic
(6) Average number of items of screening 
and monitoring prescribed per diabetic
(7) Average number of hypoglycaemic 
drugs prescribed per diabetic
(8) Average number of short-acting insulin 
items prescribed per diabetic
(9) Average number of intermediate/long- 
acting insulin items prescribed per diabetic
(10) Number of ACEI items prescribed per 
diabetic
(11) Number of Statins prescribed per 
diabetic
(12) Estimated average number of 
Ophthalmologist consultations per diabetic
(13) Estimated average number of 
Diabetologist consultations per diabetic
(14) Estimated average number of Dietician
consultations per diabetic_______________
(1) Proportion of diabetics with BP under 
control
(2) Proportion of diabetics with blood 
glucose under control
(3) Proportion of diabetics with blood 
cholesterol under control
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Table 7.10 presents the results for cost effectiveness using these different models. 
Let us focus firstly on the results from Model 7.7. Surgery 6 is cost effective, as 
previous analyses have suggested (this surgery is both cost efficient and clinically 
effective). Surgeries 9 and 23 are also classified as cost effective, despite the fact that 
they were not classified as clinically effective.
Model 7.8: Variables used for the measurement of Cost Effectiveness -  patient
focus (input oriented)
Inputs Patient centred outcomes
(1) WTE GP per registered diabetic
(2) WTE Nurse per registered diabetic
(3) Average number of Biguanides 
prescribed per diabetic
(4) Average number of Sulphonylureas 
prescribed per diabetic
(5) Average number of other anti-diabetic 
drugs prescribed per diabetic
(6) Average number of items of screening 
and monitoring prescribed per diabetic
(7) Average number of hypoglycaemic 
drugs prescribed per diabetic
(8) Average number of short-acting insulin 
items prescribed per diabetic
(9) Average number of intermediate/long- 
acting insulin items prescribed per diabetic
(10) Number of ACEI items prescribed per 
diabetic
(11) Number of Statins prescribed per 
diabetic
(12) Estimated average number of 
Ophthalmologist consultations per diabetic
(13) Estimated average number of 
Diabetologist consultations per diabetic
(14) Estimated average number of Dietician 
consultations per diabetic
( 1 ) Average proportion of diabetics who 
report that they understand enough about 
diabetes and its management
(2) Average proportion of diabetics who 
answered ‘Always’ or ‘Most times’ 
regarding the quality of the diabetes 
services delivered at the surgery
(3) Average proportion of diabetics who 
report being ‘confident’ or ‘very confident’ 
in taking good control over their diabetes
The results from Model 7.7 suggest that the five surgeries that scored poorly in terms 
of clinical effectiveness, continue to score poorly in terms of cost effectiveness, which 
means that their low outcome achievement is not explained by low use of resources. 
They are using resources, but, for some reason, they are not able to achieve a good level
of clinical outcomes.
Surgeries 8 and 13 are of particular interest because they scored relatively high in 
terms of cost efficiency, which means that they are able use their resources to deliver a 
relatively high quantity of services, but these services fail to have an impact on the 
patients’ clinical outcomes. These are the only two surgeries located in inner-city areas, 
which might partly explain their difficulties in achieving good clinical outcomes. 
Surgery 11 also scores below average in terms of cost effectiveness, because it does not 
deliver enough services for its current level of expenditure. However, Surgery 11 is 
located in a pleasant rural village where deprivation is not considered to be an issue.
Table 7.10: Cost Effectiveness results
Results Cost Effectiveness Cost Effectiveness
Clinical Focus Patient Focus
Surgeries Model 7.7 Model 7.8
Oi(y,x,w) | CRS) Oi(y,x,w) | CRS)
1 31.69% 91.41%
2 53.17% 84.47%
3 41.16% 82.33%
4 96.10% 85.24%
5 83.27% 99.33%
6 100.00% 85.96%
7 30.37% 80.96%
8 11.27% 89.72%
9 100.00% 95.95%
11 23.31% 65.57%
12 91.08% 91.95%
13 16.51% 100.00%
23 100.00% 89.81%
24 86.37% 79.83%
Average 61.74% 87.32%
Finally, we ran a DEA model (Model 7.8) that aimed to minimise the costs given the 
level achieved for the three patient-focused outcomes. An analysis of these results 
shows that the average score is 87.32%. The only surgery that is classified as cost 
effective under this perspective is Surgery 13. This surgery achieves the highest level of
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patient confidence, with the lowest level of costs per patient. Surgery 11, on the 
contrary, presents the lowest score in terms of patient-focused cost effectiveness 
(65.57%). Despite the fact that this surgery presents relatively high levels of patient- 
focused outcomes (it scores 100% in terms of patient-focused effectiveness -  Model 
7.6), once the level of resources used is taken into account, its score drops significantly. 
This suggests that there are surgeries achieving similar levels o f patient-focused 
outcomes, whilst using fewer resources.
7.5 Conclusion
In this chapter we have discussed the data used for formative evaluation and have 
presented the results obtained from a comparison of 14 surgeries. The use of DEA has 
provided interesting insights regarding the decomposition o f efficiency and 
effectiveness measures. Whilst some surgeries are technically inefficient and appear to 
over-use on all the resources, others surgeries appear to be using a non-optimal mix of 
resources given their current prices.
The important aspect to remember is that the DEA results are only as good as the 
model used, and always provide a partial view of performance due to the variables that 
might have been excluded. One example of this problem relates to the need to include 
information regarding the level of referrals, given that what appears to be an over-use of 
in-house resources may actually be compensated by a reduced rate of referrals. In this 
respect, we emphasise the importance of taking a critical stance when looking at the 
DEA results.
In the next chapter we analyse the relationships between the different performance 
measures and look for surgeries that appear to be robust performers, that is, performers 
that score reasonably well from different perspectives.
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8 A nalysis o f the Results — Looking for Robust Perform ers
8.1 Introduction
In the previous chapter, we presented the results in terms of equity; efficiency; clinical 
effectiveness; patient-focused effectiveness and cost effectiveness. In this chapter we 
analyse the relationships between these different performance criteria in order to 
evaluate the potential trade-offs between them and in order to identify surgeries that 
appear to be robust providers. By robust providers, we mean surgeries that score above 
average in most performance criteria. These are our benchmark surgeries. We find that 
an analysis of the relationships between the results for the different performance criteria 
is advantageous both to raise further questions and to point towards surgeries that may 
benefit from further investigation. Furthermore, it makes explicit the fact that the 
‘location’ of a surgery in terms of performance changes with different criteria.
We also analyse the results in terms o f robustness. When we consider the fact that a 
small sample was analysed, it is of interest to investigate the sensitivity o f  the results to 
the inclusion o f new surgeries. In this respect, we add the data from nine further 
surgeries to the sample and apply the models to this larger dataset in order to investigate 
the changes in the pattern of the results. These nine surgeries were the additional 
surgeries for which we had collected data, but which were not included in the main data 
analyses because of concerns regarding the quality of the data.
8.2 Trade-offs between the Different Measures of Performance
In this section we analyse the trade-offs between the different performance measures by 
mapping the performance results of one criterion against those of a different criterion.
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We explore the relationship between equity and efficiency, efficiency and clinical 
effectiveness, equity and clinical effectiveness and clinical effectiveness and patient- 
focused effectiveness. Table 8.1 presents the Spearman rank correlations between the 
results for the different performance criteria14. We found that the results in terms of cost 
efficiency are negatively correlated with the results in terms of patient-focused 
effectiveness. This relationship is significant at the 0.05 level. Apart from this 
relationship no other significant correlation could be found between the results for the 
different performance criteria. We will now discuss in detail each one of the 
hypothesised trade-offs. *20
Table 8.1: Spearman’s rank correlations between the different performance
measures
Equity Cost efficiency Clinical
effectiveness
Patient-focused
effectiveness
Equity 1.000 0.302
(0.293)
-0.110
(0.708)
0.059
(0.840)
Cost efficiency 0.302
(0.293)
1.000 -0.205
(0.481)
-0.539*
(0.047)
Clinical
effectiveness -0.110
(0.708)
-0.205
(0.481)
1.000 0.239
(0.412)
Patient-focused
effectiveness 0.059
(0.840)
-0.539*
(0.047)
0.239
(0.412)
1.000
P-Values20 given in parenthesis 
* Correlation is significant at the 0.05 level (2-tailed).
'* The Spearman rank correlation coefficient calculates the correlation between the ranks of the different 
measures. This coefficient was used because the performance results follow a non-normal distribution.
20 Probability that the observed relationship between the variables occurred by chance.
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Okun (1975) suggested that the most efficient solution is not the one that leads to the 
most equitable results. In order to reach a large proportion of patients, higher levels of 
resources have to be used. There is an additional problem which relates to the fact that 
in some cases the patients that are the most in need of care are those that are most 
difficult to reach, and therefore, are those that will lead to greater marginal costs. For 
this reason the patients that most need the services might actually be those that suffer 
the most from unfair access to services. This phenomenon is known as the ‘inverse care 
law’ (Tudor-Hart 1971). Unfortunately, given the small number of diabetics registered 
with most of our surgeries, it is not possible to analyse the data in terms of equity 
regarding the different socio-economic groups or different ethnic groups. Therefore, we 
have only analysed the data in terms of equity of service utilisation across the 14 
surgeries, for the whole set of diabetics. This allows us to evaluate the equity on a 
geographical basis and how it relates to the cost efficiency of the surgeries.
The trade-off between efficiency and equity has already been investigated by a 
number of other studies. Maital (1973, 1975) has suggested that an increase in the 
efficiency of public services provision tends to lead to a decrease in the equality of 
provision, benefiting those from higher socio-economic groups. Bodily (1978) used 
multiattribute utility theory to show this trade-off in terms of police services delivery. 
Mandell (1991) used the Gini coefficient to develop a model to examine the trade-offs 
between output maximisation and equality in the provision of public services. More 
recently, Golany and Tamir (1995) developed a DEA model that aims to allocate 
resources taking into account not just output maximisation considerations, but also 
equality and effectiveness considerations.
8 .2 .1  T r a d e - o f f  b e tw e e n  E q u i ty  a n d  E ff ic ie n c y
1K7
Our work differs from that of Golany and Tamir (1995) in terms of the definition of 
effectiveness. Whilst they define effectiveness in relation to the achievement of a 
certain level of output, we define it as the achievement of maximum outcomes from the 
outputs produced (services delivered). Furthermore, whilst they were concerned with 
equality of resource allocation between providers, we are concerned with equity of 
access to services between groups of patients. A fair allocation of resources between 
providers is a necessary, but not sufficient condition to guarantee equity of access to 
services across different groups of patients. Another aspect that distinguishes our work 
is the use of cost efficiency measures. These measures include both technical and 
allocative considerations. We feel that this is important in evaluating the potential trade­
offs because achieving a higher level of equity may not only lead to an increase in the 
quantities of resources used, it may also lead to the use of more expensive resource 
mixes. Similarly, to achieve a higher level of effectiveness, a more expensive resource 
mix may be necessary.
Figure 8.1 plots the results of cost efficiency against the results of equity for our 14 
surgeries. This is a very important trade-off because, ideally, we would like to improve 
on both these performance criteria. In this respect, it is important to identify surgeries 
that are able to offer fair access to the essential services, whilst delivering the services in 
a cost efficient way.
If we take the sample as a whole, we cannot find a clear trade-off between these two 
performance measures. On the contrary, a weak positive relationship is noticeable. The 
Spearman rank correlation coefficient between the equity results and the cost efficiency 
results is 0.302, but it is not statistically significant at the 0.05 level (Table 8.1).
It is interesting to note that there is a group of surgeries for which a strong positive 
relationship between equity and cost efficiency is visible (surgeries 6, 7, 11, 12, 13 and
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24). This may suggest that the relationship between these two measures might be 
contingent upon context. We obviously would need to further investigate this 
relationship in larger samples in order to be confident of this result.
Figure 8.1: Trade-off between equity and cost efficiency
Equity versus Cost Efficiency
If we take the average result of each surgery for each of the criteria and draw a line
separating the surgeries that perform below average from those that perform above 
average, we can classify the surgeries into four groups.
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The first group is composed by the surgeries that perform below average in both 
dimensions: surgeries 7, 11, 12 and 24. There is evidence that these surgeries could 
improve both in terms of equity of access to services and cost efficiency. They appear to 
deliver diabetes services to a relatively small proportion o f their patients, whilst 
spending higher than average costs.
The second group is composed by the surgeries that perform above average in terms 
o f equity of access, but below average in terms of cost efficiency: surgeries 1, 3, 4 and 
5. These surgeries are able to regularly review a relatively high proportion of their 
diabetics, but appear to be doing this at a relatively high cost.
The third group is composed by the surgeries that perform above average in terms of 
cost efficiency and below average in terms of equity of access: surgeries 8 and 9. These 
surgeries appear to be cost efficient, but are not regularly reviewing a significant 
proportion of their registered diabetics.
The fourth group is composed by the surgeries that perform above average in both 
dimensions: surgeries 2, 6, 13 and 23. These surgeries review a relatively high 
proportion o f their patients and are able to do this at relatively low costs. If we had not 
assessed performance from any other perspective, we would think that these are the 
surgeries that we need to leam from regarding diabetes service delivery. They show 
evidence of a sound system of diabetes delivery, which guarantees high accessibility of 
services at reasonable costs. However, we also need to evaluate how they score in terms 
o f effectiveness. Do the systems used by these surgeries lead to good outcomes? For 
this analysis, we turn to the next section.
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Schinnar et al. (1990) and Schinnar (1993) have pointed out the importance of 
investigating the trade-off between efficiency and effectiveness in public services 
delivery. As discussed in the literature review, in their study of mental health care 
programs, Schinnar et al. (1990) found a positive relationship between efficiency and 
effectiveness for lower than average levels of efficiency. Schinnar (1993) further 
investigates this issue and proposes that for different levels of efficiency the relationship 
may in fact change, with a positive association at low levels of efficiency and a negative 
association at higher than average levels of efficiency. In this respect, he suggests: 
“moderate efficiency levels may be indicative of higher effectiveness” (Schinnar 1993: 
188).
We feel that it is of interest to analyse the relationship between cost efficiency and 
clinical effectiveness, because these two performance measures relate to different 
priorities. Whilst cost efficiency focuses on delivering the maximum amount of services 
at minimum cost, clinical effectiveness aims to improve the clinical outcomes derived 
from the services delivered. In many situations, the most efficient solution is not 
necessarily the one that will lead to the best outcomes. Again we have used cost 
efficiency rather than technical efficiency to account for the fact that input mix is of 
particular importance. An expensive mix might be what makes the difference in terms 
of outcomes achievement.
Figure 8.2 presents the relationship between the results obtained for cost efficiency 
and the results obtained for clinical effectiveness. From our results, we cannot identify a 
clear relationship between cost efficiency and clinical effectiveness. The Spearman rank 
correlation coefficient between our results for cost efficiency and our results for clinical 
effectiveness is -  0.205, but it is not statistically significant at the 0.05 level (Table 8.1).
8 .2 .2  T r a d e - o f f s  b e tw e e n  E f f ic ie n c y  a n d  C lin ic a l E f fe c tiv e n e s s
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Furthermore, our results do not confirm Schinnar’s (1993) suggestion regarding 
different relationships at different levels o f efficiency.
If we focus on Figure 8.2 we can once again identify four clear groups. The first 
group constituted by the surgeries that perform below average both in terms of 
effectiveness and efficiency: Surgeries 1, 3 and 7. This group of surgeries appear to 
show potential for improvement both in terms of cost efficiency and in terms of 
effectiveness. It is interesting to mention that all these surgeries score 100% in terms of 
technical efficiency. In this respect, they appear to be using a sub-optimal resource mix 
without actually achieving high levels of outcomes.
The second group is constituted by surgeries that perform below average in terms of 
efficiency, but above average in terms o f clinical effectiveness: surgeries 4, 5, 11, 12 
and 24. These surgeries appear to be doing ‘the right things’ in terms of achieving the 
clinical outcomes; however they appear to be operating with a very expensive model of 
care. Surgeries 5 and 12 suffer mostly from technical efficiency, which means that there 
is evidence that all the resources could be radially decreased whilst delivering the same 
quantities of services. On the contrary, Surgeries 4, 11 and 24 are suffering mostly from 
allocative inefficiency by using an expensive mix of resources.
The third group is constituted by surgeries that operate above average in terms of 
cost efficiency, but below average in terms of effectiveness: Surgeries 2, 8 and 13. 
These surgeries seem to be delivering services in the ‘right way’ in order to save 
resources, but they do not appear to be achieving good enough clinical outcomes from 
the services delivered.
Finally, we have a group of three surgeries that appear in the upper right quadrant, 
performing above average in both dimensions. These surgeries are surgeries 6, 9 and 23, 
which appear to be doing the ‘right things in the right way’. That is, they are able to
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deliver services in a cost efficient way and at the same time, achieve a good level of 
clinical effectiveness. It is not surprising to find that these are the only three surgeries 
that score 100% in terms of cost effectiveness (Model 7.7).
Figure 8.2: Trade-off between effectiveness and efficiency
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We feel that this potential trade-off between equity and clinical effectiveness is of 
particular significance for current health care policy in the UK, given the focus on 
outcomes achievement derived from the modernisation agenda of this Government. In 
terms of primary care delivery, we believe that it would be important to further 
investigate this trade-off in order to better understand the consequences that may result 
from the implementation of the new GP contract, which introduces financial rewards for 
high level of outcomes achievement (British Medical Association 2003).
During the workshops, a number of GPs emphasised the fact that one of the ways to 
increase effectiveness may be to reduce the proportion of patients to whom services are 
delivered on a regular basis. It seems that a potential unintended consequence of this 
might be another application of the ‘inverse care law’. Those patients that most need 
health care assistance might find it more and more difficult to get appropriate care and 
dedication from the professionals. Smith (1993) also cautions to this potential 
unintended consequence of performance assessment systems that emphasise outcome 
measurement above everything else. We are not suggesting that all health care 
professionals would behave in this way, because personal gain is not the only value 
heuristic guiding their decisions. However, there might be some professionals that feel 
that it is too high a price to pay for following other values such as individual need and 
fairness.
The results of clinical effectiveness were plotted against the results of equity and the 
relationship between these two measures is presented in Figure 8.3. A clear trade-off 
between these two measures is not visible for the whole sample, which confirms that 
there may be other issues explaining the range o f performance results obtained. In this 
respect, for the period of analysis considered, and for our sample of surgeries, a clear
8 .2 .3  T r a d e - o f f s  b e tw e e n  E q u i ty  a n d  C l in ic a l  E f fe c tiv e n e s s
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trade-off between equity and clinical effectiveness is not visible. The Spearman rank 
correlation coefficient between the equity results and the clinical effectiveness results is 
equal to -  0.11, but once again this result is not statistically significant at the 0.05 level 
(Table 8.1). It would be of interest to re-run this analysis at a later stage, after the full 
implementation of the new GP contract.
From Figure 8.3, we can identify four groups of surgeries depending on their 
quadrant location. The first group contains the surgeries that perform below average in 
terms of both criteria: surgeries 7 and 8. We then have a group of surgeries that score 
above average in terms of equity, but score below average in terms of clinical 
effectiveness: surgeries 1, 2, 3 and 13. These surgeries are regularly reviewing most of 
their diabetics, but they score below average in terms of the level of outcomes 
achievement. Surgeries 9, 11, 12 and 24 achieve a high level o f clinical effectiveness 
but fail to review a significant proportion of their diabetics. Finally, we have a group of 
surgeries that are able to achieve high levels of clinical effectiveness, whilst reviewing 
most of their diabetics: surgeries 4, 5, 6 and 23. These surgeries can provide interesting 
models of diabetes care delivery. Surgery 4 is of particular interest because it achieves 
the highest score of equity, whilst scoring 100% in terms of clinical effectiveness. In the 
next chapter we shall try to identify the structures and mechanisms that are behind the 
successful performance of these surgeries.
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F ig u r e  8 .3 : T r a d e - o f f  b e tw e e n  e q u i ty  a n d  c lin ic a l  e ffe c tiv e n e s s
Equity versus Clinical Effectiveneness
8.2.4 Trade-off between Clinical and Patient Focused Effectiveness
Finally, it is interesting to analyse the trade-off between scoring highly in terms o f the 
achievement of clinical outcomes and scoring highly in terms of the achievement of 
patient satisfaction, understanding and confidence. The issue of patient satisfaction is of 
particular relevance here, because it is reasonable to expect that very intensive control
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of the clinical indicators might lead to lower levels of patient quality of life and 
satisfaction.
Figure 8.4 plots the results of clinical effectiveness against the results of patient- 
focused effectiveness. We can conclude that the results for these two measures are not 
concentrated around two quadrants, which means that a clear relationship between them 
is not applicable to the whole sample. The Spearman rank correlation coefficient 
between our results of clinical effectiveness and our results of patient-focused 
effectiveness is 0.239, but it is not statistically significant at the 0.05 level (Table 8.1).
Again we can find four distinct groups of surgeries depending on whether they 
perform below average in both dimensions (surgeries 1, 3, 8 and 13); whether they 
perform above average in terms of clinical effectiveness and below average in terms of 
patient-focused effectiveness (surgeries 6, 9 and 23); whether they perform above 
average in terms of patient-focused effectiveness but below average in terms of clinical 
effectiveness (surgeries 2 and 7); or whether they perform above average in both 
clinical and patient perspectives (surgeries 4, 5, 11, 12, and 24).
The interesting aspect to notice is that the surgeries that perform above average on 
both patient and clinical effectiveness; all perform below average in terms of cost 
efficiency. In fact, if we investigate the relationship between patient-focused 
effectiveness and cost efficiency, we find that these two variables are negatively 
correlated. The Spearman rank correlation coefficient is equal to -  0.539 and is 
statistically significant at the 0.05 level (Table 8.1). This is an interesting relationship, 
which suggests that there may be a trade-off between cost efficiency and patient- 
focused effectiveness. We would need to further investigate this aspect using a larger 
sample in order to be confident about this trade-off.
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F ig u r e  8 .4 : T r a d e - o f f  b e tw e e n  c lin ic a l  a n d  p a t ie n t- f o c u s e d  e f fe c tiv e n e s s
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8.2.5 Equity, Efficiency and Effectiveness -  What is an acceptable balance?
A fte r  a n a ly s in g  th e  re la tio n s h ip s  b e tw e e n  th e  d if fe re n t  p e rfo rm a n c e  m e a su re s , w e  c an  
id en tify  so m e  su rg e r ie s  th a t  n e e d  fu r th e r  in v e s tig a tio n  in  o rd e r  to  e x p la in  th e ir  b e lo w  
a v e ra g e  re su lts  in  te rm s  o f  p e r fo rm a n c e . F irs tly , w e  sh o u ld  fu rth e r in v e s tig a te  S u rg e ry  
7, w h ich  s c o re s  b e lo w  a v e ra g e  in  m o st c r ite r ia . S e c o n d ly , w e  sh o u ld  fu r th e r  in v e s tig a te
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surgeries 1, 3, 8 and 13 as these surgeries score below average in terms of both clinical 
and patient effectiveness. In the next chapter we will be looking at some of the factors 
that may explain these results.
From another side, an analysis of the results from the different performance criteria 
reveals three surgeries that appear to be robust performers. Surgeries 6 and 23 score 
above average in all criteria apart from patient-focused effectiveness. If a compromise 
has to be struck between achieving a high level of equity, delivering services in a cost 
efficient way, and achieving a good level of effectiveness, these surgeries appear to be 
good learning sources. However, if we ‘ignore’ costs for a moment, then Surgery 4 
appears to offer a very good example of diabetes care delivery. This surgery has the 
highest score in terms of equity (above 90% of the patients receive all the diabetes 
services on time) and it scores 100% in terms of both clinical and patient-focused 
effectiveness. Furthermore, when we look at pure technical efficiency it also scores 
100%. The only aspect that penalises its performance is that it appears to be using a 
relatively expensive input mix in order to achieve these good results. The average 
estimated cost per diabetic in Surgery 4 is £711 per year, whilst in Surgery 6 this cost is 
reduced to £580. However, analyses o f the results from the patient questionnaire reveal 
that this saving has a price in terms of reduced patient responsiveness. In Surgery 6, 
33% of the patients report unacceptably long waiting times to see a doctor and 28 % of 
patients say that they do not have enough time to talk with the doctor.
The question is how much cost efficiency are we willing to sacrifice in order to 
achieve the highest level of patient satisfaction, fairness and clinical effectiveness? This 
is certainly a political question and a full discussion of this topic is outside the scope of 
this thesis. However, we feel that it would be important to further investigate these
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trade-offs in order to make informed policy choices regarding resource allocation and 
primary health care delivery.
8.3 Robustness of the Results -  The Addition of nine Surgeries to the Sample
One of the limitations of this study relates to the small size of the sample under analysis. 
It has been suggested in the literature that the robustness of DEA results is a function of 
the size of the sample under analysis. In general, smaller samples tend to be less robust 
(Pedraja-Chaparro, Salinas-Jimenez and Smith 1999). In this section we have 
introduced data for 9 additional surgeries and have analysed the robustness of our 
performance results. Please refer to Appendix G for the data referent to these additional 
9 surgeries.
As previously discussed, we collected data for 23 surgeries and it was our initial 
objective to analyse the data for all these surgeries. However, due to concerns about the 
quality of the data for some of these surgeries and about the homogeneity o f the sample 
as a whole, we chose to concentrate on the analyses of 14 surgeries.
It is important to note that the purpose of this study is formative evaluation. It is not 
our intention to obtain a ranking of the surgeries in the sample, nor it is our intention to 
obtain a good estimator of the average efficiency or effectiveness in primary diabetes 
care delivery. We are interested in using the DEA results to learn about better ways to 
deliver diabetes care. We aim to identify surgeries that appear to be under performing in 
a particular dimension and make suggestions on how their performance could be 
improved. This means that we are interested in identifying surgeries that are all round 
good performers and that often act as peers for other surgeries.
As previously discussed, Surgeries 4, 6 and 23 appear to be ‘robust performs’, 
because they score above average in most performance criteria and are often the
2 0 0
learning peers to other surgeries. We will now discuss whether the inclusion of other 
surgeries has penalised these ‘robust performers’. We emphasise that we are not 
particularly interested in the individual scores of the surgeries. However, we are 
interested in the changes in the patterns of the results, as whole. In this respect, and in 
order to maintain consistency with the previous section, we have chosen to present the 
results using trade-off graphs. Figures 8.5, 8.6 and 8.7 present the results for the 23 
surgeries.
Analyses of these three graphs reveal that our performance results are generally very 
robust. Most of our 14 surgeries maintain their quadrant location. The only exception is 
for surgeries whose scores were initially very close to the average, which have seen 
their scores change slightly. In this case, a few surgeries have changed from one 
quadrant to the adjacent quadrant, but still remain close to the average line. Surgery 23’s 
equity score drops from slightly above average to slightly below average. With that 
exception alone, our ‘all round good performers’ maintain their status and appear 
predominantly in the upper quadrant. Surgery 4 continues to score very highly in terms 
of equity and effectiveness. If we analyse the results from the perspective of relatively 
poor performers, such as Surgery 7, we find that this surgery continues to appear in the 
lower left quadrant of the three graphs.
Finally, it is o f interest to analyse the number of times that a surgery appears as peer 
to others, when we consider our objective of identifying ‘role model’ surgeries. Both 
Surgery 6 and Surgery 23 continue to be frequent peers to other surgeries in terms of 
cost efficiency and cost effectiveness. Surgery 12 continues to be the most frequently 
chosen peer in terms of clinical effectiveness. It is now a peer to 19 surgeries. Surgery 4 
remains effective from a patient perspective and is peer to 12 surgeries. However, this
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surgery is no longer part of the frontier in terms of clinical effectiveness. Nevertheless, 
it still scores very highly in this dimension.
When we consider our concerns regarding the quality of the data for these additional 
9 surgeries, we shall not further analyse the results for the extended sample. Our 
intention is to concentrate on the results from our sample of 14 surgeries in order to gain 
some insights into diabetes service delivery and primary health care policy. This 
comparison with the results from the extended sample has reassured us regarding the 
relative robustness of the initial results. Furthermore, we would not suggest the use of 
these additional 9 surgeries as examples of ‘best practice’ due to the lack of confidence 
in their data. In the next chapter we will investigate the impact of some environmental 
variables on these performance measures.
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8.4 Conclusion
In this chapter we have discussed the results from the diabetes case study. We have 
analysed a range of alternative performance measures, as well as the trade-offs between 
them. For our sample of 14 surgeries, we could not identify significant relationships 
between equity, cost efficiency and clinical effectiveness. A significant negative 
Spearman rank correlation was found between cost efficiency and patient-focused 
effectiveness.
Based on our results for the different performance criteria, we conclude that some 
surgeries appear to be able to achieve a good balance between the major performance 
criteria considered. Surgery 4 scores above average in all performance criteria apart 
from cost efficiency. Surgeries 6 and 23 score above average in all performance criteria 
apart from patient-focused effectiveness. These three surgeries appear therefore to 
provide examples of good practice in diabetes care delivery and management.
From another perspective, there are surgeries that score highly in one dimension but 
score poorly on a different dimension. Surgery 12, for example, is 100% clinically 
effective, but presents the lowest score in terms of cost efficiency and equity. 
Additionally, there is a group of surgeries that appear to show potential for 
improvement along most of the performance dimensions. For example, surgery 7 
presents below average results for all performance criteria apart from patient-focused 
effectiveness. What remains to be explained is whether some of the surgeries operate in 
fundamentally different environments, and therefore should not be compared with the 
others, or whether they do not have adequate systems and mechanisms in place in order 
to deliver good diabetes care. We will try to answer these questions in the next chapter.
Before we move onto this analysis, it is worth emphasising that we cannot ignore the 
complexities involved in performance assessment and the difficulties in deciding which
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surgeries represent ‘best practice’, and which surgeries need to change their way of 
working. Once we recognise that decision-making in the public sector is guided by 
several distinct (and potentially conflicting) values, we also need to recognise that 
performance assessment cannot lead to a ‘black and white’ classification.
2 0 7
9 Post Evaluation: W hat can w e Learn from  the Results?
9.1 Introduction
This chapter critically analyses the results and discusses their validity and usefulness in 
practice. In the first part of the chapter we return to the trade-off analyses graphs 
regarding the different performance assessment criteria and bring in some of the 
environmental variables, in order to discuss their impact on the results. We analyse two 
types o f environmental variables: area related factors and patient related factors. 
Furthermore, we analyse the effect of different structures and processes of diabetes care 
delivery on the performance results. The fact that we compared a small sample of 
surgeries did not allow the inclusion of these factors into the DEA models.
In the second part of the chapter we discuss the results in light of the workshops 
undertaken with some of the surgeries under evaluation, as well as the workshops with 
South Peterborough PCT. The aims of these workshops were the following. Firstly, we 
wanted to identify the ‘reputational perspective’ regarding performance. Secondly, we 
wanted to ‘validate’ the results by discussing them and their meaning with the surgeries. 
Thirdly, we wanted to identify some o f the structures and mechanisms behind the 
performance results. Finally, we wanted to develop plans of action to improve the 
performance of the participating surgeries, and identify ways in which the results of this 
study could be used to develop strategies for a more equitable, efficient and effective 
diabetes care delivery.
2 0 8
We have analysed the impact of two types of environmental variables: (1) area related 
factors and (2) patient related factors. Some of these variables are categorical, whilst 
others are numerical. In order to evaluate the impact of categorical variables we have 
clustered the surgeries into sub-sets regarding their characteristics and then have looked 
for patterns in the performance results within and between the sub-sets. In order to 
evaluate the impact of numerical factors, we have calculated the Spearman rank 
correlation between each of the variables and the results for the different performance 
criteria. In this case, the Spearman rank correlation coefficient was chosen because the 
performance scores are not normally distributed. Therefore, it is preferable to calculate 
the correlation between the ranks of the measures than between the measures 
themselves.
9.2.1 Area Related Factors
In terms of area related factors, we used the level of area deprivation to distinguish 
between surgeries facing a high, medium and low level of area deprivation. We have 
also grouped the surgeries according to their location: rural, suburban, inner city and 
mixed.
9 .2  T h e  I m p a c t  o f  E n v ir o n m e n ta l  V a r ia b le s  o n  P e r f o r m a n c e
9.2.1.1 Area Deprivation
Area deprivation is a very important factor in primary health care delivery, when we 
consider that it accounts for the patients’ relative socio-economic disadvantage. Several 
UK studies have suggested that morbidity and mortality levels associated with diabetes 
tend to be worsened by socio-economic deprivation (Roper et al. 2001; Acheson Report
209
1998; Urwin et al. 1996; Connoly and Kesson 1996 and Kelly et al. 1993). In this 
respect, we have decided to analyse the impact of area deprivation on the classification 
of the surgeries.
The measure used to represent socio-economic deprivation was derived using the 
methodology developed by the Department of the Environment, Transport and the 
Regions (DETR 2000), regarding their research in terms of Indices o f Multiple 
Deprivation (IMD) for wards. “The IMD 2000 score is the combined sum of the 
weighted, exponentially transformed domain rank of the domain score” (DETR 2000: 
14). Six domains are used with the following weights: Income (25%); Employment 
(25%); Health deprivation and disability (15%); Education skills and training (15%); 
Housing (10%) and Geographical access to essential services (10%).
In order to obtain a surgery score, the patients registered with each surgery were 
assigned to a ward based on their postcodes, and an average IMD score was then 
calculated for each surgery using the ward scores obtained by DETR (2000). The higher 
the IMD score, the higher the level of deprivation. However, given that the multiple 
score results from a combination of measures which have been transformed, this score is 
not a ratio variable and we cannot say for example that a surgery with a score of 30 is 
twice as deprived as a surgery with a score of 15. For this reason, and for clarity of 
analysis, we opted to classify the surgeries into three groups regarding their level of 
deprivation: low, medium and high. We first calculated the Median IMD score for the 
surgeries under evaluation and then classified surgeries with an IMD score below the 
median IMD score as facing low deprivation. Surgeries at the median IMD as facing a 
medium level of deprivation and surgeries with an IMD score above the median as 
facing a high level of deprivation. Unfortunately, an IMD score could not be obtained 
for surgeries 23 and 24 because the data was not available. The classification of these
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two surgeries is therefore based on the judgement of the health care professionals 
working at each one of these surgeries. Table 9.1 presents the classification in terms of 
area deprivation. This classification was discussed during the workshops and it was felt 
to group correctly the surgeries into different levels of deprivation.
We have used this classification to make new maps regarding the trade-offs between 
the several performance measures in order to evaluate the patterns that occur. Three 
trade-off graphs are presented below (Figures 9.1 to 9.3).
Table 9.1: Level of deprivation
Surgery Level of area 
Deprivation
1 High
2 Low
3 High
4 Low
5 Medium
6 Medium
7 Low
8 High
9 Medium
11 Low
12 Medium
13 High
23 Medium*
24 Medium*
* Estimated classification by the health care professionals of the surgery
The analyses of these three graphs suggest that a high level of area deprivation may 
explain the low scores o f  clinical, patient-focused and cost effectiveness obtained by 
certain surgeries. We can conclude that all the surgeries facing high levels of area 
deprivation appear to perform below average in terms of clinical, patient-focused and
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cost effectiveness. The Acheson Report (1998) suggested that poor BP control can be a 
proxy for high population deprivation. We can also note that all surgeries located in 
areas of low deprivation present a higher than average level of patient-focused 
effectiveness. Given that two of the outcomes included in this model were the level of 
patient understanding and the level of patient confidence, this result is not surprising.
Surgery 8 is a good example of how difficult it may be to deliver services for a 
highly deprived population. This relatively small surgery (two GPs and one practice 
nurse), covering a highly deprived area, presents the lowest score of clinical 
effectiveness. Further analyses, based on the results from the patient questionnaire, also 
reveal that this surgery faces the highest proportion of unemployed patients and the 
highest proportion of long-term sick and disabled patients in the sample. Despite the 
fact that this relationship between high deprivation and poor effectiveness is consistent 
with the results from previous studies (Roper et al. 2001; Urwin, et al. 1996; Connoly 
and Kesson 1996 and Kelly et al. 1993), further investigations in larger samples would 
be required in order to better investigate this relationship.
Another issue of interest in terms of the effects o f deprivation in health care 
provision relates to the level o f services utilisation between different socio-economic 
groups. Le Grand (1978) suggested that patients from higher socio-economic groups 
tended to have higher rates of service utilisation than those from lower socio-economic 
groups. Our results in terms o f equity do not appear to confirm this suggestion. Two of 
our surgeries located in low deprivation areas present a lower than average level of 
equity and three of the surgeries covering highly deprived areas present a higher than 
average level of equity.
However, it is interesting to notice that based on our estimates, the average annual 
cost of diabetes varies between surgeries serving low deprivation areas (£717.14 per
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patient); medium deprivation areas (£626.60 per patient) and surgeries serving highly 
deprived areas (£600.49 per patient). One comment made by one specialist diabetes 
nurse might shed some light into this. She suggested that highly informed, highly 
educated patients tend to demand more expensive drugs and more frequent 
consultations in order to monitor their condition. For our sample, the average cost of 
prescriptions issued to each diabetic patient in surgeries covering areas of low 
deprivation is £363.46, whilst it only amounts to £287.41 in surgeries covering highly 
deprived areas. However, due to the small size of our sample, it is not possible to make 
firm conclusions regarding the meaning of these results. It would be interesting to 
further investigate this issue.
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9 .2 .1 .2  L o c a tio n
We would expect the location of a surgery to have an impact on the way it operates. It is 
plausible to think that surgeries located in a rural area will have to operate rather 
differently than those located in an inner-city area. Furthermore, patients’ area of 
residence can have an effect on healthcare utilisation and health outcomes (Mitchell et 
al. 2000, Gilthorpe and Wilson 2003). From our 14 surgeries, two surgeries are located 
in an inner-city location; three are located in a suburban location; four are located in a 
mixed location and the remaining five are located in a rural area. Table 9.4 presents the 
location of each surgery.
Table 9.4: Location
Surgery Location
1 Mixed
2 Rural
3 Suburban
4 Rural
5 Rural
6 Mixed
7 Rural
8 Inner city
9 Mixed
11 Rural
12 Suburban
13 Inner city
23 Suburban
24 Mixed
In order to analyse if location has an impact on the performance measures obtained, 
we have once again re-mapped the surgeries in terms of their performance scores, 
making their location explicit. These analyses do not suggest any relationship between 
location and our measures of performance, and due to space limitations, we have opted
to leave these maps out. The only pattern that we can note is that all surgeries located in 
rural areas score above average in terms of patient-focused effectiveness. This means 
that, on average, these surgeries score better in terms of patient understanding, 
confidence or satisfaction. Given that most of our surgeries located in rural areas face a 
low level of deprivation, this may just say something about the type of population 
covered by these surgeries and their motivation in terms of diabetes control. In order to 
investigate the impact of patients’ characteristics on the performance results, let us now 
turn to patient related factors.
9.2.2 Patient Related Factors
We have attempted to analyse the impact of the patient related factors by looking at: (1) 
the level of patient compliance, patient confidence and patient understanding of 
diabetes; (2) the proportion of elderly patients; the proportion of newly diagnosed 
patients; the proportion of patients with type-1 diabetes and the proportion of patients 
with diabetes related complications.
9.2.2.1 The Effect o f ‘Patient Cooperation’ on Performance
The level of patient compliance, confidence and understanding are three important 
factors in chronic disease management. These are both inputs and outcomes of diabetes 
care. From one perspective, they are inputs because a greater level of patient 
compliance, confidence and understanding can help in the achievement of better clinical 
outcomes. However, from another perspective, the quality of the diabetes care in itself 
will influence the level o f patient compliance, confidence and understanding of 
diabetes. We have used these three variables as proxies for the level of patient 
cooperation in diabetes management. Table 9.5 presents the data for these three
218
variables and Table 9.6 presents the Spearman rank correlations between these variables 
and the performance results21. Based on the correlation results, we can conclude that the 
only variable that presents a significant correlation with the performance results is the 
level of patient understanding, which is positively correlated with patient-focused 
effectiveness. This result is not surprising because patient understanding was one of the 
outputs used to measure patient-focused effectiveness. We will now discuss each one of 
the hypothesised relationships in more detail.
Table 9.5: Patient cooperation in diabetes management
Surgery % of smokers who 
understand the effects of 
smoking
% of confident and 
very confident patients
% of patients who say they 
understand enough about 
diabetes
1 35.00% 87.60% 77.82%
2 39.00% 90.60% 80.98%
3 25.00% 94.19% 80.66%
4 26.00% 94.70% 80.52%
5 20.00% 92.00% 75.60%
6 35.00% 89.73% 78.24%
7 26.00% 88.00% 82.80%
8 29.00% 88.46% 76.98%
9 19.00% 89.72% 74.32%
11 17.00% 100.00% 84.55%
12 57.00% 81.82% 76.63%
13 27.00% 94.44% 76.90%
23 38.00% 86.55% 76.00%
24 16.00% 90.23% 77.44%
Average 29.21% 90.57% 78.53%
21 The Spearman rank correlation coefficient calculates the correlation between the ranks of the different 
measures. This coefficient was used because the performance results follow a non-normal distribution.
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T a b le  9 .6 : S p e a r m a n ’s r a n k  c o r re la t io n s  b e tw e e n  th e  d if f e re n t  p e r fo r m a n c e
c r i t e r i a  a n d  p a t i e n t  c o o p e r a t io n
Equity Cost efficiency Clinical
effectiveness
Patient focused 
effectiveness
Patient
non-compliance 0.249 0.316 -0.149 -0.136
(0.391) (0.270) (0.612) (0.644)
Patient confidence 0.323 -0.205 0.052 0.409
(0.260) (0.481) (0.861) (0.146)
Patient
understanding 0.244 -0.223 -0.241 0.645*
(0.401) (0.444) (0.408) (0.013)
P-Values”  given in parenthesis
* Correlation is significant at the 0.05 level (2 tailed)
There are two types of non-compliance: (1) voluntary (results from patient choice) 
and (2) involuntary (results from mistakes or lapses in memory). Both types of 
compliance are important factors that may influence clinical and cost effectiveness. 
However it is very difficult to assess any of these types. We have attempted to assess 
the level o f voluntary non-compliance, using the data from the patient survey. The 
patients were asked two separate questions and the answers to these questions were 
collated to infer about the level of voluntary non-compliance. We have used the 
proportion of smokers who say that they understand the impact of smoking on their 
diabetes as a proxy for voluntary non-compliance. It is our conviction that surgeries 
with a higher proportion of non-compliant patients face more difficulties in achieving 
good clinical outcomes.
A similar argument could be made regarding the level of patient confidence. Patients 
who do not feel confident in taking a good control of their diabetes may lack the 2
22 Probability that the observed relationship between the variables occurred by chance.
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motivation to follow the diet and medication. Therefore, surgeries with a larger than 
average proportion of patients with low confidence may find it more difficult to deliver 
effective care.
In our small sample, it is not possible to identify any clear evidence regarding the 
influence of patient non-compliance and confidence on the performance results. Please 
refer to Table 9.6 for the Spearman correlations between these variables and the 
performance results for the different criteria.
The level of patient understanding is another factor that could explain the willingness 
of the patients to follow the professionals’ instructions, and could therefore lead to a 
higher level of services utilisation and better clinical outcomes. Surgeries 7 and 11 have 
the highest proportion of patients reporting a good understanding of diabetes. These are 
two surgeries located in a rural area, with a low level of deprivation. However, neither 
one of them appears to distinguish itself in terms of good performance. On the contrary, 
Surgery 9 presents the lowest level of patient perceived understanding and still manages 
to be cost effective. When we analyse the correlations between patient understanding 
and the results for the different performance criteria, we conclude that they are not 
statistically significant (Table 9.6).
9.2.2.2 The Effect of Patient Characteristics on the Performance Results
The characteristics of the patients registered with each surgery can have an impact on 
the level of spending, services delivered and outcomes achieved. The inclusion of 
measures related to the case-mix o f the patients registered with each surgery would have 
led to a fairer comparison between the surgeries. Unfortunately, the fact that we have 
compared a small sample of surgeries placed limitations on the number of variables that 
we could include in the DEA models. In this respect, in order to evaluate the impact of
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patient case-mix, we have investigated the correlations between several patient related 
factors and the performance results. In terms of diabetes care, we believe that there are 
five patient related factors that may impact on the performance of the surgeries: (1) the 
proportion of patients from ethnic minorities; (2) the proportion of elderly patients; (3) 
the proportion of newly diagnosed patients; (4) the proportion of type-1 patients and (5) 
the proportion of patients with complications. Table 9.7 presents the data for these 
variables and Table 9.8 presents the Spearman rank correlations between each one of 
these variables and the performance results23. Based on the correlation results, we can 
conclude that, for our sample o f surgeries, none of these variables is significantly 
correlated with the results for the different performance criteria evaluated.
Table 9.7: Patient characteristics
Surgery % of elderly 
patients (aged 75 
years old or more)
%  of newly 
diagnosed 
patients
%  of patients 
with type-1 
diabetes
% of patients with 
diabetes related 
complications
1 25.12% 11.27% 9.16% 48.12%
2 21.39% 14.16% 8.48% 53.76%
3 15.64% 18.01% 4.65% 46.45%
4 25.52% 18.88% 3.27% 58.04%
5 23.83% 15.42% 1.94% 54.21%
6 18.00% 18.44% 8.05% 63.77%
7 24.14% 17.24% 8.00% 48.28%
8 26.32% 15.79% 7.69% 45.61%
9 24.69% 9.62% 4.59% 54.81%
11 20.00% 28.00% 0.00% 64.00%
12 11.76% 17.65% 13.64% 33.33%
13 22.73% 38.64% 5.40% 46.59%
23 19.11% 12.53% 2.50% 59.24%
24 27.06% 10.19% 5.96% 53.70%
Average 21.81% 17.56% 5.95% 52.14%
23 The Spearman rank correlation coefficient calculates the correlation between the ranks of the different 
measures. This coefficient was used because the performance results follow a non-normal distribution.
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T a b le  9 .8 : S p e a r m a n 's  r a n k  c o r r e la t io n s  b e tw e e n  th e  d if f e r e n t  p e r f o r m a n c e
m e a s u r e s  a n d  p a t i e n t  c h a r a c te r i s t i c s
Equity Cost efficiency Clinical
effectiveness
Patient focused 
effectiveness
Proportion of elderly
patients 0.024 0.148 -0.146 -0.066
(0.935) (0.614) (0.618) (0.823)
Proportion of newly
diagnosed patients 0.130 -0.316 -0.088 0.396
(0.659) (0.272) (0.766) (0.161)
Proportion of type-1
patients 0.037 0.038 -0.178 -0.066
(0.899) (0.899) (0.544) (0.823)
Proportion of patients
with complications 0.090 0.298 0.452 0.132
(0.759) (0.301) (0.105) (0.653)
P-Values“4 given in parenthesis
Firstly, the proportion of patients from ethnic minorities is one o f the factors that 
may partly explain the performance results in diabetes care, when we consider the 
difficulties that the patients may have in understanding the language and when we 
consider their different cultures and lifestyles. The proportion of patients from ethnic 
minorities in all the surgeries compared in this study is very small (less than 1%) and, 
for this reason, we believe that this factor does not significantly affect the performance 
results.
Secondly, the proportion of elderly patients (patients aged 75 years old or more) can 
have an impact on the level of resource usage and the achievement o f outcomes. The 
management of diabetes in elderly patients tends to be more difficult. A number of 
health complications may be present, such as poor eyesight and poor mobility and these 
can place additional difficulties in metabolic control. More frequent consultations may 24
24 Probability that the observed relationship between the variables occurred by chance.
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therefore be necessary in order to adequately manage their diabetes. We have calculated 
the Spearman rank correlation coefficient between the proportion of elderly patients 
registered with each surgery and the results for each of the performance criteria and 
cannot find any significant correlation between them (Table 9.8).
Thirdly, the proportion of newly diagnosed patients (patients diagnosed less than one 
year ago) is another factor that can explain the performance results. Newly diagnosed 
patients represent a different group o f patients. They require longer and more frequent 
consultations until they adjust to the condition. Furthermore, it is possible that their 
metabolic values have not yet had a chance to respond to medication. In our sample, the 
proportion of newly diagnosed patients registered with each surgery varies 
considerably. Surgery 9 presents the lowest proportion of newly diagnosed patients 
(9.62%), whilst surgery 13 presents the highest proportion (38.64%). However, when 
we analyse the results for the sample as a whole, we cannot identify any significant 
correlation between this variable and the performance results (Table 9.8).
Fourthly, we have investigated the impact of the proportion of patients with type-1 
diabetes25 on the performance results. Type-1 patients require treatment with insulin, 
which is more expensive. Furthermore, the majority of type-1 patients are seen by a 
hospital diabetologist, which may result in a different level of service delivery and 
outcomes achievement. For these reasons, it is of interest to investigate whether 
surgeries with a larger proportion of type-1 patients perform significantly different on a 
particular criterion. We have analysed the data for this variable and we cannot identify 
any significant correlation between this variable and the performance scores (Table 9.8).
25 We have used the data from the patient questionnaire to estimate the proportion of type-1 diabetic 
patients for each surgery. This was estimated by calculating the proportion of patients aged 40 years old 
or less, who are treated with insulin.
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IFinally, in order to account for the quality of the diabetes care provided in the past, 
we have estimated the proportion of patients who have developed diabetes related 
complications. A high proportion of patients with diabetes related complications may 
suggest a relatively difficult mix of patients, and may also lead to the practise of 
reviewing them more often, impacting on cost efficiency. Once again, it is not possible 
to find a correlation between this variable and the performance results (Table 9.8). For 
example, surgery 6 has the highest proportion of patients with complications and is 
nevertheless one of the best performers. On the other hand, surgery 12 has the lowest 
proportion of patients with complications and is inefficient (this surgery has the highest 
WTE GP per patient).
The difficulty in estimating the effects of environmental variables on the 
performance of primary care providers may be explained by the fact that in most cases 
the effect results from the combination of the several variables. Different factors interact 
to impact on the resources usage, service delivery and outcomes achieved and their 
effect is only visible if a multi-level system of equations is used (Salinas-Jimenez and 
Smith 1996). Johnson et al. (2002) in their study of variation of diabetes outcomes 
concluded that significant variability in glucose control was still found after it was taken 
into account for different levels of severity, compliance and knowledge, suggesting that 
other factors may influence the achievement of diabetes outcomes.
9.3 Surgery Related Factors: The Impact of Structure and Processes of Care
We can expect that the performance results obtained be partly explained by the different 
structures and processes in use in each surgery. We now return to the characteristics of 
these 14 surgeries and investigate the apparent relationship between different structures 
and processes, and the results in terms of the different performance criteria evaluated.
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In terms of surgery related factors, we have grouped the surgeries depending on 
whether they appear to operate the diabetes services based on a GP-led, a nurse-led or a 
balanced system. We have also investigated which surgeries have a professional with 
formal training in diabetes, and whether this is the professional who delivers most of the 
diabetes services. Furthermore, we investigate whether a particular professional has 
ownership and autonomy in terms of diabetes care by comparing the professional who 
runs the diabetes clinics with the professional identified as the formal lead for diabetes.
We also grouped the surgeries into training and non-training surgeries, and into 
surgeries working under Personal Medical Services (PMS) contracts or working under 
General Medical Services (GMS) contracts, and investigated the impact of these two 
factors on the performance results.
9.3.1 GP-led versus Nurse-led Services
One aspect that can have an impact on performance is the success of the teamwork 
between the health care professionals operating at each surgery. Of particular relevance 
to primary care is the partnership between GPs and nurses, and the way both types of 
professionals work in order to better meet the needs of the patients at the lowest 
possible cost. Ovhed et al. (2000) investigated the importance of the role o f the diabetes 
nurse in primary diabetes care in Sweden and concluded that primary care teams where 
nurses had a leading role performed better than those where nurses only had an assistant 
role.
In our sample of surgeries we have come across three different models of operation 
regarding the role of the nurses in diabetes care delivery. Whilst in some of the 
surgeries, the nurses have a leading role, running specialised diabetes clinics, 
prescribing medication and educating the patients; in other surgeries they only have a
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supplementary role of assistance to the GPs. In others surgeries a more ‘balanced 
model’ is used, where both GPs and nurses are involved in diabetes care.
We used the responses from the Practice Profile Questionnaire (Appendix E), in 
order to characterise the different models of diabetes care delivery. Firstly, we asked 
each surgery to say if they have a leading person for diabetes care, and if the answer 
was yes, we asked for the name and profession of this person. We defined this 
individual as the ‘formal lead person’ for diabetes care. Secondly, we asked each 
surgery to say if they run specific diabetes clinics, and whether they are GP-led, nurse- 
led or both. Thirdly, we asked the surgeries to describe the level of formal training in 
diabetes of the GPs and nurses involved in diabetes care. Additionally, we have 
calculated the ratio between the WTE GP and the WTE nurse spent with diabetics based 
on the number and type o f consultations delivered by GPs and nurses. Table 9.9 below 
presents this information for each surgery.
We have used the ratio of WTE GP to WTE nurse to group the surgeries into three 
categories: GP-led (if the ratio is larger than one), nurse-led (if the ratio is smaller than 
one) and Balanced (if the ratio is approximately equal to one). We have re-mapped the 
surgeries in terms of their performance results making their system of operation explicit. 
Analyses of the results taking this factor into account suggest that there is no visible 
effect on equity, efficiency and effectiveness derived from the three alternative systems 
of care. There is no indication that the balance between GP and nursing time is a 
determinant of performance. These results contrast with the results of the study 
undertaken by Ovhed et al. (2000), where it was found that surgeries where nurses had a 
more active and independent role in diabetes care performed better in terms of 
achieving clinical outcomes.
T a b le  9 .9 : G P s  a n d  n u r s e s  ro le  in  d i a b e t e s  c a r e  d e l iv e ry
Surgery Formal 
Lead person 
for diabetes
Professional who 
runs the diabetes 
clinics
Ratio of 
W TE GP to 
W TE Nurse
At least one GP  
has formal 
training in 
diabetes
At least one practice 
nurse has formal 
training in diabetes
i GP GP and nurse 1.57 Yes Yes
2 GP Nurse 0.85 Yes Yes
3 GP Nurse 0.81 No Yes
4 Nurse Nurse 0.97 No Yes
5 Nurse Nurse 0.82 Yes Yes
6 GP GP and nurse 0.85 Yes Yes
7 GP No diabetes clinics 1 Yes No
8 GP GP and nurse 0.79 No No
9 No one No diabetes clinics 1.24 No Yes
11 Nurse Nurse 2.53 No Yes
12 Nurse Nurse 1.42 No Yes
13 Nurse No diabetes clinics 0.78 No Yes
23 GP GP and nurse 2.13 Yes Yes
24 GP GP and nurse 0.85 No Yes
9.3.2 Ownership of Diabetes Care
From Table 9.9 we conclude that the formal lead person for diabetes is not necessarily a 
person with training in diabetes, nor is the person who runs the diabetes clinics. 
Furthermore, the fact that a particular professional was identified as the formal lead for 
diabetes does not mean that this professional consults with the diabetics more often. For 
example, Surgery 11 has identified a nurse as the formal diabetes lead, however the 
ratio of WTE GP to WTE nurse is 2.53, which suggests that this surgery operates with a 
GP-led system. This may in fact be sub-optimal because the nurse has formal diabetes 
training whilst the GP does not. In Surgeries 3, 8 and 24 we have the reverse situation. 
A GP was identified as the formal lead person for diabetes, however this professional 
does not have formal training in diabetes. In these three surgeries, the majority of 
diabetes consultations are delivered by the nurses (WTE nurse is superior to WTE GP).
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However, the nurses may not feel that they ‘own’ the diabetes service delivery because 
they are not the formal lead for diabetes.
We can identify five surgeries where the formal and the operational roles of diabetes 
care have been attributed to the same professional: surgeries 1, 4, 5, 13 and 23. In 
surgery 4 we have one diabetes specialist nurse who is the formal lead person for 
diabetes, she has an interest and training in diabetes and runs all the diabetes clinics. 
She works on a P/T basis and only sees diabetics. In Surgery 5, we have two practice 
nurses who have been identified as the formal lead for diabetes and run the diabetes 
clinics. In Surgery 13, we have a practice nurse with a special interest and training in 
diabetes; she delivers most of the consultations to diabetics, despite not running diabetes 
clinics, and is the formal lead for diabetes. In Surgeries 1 and 23, which are larger 
surgeries, the diabetes clinics are run both by a GP and a nurse, both professionals have 
an interest and formal training in diabetes; the GP delivers most o f the diabetic 
consultations and the GP was also identified as the formal lead person for diabetes. All 
these surgeries have scored higher than average in terms of equity, and apart from 
surgeries 1 and 13 (which cover highly deprived populations) all of them have scored 
higher than average in terms of clinical effectiveness.
We certainly would not want to make any generalisations from these results because 
they are based on a small sample. However, all we want to suggest is that part of the 
reason why some surgeries don’t perform as well as they could may be because they 
lack a professional (or group of professionals) who feel responsible for a good delivery 
of diabetes care, takes pride in it and can be identified by the patients as ‘the diabetes 
person’. The existence of such a professional should lead to professional ownership and 
to the development of a long-term relationship between the patients and the 
professional, which may contribute to better results both in terms of regular monitoring
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and in terms of outcomes achievement. The importance of this aspect was also 
highlighted during the workshops with some of the surgeries.
9.3.3 Other Surgery Related Factors
We will now discuss the effects of other surgery related factors on performance. Table 
9.10 presents the data regarding the type of contract that each surgery works with and 
regarding the training status of each surgery.
Personal Medical Services (PMS) contracts were first introduced in 1998. They 
provide a more flexible alternative to the General Medical Services (GMS) contracts. 
PMS contracts were created to fund the delivery of primary care with more innovative 
approaches. Using these contracts, surgeries can negotiate local arrangements for 
service provision, including the recruitment of salaried professionals and the 
commission of services from other organisations. As a result of this increased 
flexibility, we could expect the performance of surgeries working under PMS contracts 
to be better than the performance of surgeries working under GMS contracts. The 
evaluation of the first wave of PMS pilots concluded that some selected PMS sites 
showed improved access to patients, enhanced intra and inter-professional collaboration 
and clinical and cost-effective prescribing (The PMS National Evaluation Team 2002: 
22). We have grouped the surgeries into two sub-sets according to the type of contracts 
that they operate under in order to analyse the effects of this factor on performance. No 
clear effect of this factor on the performance results can be observed.
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T a b l e  9 .1 0 : O t h e r  s u r g e r y  r e la te d  f a c to r s  t h a t  m a y  im p a c t  on  p e r fo r m a n c e
Surgery GMS versus PMS 
contracts
Training versus non­
training surgery
1 GMS Non-training
2 PMS Training
3 PMS Training
4 GMS Non-training
5 PMS Training
6 GMS Training
7 GMS Training
8 GMS Non-training
9 GMS Non-training
11 PMS Non-training
12 PMS Non-training
13 GMS Non-training
23 PMS Training
24 PMS Training
Finally, we have investigated the effect of the training status of the surgeries on their 
performance. A training practice is expected to keep better records and ensure that a 
better-organised system o f service delivery is in place. For example, Baker (1992) and 
Van Den Hombergh et al. (1998) concluded that training practices scored higher than 
average in terms of the use of innovative equipment, delegation of medical tasks and 
organisation of care. It is therefore interesting to evaluate whether training practices 
appear to score better in terms of equity, efficiency and effectiveness.
Once again, we separated the surgeries into two sub-sets and looked for patterns in 
the results. Training status, per se, does not appear to explain the performance results. 
For example, surgery 4 is a non-training practice and achieved the highest score in 
terms of equity. This surgery also scores 100% in terms of clinical effectiveness. 
Another example of a non-training practice that is a relatively good performer is surgery
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9. On the contrary, surgery 7 is a training practice, but it appears to have potential for 
improvement in terms of equity, cost efficiency and clinical effectiveness.
9.4 A Summary of the Impact of the Environmental Variables on the Performance 
Results
Our analyses regarding the impact of area related factors suggest that surgeries facing a 
high level of population deprivation may have increased difficulties in achieving a good 
level of clinical and patient-focused outcomes. In our sample of 14 surgeries, all the 
surgeries covering areas of high deprivation scored below average in terms of both 
clinical and patient-focused effectiveness. Furthermore, these were the only surgeries 
that scored below average on both of these performance criteria.
In this respect, we feel that it would be appropriate to separate the surgeries into 
three different sets (low deprivation, medium deprivation and high deprivation) and 
undertake separate comparisons within each set. Alternatively, the level of deprivation 
could be used as a hierarchical categorical variable, following the methodology 
proposed by Cooper, Seiford and Tone (2000). According to this methodology, the 
surgeries facing a high level of deprivation would be evaluated only with reference to 
other surgeries facing a similar environment. Surgeries facing a medium level of 
deprivation would be evaluated with reference to surgeries facing a medium and high 
level of deprivation and surgeries facing a low level of deprivation would be evaluated 
with reference to all the surgeries.
With regards to patient related factors, we performed two types of analyses. Firstly, 
we analysed the effect of the level of patient compliance, confidence and understanding 
on the performance results. We concluded that, for our sample of surgeries, none of 
these factors appears to have a significant impact on the performance results. Secondly,
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we analysed the impact of the proportion o f elderly patients, newly diagnosed patients, 
type-1 patients and patients with diabetes related complications on the performance 
results. It was not possible to identify a significant correlation between any of these 
variables and the performance results.
With regards to the structures and processes of care, firstly, we investigated the 
impact of the different models of diabetes care delivery on the performance results. In 
this respect, we firstly distinguished between surgeries with GP-led diabetes care, 
surgeries with nurse-led diabetes care and surgeries with a balanced model of care. We 
concluded that this aspect, per se, does not explain the variability in the performance 
results. Secondly, we investigated whether the professional with training in diabetes was 
the formal diabetes lead and delivered the majority of the diabetes consultations. 
Professional ownership in diabetes care was proposed as one of the factors that may 
lead to improved performance in terms of equity of access to services and clinical 
effectiveness. We concluded that in some surgeries there is potential to improve in this 
aspect. For example, surgery 11 has a nurse with formal training in diabetes, but the 
majority of the diabetes consultations are delivered by the GP (who does not have 
training in diabetes). This surgery presents a very expensive type of diabetes delivery, 
which does not appear to compensate in terms of clinical outcomes, and this may 
suggest that a greater involvement of the practice nurse in diabetes care delivery could 
lead to an improvement in cost efficiency and cost effectiveness.
Finally, we investigated the impact of two other surgery related factors on the 
performance results. Neither the training status of the surgeries or the type of contract 
with which they work (PMS versus GMS) appears to have a significant impact on the 
performance results.
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Before we continue it is perhaps worth summarising the results for each one of our 
14 surgeries, offering some guidance regarding which aspects require particular 
attention in each surgery. Table 9.11 provides this summary.
9.5 Validation and Implementation of the Results in Practice
We presented the results to each surgery using the trade-off graphs presented earlier. A 
meeting was requested with each one of the participating surgeries to provide them with 
the results. The average duration of these meetings was ninety minutes. At the time of 
submission, meetings had taken place with 8 of the 14 surgeries. In surgeries 7, 8 and 
13, all the GPs and nurses took part in the meeting. In surgeries 2, 4, 6, 23 and 24 only 
the professionals involved in diabetes care took part in the meeting.
In addition to these meetings with the individual surgeries, three further meetings 
took place. Firstly, a meeting with South Peterborough PCT, including the director of 
performance and three members of the Board (a GP, a nurse and the manager for 
primary care services delivery). Secondly, a meeting with the diabetes specialist nurse 
employed by South Peterborough PCT. She provides extra diabetes care and advice to 
any surgery that requests her services and is known as ‘the trouble-shooting diabetes 
nurse’. Finally, a meeting with the hospital diabetologist providing services to all the 
surgeries covered by South Peterborough PCT.
A report with the results and analyses was provided to South Peterborough PCT and 
to each of the participating surgeries. The identification of each surgery was not 
disclosed to the PCT or any of the professionals involved in the meetings. It was only 
during the individual meetings with each surgery that their own identification number 
was disclosed.
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T a b le  9 .1 1 : S u m m a r y  o f  th e  p e r f o r m a n c e  r e s u l ts  fo r  e a c h  s u r g e r y
Surgeries Performance criteria that 
require particular attention
Factors that may partly explain the results
1 Cost efficiency 
Clinical effectiveness 
Patient-focused effectiveness
High level of population deprivation.
A relatively large proportion of elderly patients.
2 Clinical effectiveness
3 Cost efficiency 
Clinical effectiveness 
Patient-focused effectiveness
High level of population deprivation.
4 Cost efficiency A system of frequent reviews and intensive treatment 
operates at this surgery, which leads to higher costs.
5 Cost efficiency
6 Patient-focused effectiveness Patient satisfaction requires particular attention. Patients 
report relatively long waiting times to see a doctor and 
not enough time to speak with the doctors.
7 Equity
Cost efficiency 
Clinical effectiveness 
Cost effectiveness
Inadequate system of diabetes management. The surgery 
does not run diabetes clinics and the patients are not 
invited for regular reviews. Instead, a system o f patient 
initiated consultations is used.
8 Equity
Clinical effectiveness 
Patient focused effectiveness
High level of population deprivation.
Lack of professional training in diabetes care. In this 
surgery there is no nurse or GP with training in diabetes.
9 Equity The surgery had a GP vacancy during the year of 
analysis, which may explain the relatively poor access to 
services.
11 Equity
Cost efficiency
Single GP who delivers most of the diabetic 
consultations.
12 Equity
Cost efficiency
Single GP who delivers most of the diabetic 
consultations.
13 Clinical effectiveness 
Patient-focused effectiveness
High level of population deprivation.
23 Patient-focused effectiveness Patient education requires particular attention. The level 
of patient understanding is lower than average.
24 Equity
Cost efficiency
The F/T diabetes specialist nurse working at this surgery 
follows a policy of intensive treatment with medication, 
which may explain the relatively high prescription costs 
incurred.
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9.5.1 Assessing the Reputational View o f Performance
In order to assess the ‘reputational view’ o f performance, we asked those who took part 
in the PCT meeting, the trouble-shooting diabetes nurse and the hospital diabetologist to 
place the 12 surgeries from South Peterborough PCT in three blank performance trade­
off graphs. Based on their responses, we concluded that surgeries 2, 4, 6 and 9 were 
identified as good performers by all professionals. The perception regarding the other 
surgeries tended to vary between professionals. The interesting aspect to notice is that a 
perception of the potential trade-offs between these criteria was not always evident. 
Surgeries 4, 6 and 9 are in fact the three surgeries that appear as robust performers. 
Surgery 2 is an interesting case because despite the fact that it scores very highly in 
terms of equity and efficiency, it scores below average in terms of clinical effectiveness, 
which was a cause of surprise to most professionals involved in the workshops.
We also asked each surgery to make a self-assessment of their performance in terms 
of the different performance criteria. In most cases, the surgeries perceived their relative 
performance to be better than what was shown by the results, exception made to 
surgeries 4, 13 and 23, which appeared to have a good idea regarding their relative 
performance in the different criteria. An aspect of interest to notice is the fact that the 
surgeries had never considered labour as a cost of diabetes care and were therefore very 
surprised to see it included in the analyses. In their internal audits, the only cost that was 
considered was the cost of prescriptions.
9.5.2 Using the Results in Practice
Both the PCT and the individual surgeries felt that the results of the research project 
were very useful in terms of pointing towards areas that needed to be improved. The 
results from the patient questionnaire were particularly useful in identifying aspects of
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care that needed to be improved in each surgery, as well as recognising some of the 
positive aspects. The wide variation in the results, the implicit trade-offs between some 
of the performance measures, and the impact of area deprivation were recognised as 
important issues that needed to be further investigated.
We believe that the fact that the performance assessment framework and the patient 
questionnaire were discussed with all the surgeries prior to the data extraction was an 
important part in the process. Furthermore, keeping anonymity o f the results, together 
with an emphasis on formative evaluation provided the elements for an open discussion 
of the results. We believe that this is essential in order to ensure that the performance 
results are taken seriously and acted upon by each provider. Below, we provide some 
specific examples of the actions taken by each surgery after the discussion of the results.
The formal lead for diabetes in Surgery 2 (a GP) was surprised to discover that his 
surgery scored relatively poorly in terms of clinical effectiveness. The good results in 
terms of equity and cost efficiency were pointed out as positive aspects, and it was 
suggested that this might partly explain the low level of clinical effectiveness achieved. 
The GP said that his surgery follows a policy o f high coverage, aiming to review most 
of their diabetics yearly, and that this is their first objective in terms of diabetes care. 
Nevertheless, the need to investigate the relatively poor level of outcomes achievement 
was recognised. In terms of the results from the patient questionnaire, particular 
relevance was given to the fact that 50% of the patients who answered the questionnaire 
said that they were not always satisfied with the diet advice received at the surgery.
The diabetes specialist nurse in Surgery 4 was particularly pleased with the results, 
as she felt that her work and dedication were shown in the study. The nurse 
acknowledged that the location of the surgery in a non-deprived area was an important 
factor contributing to the relatively good performance results. Furthermore, her
A
established autonomy and professional pride in diabetes care delivery were suggested as 
essential elements in the achievement of good results. From the results of the patient 
questionnaire, the nurse decided to improve in terms of the quality of the educational 
materials provided to the patients. The usefulness of the educational materials was the 
quality item where this surgery scored lowest. In this respect, one of the walls in the 
patients waiting area was covered with colourful and informative posters regarding the 
importance of diabetes control, including the results from some research studies. 
Furthermore, new leaflets were produced and are now being distributed to the diabetic 
patients.
Surgery 7 was surprised to find that its performance results were lower than average 
in most performance dimensions. This surgery does not operate diabetes clinics. The 
justification for this is that these clinics tend to limit the flexibility of the appointment 
times and appear to be less convenient for patients. However, the results from the study 
prompted them to discuss different models of diabetes care delivery in order to improve 
in terms of equity and effectiveness. Interest in meeting the specialist diabetes nurse 
from surgery 4 (one of the peers for surgery 7) was expressed, and contacts were made 
to arrange a joint workshop. The specific comments from the patient questionnaire 
were used to improve the services. Four essential issues were identified: (1) the surgery 
is very busy and patients feel that they never see the same doctor, which compromises 
continuity of care; (2) poor communication between health care professionals and 
conflicting advice given to patients; (3) the patients are not invited for an annual review. 
Instead, the patients have to take the initiative and make their own appointments; (4) a 
number o f patients felt that they do not have enough time to talk with the doctors.
The diabetes specialist GP in Surgery 23 was very pleased with the results. However, 
his suspicions regarding a relatively low level of patient satisfaction were confirmed and
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therefore he decided to target this area as an area for improvement in the near future. 
Five essential aspects that can be improved were identified: (1) patronising attitude of 
some nurses and some of the administrative staff; (2) poor written education materials, 
particularly in terms of diet and effects on diabetes control; (3) poor initial consultations 
to newly diagnosed patients; (4) some patients felt that their concerns are not being 
listened to; (5) difficulties in making appointments with the diabetes specialist GP 
between reviews.
Surgery 24 recognised that despite the fact that they achieve a high level of clinical 
effectiveness; their system of diabetes care delivery still needs to improve in terms of 
equity and in terms of cost efficiency. All the diabetics that had not received an annual 
review were identified and a letter was sent inviting them for a full annual review. 
Furthermore, given that Surgery 23 is one of the peers to Surgery 24, the diabetes 
specialist nurse was very interested in meeting with the diabetes care team from Surgery 
23 in order to exchange ideas regarding diabetes care delivery. Contacts were 
established to arrange a joint workshop.
At a more strategic level, the PCT is particularly interested in improving the levels of 
equity and cost efficiency. In order to increase the proportion of patients receiving a full 
annual review, the services of a health care assistant were offered to the surgeries that 
scored below average in terms o f  equity and cost efficiency.
This research project is still ongoing and other meetings with South Peterborough 
PCT will be scheduled to discuss the results in more depth and to assess other ways in 
which these results can be used in practice.
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9.6 What Role for DEA in Formative Evaluation in Primary Care?
The purpose of this study was to use DEA in the formative mode in order to better 
understand the reasons behind differences in performance in primary care and in order 
to identify strategies for performance improvement in practice. The small number of 
surgeries that has been compared placed strong limitations regarding the type of 
analyses that could be made and regarding the robustness of the conclusions taken. 
Nevertheless, it is worth making a tentative assessment regarding the usefulness of the 
results in practice and the limitations faced.
The most important aspect to notice relates to the great deal of variability found in 
the performance results amongst a small sample of surgeries. Even after narrowing the 
analyses down to a speciality, using a performance assessment framework developed 
with the providers, and considering the efforts made to extract data of high quality, a 
great deal of variability was still found in most of the performance criteria. Part of the 
variability can be explained by the small numbers of patients involved and by the fact 
that a single measurement was used for each variable. Furthermore, the level of 
population deprivation was found to explain part of the variability, especially in terms 
of effectiveness. However, there remains a significant amount of variability that could 
not be adequately explained and that needs to be carefully interpreted.
Our aim has been solely exploratory and a great deal of care has been taken to 
prevent the misuse of the results. In this respect, no rankings or targets have been 
produced and anonymity of the surgeries has been kept. We have to recognise that the 
DEA results have not answered many questions. Instead, they raised a number of 
questions, whose answers only those involved in the delivery of the services can 
appropriately provide. This is the reason why we believe that the establishment of 
learning networks between the different surgeries can bring interesting insights.
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Nevertheless, despite our formative aim, the potential unintended consequences that 
may result from any performance assessment exercise cannot be ignored (Smith 1995). 
If the potential benefits resulting from a performance assessment exercise do not 
outweigh the costs, then one must ask whether the exercise is worth the efforts (Smith 
1990, Power 1997). Answer to this question requires careful investigation of the effects 
of the study in practice, which is not easily accomplished. This difficulty is exacerbated 
because the use of formal mechanisms of performance assessment can result in the loss 
of informal mechanisms of quality assurance, such as personal pride, professional 
commitment (Smith 1992) and trust (Davies and Mannion 2000). In this respect, a 
combination of formal and informal mechanisms for performance assessment may be 
more advantageous (Goddard, Mannion and Smith 1999, Mannion and Smith 2000). 
The use of DEA, a formal mechanism, in a formative and exploratory mode, can 
harness the benefit of both formal and informal approaches.
9.7 Conclusion
In this chapter we have analysed the impact of the environmental variables on the 
performance results. We have also investigated the impact of different structures and 
mechanisms on the performance results. The usefulness of the results in practice was 
discussed and strategies for performance improvement were outlined for some of the 
participating surgeries.
We analysed the impact of area deprivation and surgery location, and concluded that 
surgeries covering populations with a high level of deprivation showed lower than 
average results in terms of effectiveness. Furthermore, we analysed the impact of patient 
cooperation and patient characteristics on the performance results. None of the variables 
considered was found to correlate significantly with the performance results.
241
Finally, our analyses o f the performance results together with the interviews 
undertaken with the participating surgeries suggest that one way to improve the quality 
of diabetes service delivery might be to attribute it to one professional (or group of 
professionals) with an interest and training in diabetes care. This professional is given 
the responsibility to ensure that all registered patients get all the essential services once 
a year. If nobody else has this responsibility, clear accountability can be established and 
a sense of professional ownership is also achieved. If this model is to be effective in 
terms of outcomes achievement, the professional needs to have some autonomy 
regarding diabetes prescribing, and good communication with all the other professionals 
consulting diabetics has to be ensured. Above all, a long-term relationship of trust needs 
to be established between the professional and the patients.
10 Conclusions
10.1 Summary and Contributions of this Study
The purpose of this thesis was to address issues raised by performance assessment in 
primary health care, in order to develop a comprehensive framework to compare 
primary care providers. In particular, considering performance as multidimensional, this 
study has addressed the question of conflicting objectives in health care provision, and 
attempted to investigate some of the potential trade-offs between different performance 
criteria. A discussion about ways to achieve an adequate balance between several 
performance criteria was also included.
There are two aspects in this study, which distinguish it from others in this research 
area: (1) the framework used and (2) the use of this framework. This study can be 
characterised as a pluralistic evaluation, given that it has focused on the comparison of 
primary care providers using multiple criteria and given that it used several methods to 
collect and analyse the data. Furthermore, given its objectives and the methodology 
used, it can be characterised as a formative evaluation study.
A review of the studies that have been published comparing primary care providers 
was undertaken. Based on this review we identified some issues that needed to be 
addressed in order to develop a comprehensive performance assessment framework. 
Firstly, the use of Pis was discussed and it was argued that they tend to be inadequate, 
as they do not establish a link between the resources used, services delivered and 
outcomes achieved. The use of parametric techniques was recognised as a suitable 
alternative to Pis, but the difficulties in specifying an appropriate functional form for the
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transformation processes in primary care were an obvious obstacle. In this respect, DEA 
was proposed as a suitable technique to compare primary care providers because it can 
manage the existence of: multiple inputs, multiple outputs and multiple outcomes; and 
does not require the specification of a functional form.
Previous studies that have used DEA to compare primary care providers were 
reviewed and it was argued that they have focused mostly on structure and outputs, 
without taking into account the achievement of outcomes, which is the ultimate aim of 
primary care delivery. The potential for unintended consequences resulting from the 
publication of performance results, particularly in the form of league tables, was 
rehearsed and it was suggested that DEA can be most useful if it is used in a formative 
and exploratory way. In this respect, the importance of involving the decision-makers 
during the full process of evaluation was highlighted, both to provide the researcher 
with a better understanding of the context and to increase the confidence of the 
decision-makers in the results.
Based on the issues identified in the literature review, a conceptual framework was 
developed in order to compare GP surgeries (Figure 4.3 presented in page 84). This 
framework was developed in collaboration with a sample o f PCG/Ts and its aims were 
to establish a link between local needs, resources used, services delivered and outcomes 
achieved in primary care delivery. By focusing on the relationships between these 
elements, different performance assessment criteria were proposed: equity, technical 
efficiency, cost efficiency, service effectiveness and cost effectiveness. Three methods 
were proposed to measure equity: (1) resources over needs; (2) services delivered over 
needs; (3) outcomes over needs. The use of DEA was suggested to measure technical 
efficiency, cost efficiency, service effectiveness and cost effectiveness. The approach
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emphasised the use of several inter-connected DEA models to measure performance as 
opposed to the use of a single all-embracing DEA model.
The feasibility of applying the conceptual framework developed to compare GP 
surgeries in terms of their delivery of primary care as a whole was then discussed. The 
absence of appropriate data for outcomes of primary care and the lack of well 
determined models of primary care delivery that work within the production metaphor, 
meant that the comparison of GP surgeries in terms of their delivery of primary care as a 
whole would not be feasible at this stage. The existence of clear protocols regarding the 
delivery of diabetes care and the availability of appropriate data suggested that a 
formative evaluation in this context would be feasible. Furthermore, given the rising 
costs of this condition and the evidence regarding varying standards of practice across 
different providers (The Audit Commission 2000b), it was felt that a formative 
evaluation of primary diabetes care delivery would be very timely. Previous studies 
focusing on primary diabetes care delivery were reviewed and it was argued that most 
studies failed to establish a link between local needs, resources used, services delivered 
and outcomes achieved.
The conceptual framework for primary care evaluation was therefore applied to 
diabetes care at the level of GP surgeries. Workshops were undertaken with the 
participating PCG/Ts in order to identify the specific measures for local needs, inputs, 
outputs and outcomes in primary diabetes care delivery. Based on this framework, a 
comparison of a sample of GP surgeries was then undertaken. The objective of the 
comparison was a formative one, which focused on (1) the investigation of the 
relationships between the different performance criteria and (2) the identification of 
criteria in which the performance of each surgery could be improved. In this respect.
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this study has provided some interesting insights regarding the use of DEA as a tool for 
performance improvement in practice.
Firstly, in agreement with available literature (see for example, Smith 1997; Garcia 
et al. 1999 and Parkin and Hollingsworth 1999), we found that DEA results can be 
greatly influenced by the model used. For example, adding a new input or output may 
lead to different results, conclusions and actions. In this respect, we would like to re­
emphasise the importance of remembering that the performance results are a function of 
the model we have used, and that this model is only one out of several plausible 
specifications. It is in this respect that the use of theories and evidence regarding the 
links between inputs, outputs and outcomes becomes crucial. Additionally, the 
involvement o f the providers in the development of the models provides another source 
of model validation.
Secondly, we found that using input prices leads to more meaningful estimates of 
efficiency, given that surgeries are not allowed to choose freely an input weight 
structure that may lead to non-realistic technological trade-offs. Furthermore, the 
decomposition o f efficiency into technical and allocative efficiency, together with an 
analysis of the optimal input mixes helps in the investigation of the sources of 
inefficiency. Whilst some surgeries suffer from technical inefficiency and should be 
able to radially reduce all the inputs, others appear to use a non-optimal mix of 
resources.
Thirdly, we found that DEA can also be very useful in measuring both clinical 
effectiveness and cost effectiveness. An analysis of the effectiveness results provides 
another perspective into performance assessment, which is essential if we are to use the 
results for performance improvement.
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Fourthly, we found that complementing the DEA results with an analysis of equity of 
access to services is essential if we are interested in assuring a minimum standard of 
quality of access to services. Some of the surgeries that were deemed efficient fail to 
provide the essential services to a significant proportion of their patients.
Finally, we found that reporting the results to the providers by using trade-off graphs 
was extremely helpful. This approach does not emphasise the ranking of the providers, 
nor does it emphasise the performance scores, or performance targets. Instead, it shows 
that the performance results change with the criterion used. Furthermore, it shows that 
in most cases, learning can happen in two directions. For example, Surgery A can learn 
from surgery B in terms of efficiency, whilst surgery B can learn from surgery A in 
terms of effectiveness. We feel that this is a very useful way to initiate a discussion of 
performance improvement strategies, as most providers were happy to discuss their way 
of working as long as they had not been characterised as ‘bottom of the league 
performers’.
The use of trade-off graphs also provided interesting insights regarding the 
relationships between the different performance criteria. We investigated the 
relationships between equity and cost efficiency, cost efficiency and clinical 
effectiveness, equity and clinical effectiveness and clinical effectiveness and patient- 
focused effectiveness.
Firstly, for the sample of surgeries studied, we could not find a significant trade-off 
between equity and cost efficiency. On the contrary, a strong positive correlation 
between these two measures was identified for a group of surgeries. This suggests that a 
high level of service accessibility does not have to compromise cost efficiency. It 
appears to be possible to develop systems of diabetes care delivery that are cost efficient 
and simultaneously respect standards of accessibility. When we consider the fact that
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our analyses are based on a small sample, we feel that it would be interesting to further 
investigate this relationship using a larger sample of surgeries. Furthermore, we feel that 
it would be interesting to extend this type of analyses by measuring equity of access to 
services focusing on factors such as the socio-economic group and ethnicity of patients.
Secondly, in terms of the relationship between efficiency and effectiveness, our 
results did not show a significant relationship between these two performance measures, 
despite the fact that during the workshops, most health care professionals hypothesised 
the possibility of this trade-off. Furthermore, our results did not confirm the theory 
proposed by Schinnar (1993) regarding greater effectiveness levels for moderate levels 
of efficiency. We identified a group of surgeries, which perform very highly in terms of 
both efficiency and effectiveness. The investigation of this relationship using larger 
samples is therefore required in order to reach firm conclusions.
Thirdly, we investigated the relationship between equity and effectiveness. For our 
sample of surgeries, it was not possible to identify a significant trade-off between these 
two measures. Nevertheless, we feel that this trade-off is worth further investigation, 
given the potential dysfunctional incentives that may result from the implementation of 
the new GP contract. The establishment of performance related pay based on outcome 
targets, as proposed in the new GP contract (British Medical Association 2003), might 
lead to a decrease in the level of fairness of access to services. There is a danger that 
professionals may start to focus on the patients that appear to cooperate and those that 
appear to lead more effectively to the achievement of the performance targets, at the 
expense o f  more difficult cases, for whom only a box ticking exercise will be carried 
out. Additionally, exercises o f patient re-coding can take place in order to report better 
outcome results. Furthermore, there is a danger that some selection bias could take place
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at new patient registration. Hence the importance of investigating equity when assessing 
primary care providers.
Finally, we investigated the trade-off between clinical effectiveness and patient- 
focused effectiveness. Whilst clinical effectiveness focuses on the achievement of 
clinical outcomes, patients focused effectiveness is concerned with the achievement of 
patient related outcomes such as patient satisfaction, patient understanding and patient 
confidence. No clear relationship between these two performance criteria was identified. 
However, it was interesting to notice that the surgeries that performed above average in 
terms of both clinical and patient focused effectiveness, all performed below average in 
terms of cost efficiency. Furthermore, a significant negative correlation was identified 
between cost efficiency and patient focused effectiveness, which may suggest that 
higher levels of patient understanding, confidence and satisfaction may be associated 
with higher levels of spending. This takes us into a crucial issue in performance 
assessment in primary care: the role of the patients as co-producers of care. Patient 
characteristics and willingness to cooperate can be expected to have an impact on the 
performance of the surgeries.
We investigated the impact of both area related factors and patient related factors on 
the performance of the surgeries. In terms of area related factors, we investigated the 
impact of different levels of deprivation and the impact of different locations. With 
regards to patient related factors we investigated the impact of patient non-compliance, 
understanding and confidence; and also investigated the impact of the proportion of 
patients with diabetes related complications, elderly patients, newly diagnosed patients 
and type-1 patients.
In consistency with the results of other studies (Roper et al. 2001; Acheson Report 
1998; Urwin et al. 1996; Connoly and Kesson 1996; Kelly et al. 1993), our study
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suggests that surgeries covering highly deprived populations may find it more difficult 
to achieve good clinical and patient-focused outcomes in diabetes care delivery. In this 
respect, it may be appropriate to develop different performance assessment frameworks 
for surgeries covering highly deprived areas. These surgeries should be subjected to 
different outcome targets, and should only be compared with each other. Furthermore, it 
may be necessary to develop different models of diabetes care delivery in order to 
increase the level of effectiveness. Strategies characterised by a wider action, aiming to 
reduce the discrepancies in terms of area deprivation would also be appropriate.
In terms of our analysis of the impact of patient related factors on the performance 
results, we concluded that none of the factors individually explained the variability 
obtained in the performance results. The performance variability is likely to be the result 
of a complex combination of multiple factors.
10.2 Implications for Health Care Policy
We have attempted to draw some implications for primary health care policy and 
diabetes care delivery from the analysis of the performance results and from the 
workshops undertaken with the healthcare professionals.
Considering the difficulties we faced in extracting the necessary data for the 
performance analysis, we would suggest that a great deal of improvement in the data 
recording and data retrieval practices still needs to take place before an extensive 
formative evaluation exercise in primary care can be implemented. This need for 
improvement is evident in terms o f  several aspects: (1) the electronic entry of 
information regarding consultations and procedures taking place at the surgery, (2) 
better coordination of information between the surgeries and other providers by 
electronic recording, (3) the standardisation of the codes used by the professionals in
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different surgeries and (4) better familiarisation of the professionals with simple ways to 
extract relevant data for audit and quality control.
Further issues regarding inadequate data availability relate to the difficulty in 
extracting data for the costs of laboratory tests. Currently, each surgery is not charged in 
proportion to the number of laboratory tests requested. A block contract exists between 
the PCTs and the laboratories, and payment is independent of the number of tests 
requested. With a system driven by strong outcome targets, and without a monitoring 
mechanism, we think that there is a clear danger o f over-testing and resource wasting. 
Furthermore, our study suggests that due to the poor coordination between services, 
there is a danger of service duplication across different providers. For example, we 
found that a significant proportion of patients had their eyes checked and their blood 
tested at several different providers. Whether or not these services were necessary, we 
cannot say, but a better coordination between the providers could prevent such 
duplication from happening. Improved coordination between providers, with electronic 
recording of the services provided by the hospital and other local providers can also 
ensure that all patients receive the services that they need.
A further issue that was identified during our study relates to the difficulty of 
extracting data regarding the costs involved in primary diabetes care. Speciality based 
costing is not undertaken in primary care, despite the fact that speciality based 
frameworks for service delivery and for performance assessment are currently being 
implemented in the UK. We feel that if speciality based targets are going to be imposed 
on the surgeries, it is essential to take into account the costs involved in their 
achievement. If appropriate additional funding is not provided, the surgeries may 
attempt to meet diabetes related targets by ‘shifting’ resources from other areas of 
primary care delivery where targets have not been imposed.
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Furthermore, we feel that the strategy of speciality based service delivery in primary 
care can have other dysfunctional consequences. The existence of several non- 
integrated National Service Frameworks without a global framework that integrates all 
the specialities and draws from the synergies between them can lead to a fragmented 
delivery of primary care. We feel that this may lead to a disruption in the personal and 
continuous relationship between primary health care professionals and patients. This 
continuous relationship is essential to build trust and is one of the founding bases of 
primary care. We feel that the consequences of disrupting this relationship should be 
further investigated before moving into a more specialised primary care delivery 
system. Furthermore, a system characterised by a specialist delivery of primary care 
services may lead to the potential loss of skills of GPs in terms of the diagnosis and 
management of certain diseases.
Patient responsiveness and patient choice are two of the stated objectives for the 
NHS (The Department of Health 1997). Our study suggests that the level of patient 
responsiveness in diabetes care delivery could be improved. A significant number of the 
patients who answered the patient questionnaire expressed strong dissatisfaction 
regarding the large number of appointments they have to make and the inconvenience of 
the appointment times. The multiplicity of appointments causes great costs to patients, 
who find that they have to take several days off work in order to attend the 
appointments. Furthermore, it creates a stigma around this condition, when in fact a 
large proportion o f diabetics lead a healthy life. For a chronic condition that affects a 
large number of working patients, it is urgent to develop new models of service delivery 
more adapted to patients’ needs and lives. For example, a ‘one-stop’ approach for 
reviews and tests combined with follow-up telephone consultations could both save 
money and increase patient responsiveness.
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Another strategy outlined by this Government regarding the management of chronic 
conditions is to increase patient empowerment by giving patients a better understanding 
of their condition (The Department of Health 2001b). This strategy assumes that 
patients both want and have the ability to be empowered and to take control of their 
condition. The results from our patient survey reveal that 99.2% of the patients think it 
is important to have a good understanding of diabetes and its management. However, 
we found that only 49% o f  the patients were satisfied with the education materials 
provided by the surgeries. There is a need for more innovative approaches. Most of the 
surgeries studied only offer leaflets to the patients. However, leaflets are very difficult 
to update and are difficult to tailor to the different levels of patient need and 
understanding. It is common for patients to be given leaflets covering both types of 
diabetes without an appropriate explanation regarding which type of diabetes they have 
and which information is therefore relevant to them. A computer could be installed in 
the waiting area of the surgery and patients could have a chance to fill in a questionnaire 
about the quality of the services and about their level of understanding, as well as to 
consult their test results. The computer could then offer patients some up to date, 
personalised advice, regarding their diabetes management. All of this could be done 
while patients wait to see the nurse or the GP. Furthermore, a website could be created 
to provide up to date information to the patients who have access to the Internet.
10.3 Limitations of this Study and Suggestions for Further Research
This study suffers from several limitations. Below we discuss these limitations and 
suggest ways in which this research can be extended.
Firstly, it is very difficult to draw robust conclusions from a sample of 23 surgeries. 
The investigation of a larger sample of surgeries would be required in order to obtain
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more reliable results and to establish more reliable conclusions. The use of a larger 
sample would also have allowed separate analyses by surgeries covering areas with 
different levels of deprivation and the inclusion of indicators regarding patients’ 
characteristics.
Secondly, this study represents a snapshot of performance. A dynamic analysis of 
data for several years could provide very interesting insights into the evaluation of 
performance, as well as provide us with greater confidence regarding the robustness of 
the results. If data for several years was available an evaluation including indicators of 
change in the level of outputs and outcomes could also be undertaken.
Thirdly, we did not take into account the influence of stochastic factors on 
performance. It can certainly be expected that part o f the variability encountered is the 
result of natural stochastic factors. If a larger sample of providers was available, SFA 
could be used to separate between stochastic variability, the effects of environmental 
factors and pure inefficiency and ineffectiveness (Fried et al. 2002).
Fourthly, it would have been useful to undertake a longer qualitative investigation 
into the usefulness of the performance results in practice. A posterior investigation 
regarding the effects of this study in practice, with particular relevance to the usefulness 
of DEA information about peers and targets, could provide interesting insights. 
Unfortunately, due to limitations of time both from the part of the researcher and the 
part of the health care professionals it was not possible to undertake any further 
workshops before submission. This is the subject of future research.
Fifthly, given the small number of diabetics registered with most of our surgeries, it 
was not possible to investigate the equity of utilisation of services across different 
groups of patients within each surgery. An assessment of the equity o f utilisation across
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different socio-economic groups and across different ethnic groups should be included 
in a future study undertaken in this research area.
Finally, the difficulties in estimating the inputs that relate solely with diabetes care 
delivery meant that some assumptions had to be made regarding the level of resources 
usage. All the consultations with diabetics were included as an input o f  diabetes care 
and an average duration of consultations across surgeries had to be assumed because 
some surgeries were unable to provide us with data for the duration of their 
consultations.
The difficulties encountered in terms of obtaining appropriate data for performance 
assessment in primary care delivery suggest that the successful application of DEA in 
this research area is still a challenge. Nevertheless, it is our conviction that DEA is a 
strong analytical technique upon which to build. However, one of the premises of this 
thesis is that DEA has to be broadened to address problematic situations such as those 
faced by today’s NHS in order to contribute to performance improvement in practice. 
One part of this broadening entails making values and assumptions explicit before 
engaging in the performance measurement exercise. The other part o f  the broadening 
relates to the need to move away from the ‘black box’ type o f  evaluation, by 
incorporating the DEA exercise into case studies and context-driven research projects in 
order to facilitate the implementation of the results in practice. As pointed out by 
Goddard, Mannion and Smith (1999) the combined use o f ‘soft’ and ‘hard’ information 
plays a crucial role in performance assessment in the health care sector given the 
complexity of the ‘production process’.
By using DEA in a formative mode, this research has contributed to a discussion 
regarding the usefulness of this technique for performance improvement in practice. The 
existence of multiple, incommensurable and potentially conflicting values in public
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services delivery was acknowledged and a framework was developed in order to 
account for potential trade-offs between the different criteria. Future research studies 
should investigate ways in which DEA can be combined with other methodologies in 
order to better inform decision-making and policy making in public services delivery.
“No amount o f guidance from the NHS Executive or hectoring by politicians can 
substitute for a drive to improve performance that comes from within and is 
acknowledged and valued by those steering the process o f change.”
(Ham 1999: 1492)
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Appendix A High Level Performance Indicators for Health Authority
High Level Performance Indicators (Health Authority Level)__________
I. Health Improvement__________________________________________
Deaths from all causes (for people aged 15-64)
Deaths from all causes (for people aged 65-74)
Cancer registrations 
Deaths from malignant neoplasms 
Deaths from all circulatory diseases 
Suicide rates
Deaths from accidents__________________________________________________
II. Fair Access_________________________________________________
Surgery rates
Size o f inpatient waiting list per head o f population (weighted)
Adults registered with an NHS dentist 
Children registered with an NHS dentist
Early detection o f cancer_______________________________________________
III. Effective Delivery of Appropriate Health Care___________________
Disease prevention and health promotion 
Early detection o f cancer 
Inappropriately used surgery 
Surgery rates 
Acute care management 
Chronic care management 
Mental health in Primary Care 
Cost effective prescribing
Discharge from hospital________________________________________________
IV. Efficiency__________________________________________________
Day case rate
Length o f  stay in hospital (case-mix adjusted)
Unit cost o f  maternity (adjusted)
Unit cost o f  caring for patients in receipt of 
Specialist mental health services (adjusted)
Generic prescribing___________________________________________
V. Patient / Carer Experience of the NHS__________________________
Patients who wait less than 2 hours for emergency admission (through A&E) 
Patients with operation cancelled for non-medical reasons 
Delayed discharge from hospital for people aged 75 or over 
First outpatient appointments for which patient did not attend 
Outpatients seen within 13 weeks o f  GP referral
Percentage o f those on waiting list waiting 12 months or more_____________
VI. Health Outcomes of NHS Health Care________________________
Conceptions below age 16
Decayed, missing and Filled teeth in five year old children 
Adverse events /  complications o f treatment 
Emergency admissions to hospital for people aged 75 and over 
Emergency psychiatric re-admission rate 
Infant deaths
Survival rates for breast and cervical cancer 
Avoidable deaths 
In-hospital premature deaths
Source: NHS Executive (1999).
Appendix B Copy of the Diabetes Services Questionnaire
Diabetes Services Questionnaire
<Patient’s Name> 
<Patient’s Address 1> 
«Patient’s Address 2> 
«Patient’s Address 3> 
«Patient’s Post Code>
Dear «Patient's name>,
Your GP surgery is asking people with diabetes what they think about the services 
provided, and we would be grateful if you could help by filling this questionnaire. This 
is a confidential, anonymous survey.
The answers to this questionnaire will be analysed by an independent researcher from 
the University of Warwick, studying the quality of diabetes service delivery. What you 
tell us will help doctors and nurses to improve diabetes services locally.
We expect that this questionnaire will not take you more than 10 minutes to complete.
Please feel free to use any extra paper for your comments and suggestions for the 
improvement of the services.
We would appreciate if you could answer all the questions and return the 
questionnaire in the sealed FREEPOST envelope provided.
Please write in BLOCK CAPITAL LETTERS.
The results from the survey will be fed-back to you via your Practice.
Thank you very much for your help.
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S e c tio n  A  -  1 ) A b o u t  th e  s e rv ic e s  y o u  h a v e  re c e iv e d  in th e  p a s t 12 m o n th s .
We would appreciate if you could check your records or confirm with someone in your family the number of 
times you have received each service both at the GP surgery and somewhere else.
• Please tick a box correspondent to the number of times you received each service in the last 12 
months, or fill in the empty square with the number of times, if it is more than 3 times;
• Please separate the number of times you had it at the GP surgery and the number of times you had it 
outside the GP surgery.
Services received during the past 12 
months
Number of times you had it 
done at the GP Surgery
Number of times you had it 
done outside the GP Surgery
a. Eyes check (with drops put in the eyes)
b. Legs and feet check (without 
shoes/socks)
c. Blood Pressure check
d. Long term Blood Sugar level check 
(HbA1c)
e. Blood cholesterol check
f. Blood/ urine tests to check if
the kidneys are working well
g. Consultation with a dietician
h. Consultation with a doctor
to review the diabetes treatment
i. Consultation with a nurse
to review the diabetes treatment
2) If you have not received some of these services during the last 12 months, or if you did not find 
some services useful, please explain why:
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S e c tio n  B  -  A b o u t  y o u r  U n d e rs ta n d in g  o f D ia b e te s  a n d  its  M a n a g e m e n t
1. In relation to your diabetes, how much do you think you understand about each one of these 
aspects? Please tick one box for each statement.
Aspects of diabetes I understand I understand I understand N/A
nothing very little enough
a. Objectives of treatment
b. Diet requirement and meal 
planning
c. Benefits of regular exercise
d. Improvements in life style 
effects of smoking and alcohol intake 
(If you not smoke or drink, tick N/A)
e. Link between food intake, 
exercise and tablets or insulin
f. How to cope with diabetic 
emergencies
(e.g. high or low blood sugar)
g. Signs, symptoms, and prevention 
of complications of feet, eye and 
heart
h. Effects of an illness like flu on 
your diabetes
I. Measuring your blood sugar, 
meaning of values and actions to 
take
J. Insulin injection
(If insulin is not required, tick N/A)
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ n □ □
□ □ □ □
□ □ □ □
□ □ □ □
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S e c tio n  B  -  C o n t in u a t io n
2. How important is it for you to have a good understanding of diabetes and its management?
Not important | | Important | | Very Important Q  |
3. Overall, how confident do you feel in taking good control over your diabetes?
Not confident | | Confident I 1 Very Confident | |
4. Where do you find the most helpful information regarding your diabetes? (Please tick all the 
relevant options)
GP Surgeryj I Hospital f  I Library | | Internet | | Diabetic associations Q  I
Other (please specify)
5. What type of information do you find most helpful? (Please tick all the relevant options)
Individual consultation with a doctor | | Individual consultation with a nurse □
Presentation to a group of patients | | Discussions with other patients I I
Books | | Leaflets □  Magazines | | Videos | | TV Programmes I 1
Other (please specify)
6. Who do you think has helped you most regarding your diabetes management and control?
(Please tick all the relevant options)
GP| I Specialist Doctor I I Nurse I I Family and Friends Q  |
Other Patients | | Social Services £  |
Other (Please specify)
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S e c tio n  C  -  A b o u t  th e  D ia b e te s  C a re  Y o u  R e c e iv e d  a t th e  G P  S u rg e ry  in  th e  P a s t 12  M o n th s
1.1. Please tick one box for each statement, depending on whether you think that it corresponds to 
the truth ‘Always’, ‘Most times’, ‘Sometimes’ or ‘Never’.
1.2. Please sav how important each of these aspects of care are for you, by choosing a number for 
each statement, with: 1 = Very important; 2 = Important; 3 = Not important.
Statem ent
a. It is easy for me to get health advice at 
the GP Surgery when I need it
b. The time I have to wait for an 
appointment with the doctor is acceptable
c. The appointment days and times given at 
the surgery are convenient to me
d. The doctors and nurses involve me in the 
decisions about the treatment of my 
diabetes
e. The doctors and nurses explain the 
importance of following their advice, in a 
way that I understand
f. The doctors and nurses are very caring 
and supportive
g. I feel that the doctors have enough time 
to talk/ listen to me regarding my diabetes
h. I feel that the nurses have enough time to 
talk/ listen to me regarding my diabetes
I. I receive consistent advice about my 
diabetes and treatment
J. I am satisfied with my diabetes treatment, 
including the medication I have to take and 
its effects on the quality of my life
k. I am satisfied with the foot care that I 
receive l.
l. I am satisfied with the diet advice that I 
receive
m. The surgery provides me with useful 
educational materials regarding diabetes
Always Most times Sometimes Never
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
Importance
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S e c t i o n  C  -  C o n t i n u a t io n
2. Have you visited your GP surgery during the last 12 months for any service other than 
the diabetes services?
Yes | | No | |
3. If the answer to the last question is Yes, how would you rate the quality of the other 
services provided at your GP surgery?
Very Good I I Good I I Reasonable! I Poor I I Very Poor I I
Section D - About you
1. How old are you?
Under 2 d  I 2 1 - 4 0 ! ! □  41 -  5 o lH D  5 1 - 6 5 E D  6 6 - 7 5 Q  Over 7 5 1 I
2. You are: Male I I Female I I 3. Do you smoke? Yes l I No I I
4. To which ethnic group do you belong?
5. Which one of these categories best describes your current situation?
In paid employment
Unemployed I I Retired
What is your job title?-------------------------------------------------
Looking after the family/ home I I Full-time student I I
Long-term sick or disabled □  Other (please specify)
6. What is your level of education (e.g. Degree, O-level, etc...)? -----------------------------------------
7. How old were you when your diabetes was diagnosed?
Under2 0 2 1 - 4 0  □  41 - 5 0 1 I 5 1 - 6 5 C D  6 6 - 7 5 [ H l  O v e r 7 5 n
8. How do you control for your diabetes?
Diet only! I Diet and Tabletsl I Diet and Insulin! I Diet. Tablets and Insulin! I
9. Please use this space to make comments regarding the diabetes services and 
suggestions for their improvement (Feel free to write overleaf, if necessary):
Thank you for your time.
Please use the freepost envelope and post the questionnaire ASAP.
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Appendix C  C o p y  o f  E th ic s  A p p ro v a l  L e t t e r
M l l.'l l-C KM I KK RESEARCH ETHICS C OMM ITTEE 
RESPONSE FORM
DETAILS O F APPLICANT:
1. Name ami address of Principal Researcher:
Ms Carla Amado 
University Lecturer 
Warwick Business School 
The University o f Warwick 
Coventry 
CV 4?A L
2. T ide of project:
Linking Costs and Outcomes o f Diabetes care Towards a more effective service 
Delivery
3. Na
DETAILS O F  MRKC:
4. Name and address of MKEC:
MREC West Midlands
Bit inhigham and The Black ('ountry Health Authoniy
27 Highfteld Road
Edgbaston
Bimuitghain
H I5 3DP
5. MREC' Relereiice Number:
MREC 02/7 64__________________________________
l isted below Is a complete record of the review undertaken by MREC w ith the decisions made, 
dates of decisions and the requirements at each stage of the review :
I he Application was reviewed at the meeting on 24"1 July 2002. A discussion look place uml the 
application w as approved subject to review by the Chairman o f satisfactory responses to the
following:
General Comments
a) Committee noted that the hospital consultant will not be informed that
their patient will he involved in the study and us some patients will be under shared 
care, it was felt that the consultant should he informed out of courtesy.
b) It was noted that there is r.o sample si^e calculation. It appealed that an unusually 
large number o f subjects were to be studied and MRF.C wondered whether this was 
really necessary.
A: 0264rotp due
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A satisfactory response dated 5th Augusl 2002 has now been received from the principal 
researcher and the application has now been APPROVED.
T H E  F IN A L  D O C U M E N T S A N D  A R R A N G E M E N T S  A P P R O V E D  BY T H E  M R E C
The follow ing items have been approved by the MREC West Midlands:
Letter to inform the Hospital Consultant, dated 5 August 2002 
Professional Indemnity, dated 31 July 2002 
Application Form, dated 2 July 2002 
Referee’s Letter, dated 2 July 2002
Diabetes Service Questionnaire, including Patient Information Sheet, final version, dated 
2 July 2002
Research Protocol, dated 2 July 2002 
Framework fo r  Performance Assessment, undated 
Principal Researcher’s CV, undated 
Methods o f  initial Recruitment to study 
Compensation Arrangements fo r  subjects
A:\0264resp .doc
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A ppendix D Copy of the Practices Profile Questionnaire 
Practice Characteristics
1. What is the total number of patients registered with your practice? ______________
2. Is your practice: Inner city I I Suburban I I Rural CZIZI Mixedl__ 1
3. Is your practice a training practice? Yes /No
4. Is your practice a PMS practice? Yes/No
5. Does your practice have a lead person for diabetes? Yes/No
6. If yes, what is their name and profession? ________________________________
7. Please fill this table regarding the number of professionals employed by your practice:
P ro fess io n a l N u m b e r  o f 
peo p le
W T E  h o u rs  p e r 
w eek  ( if  possible)
GPs -  full time
GPs -  part time
GP trainees
Practice nurses
Nurse practitioners
Practice manager
Administration/ Reception staff
Other -  please specify
8. Please fill this table regarding the professionals that regularly attend your practice:
P ro fe ss io n a l N u m b e r  o f 
peo p le
W T E  h o u rs  p e r  
w eek  ( if  possib le)
District Nurses
Health visitors
Community Diabetes Specialist Nurse
Community Dietician
Community Chiropodist
Community Physiotherapist
Community Optometrist
Community Physiotherapist
Psychologist/ Counsellor
Visiting members of a hospital based team
Other -  please specify
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9.
10. 
11.
12.
13.
14.
15.
16.
Are there any GPs in your practice with a special interest in diabetes? Yes / No 
Are there any nurses in your practice with a special interest in diabetes? Yes / No 
Does your practice have specific clinics for seeing patients with diabetes? Yes / No
I f the answer is No, please go to question 15 
How often are these clinics held (please state the frequency) _________________
Are these sessions: GP led Nurse led Combined Other (please specify)
Does your practice hold any evening or out of hours diabetes clinic? Yes / No
Please go to question 16
If there are no specific practice diabetes clinics, when are patients with diabetes seen in 
your practice?
Patient initiated appointments specifically for diabetes | |
Doctor or nurse initiated appointments specifically for diabetes | |
Opportunistic appointments, when the patient is being seen for something other than 
diabetes I I
Other -  please specify _________________________________________________
If a patient does not attend an appointment to the practice, what do you do? Please tick 
the appropriate boxes.
Diabetes clinic 
appointment
Routine surgery appointment
Do nothing
Send another 
appointment invitation 
by post
Contact the patient
Other -  Please specify
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17. Does your practice have a dedicated diabetes telephone help/advice line that patients 
can ring when they need advice? Yes / No I f  the answer is No, please go to
question 20
T e le p h o n e  H e lp  l in e  fo r  d ia b e te s
18. Who supervises the dedicated telephone help line?
19. When is the dedicated telephone help line available?
Weekdays office hours] | Weekdays evenings) | Weekend office hours | [ 24hours/ 7days | |
Please go to question 22
20. If there is no dedicated telephone help line, when can patients with diabetes contact the 
practice?
Weekdays office hours [ | Weekdays evenings) | Weekend office hours | [ 24hours/ 7days Q ]
21. Who are patients able to speak to when they contact the practice?
Screening and diagnosis
22. Does your practice have a policy for screening patients for diabetes? Yes / No 
Referrals to specialists
23. Please estimate the proportion of diabetes care that is undertaken by the practice 
when compared to the referrals made to specialists
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Diabetes annual reviews
24. Please indicate the percentage of diabetic patients that regularly attend the surgery for 
diabetes reviews; those that attend the hospital and those under shared care:
P e rc en tag e  o f  d iab e tic  p a tie n ts
Attend hospital diabetes clinic only
Attend your practice only
Attend BOTH the hospital and your 
practice for regular diabetes reviews
R o u tin e  R eview s
25. Apart from annual reviews, does your practice ro u tin e ly  rev iew  diabetic patients? Yes 
/No.
I f  the answer is No, please go to question 28.
26. If your practice routinely reviews diabetic patients, how often is it done? __________
27. Who does these routine reviews? _________________________________________
28. How long do the consultations for diabetic patients last on average? Please write the 
average duration in the appropriate boxes.
A v e rag e  d u ra tio n  o f  a 
c o n su lta tio n  w ith  th e  G P
A v erag e  d u ra tio n  o f  a 
c o n su lta tio n  w ith  th e  n u rse
Newly diagnosed patient
Routine consultation
Annual review
29. In terms of the nurses who consult diabetic patients in your practice, what is the cost of 
one hour of nurse consultation time?
30. Are diabetic patients asked to have their blood taken for HbAlc a few days before they 
attend their routine/ annual review? Yes / No
2 7 0
31. Are patients with diabetes provided with glucose self-monitoring diaries? Yes / No
32. What education materials are available for diabetic patients?
Training
33. Are clinical guidelines available for the management of people with diabetes in your 
practice?
Yes / No
34. Are these guidelines: National / Regional / Local / Primary care only / Applied in 
hospital
35. Please describe the type of diabetes training that the GPs in your practice have received 
in the past 2 years.
36. Please describe the type of diabetes training that the nurses in your practice have 
received in the past 2 years.
T h a n k  y o u  fo r y o u r  he lp .
O nce  co m p le ted , p lease  use  th e  fre e p o s t envelop  p ro v id ed  a n d  post th is  q u e s tio n n a ire .
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(Source: The Department of Health 2002: 5)
Appendix E  S t a n d a r d s  of D ia b e te s  C a r e
Standards table
Standard 1s Prevention of Typ* 2 diabetes
I. I he Nl Is* will devek «p. implement ami n* *nit* c strategies to reduce the risk < f  devel«i)liig Type 1 dlalxtes in the population as a whole and to reduce lire ine« |i tali ties in tlx* risk "1 developing Ty|x* 2  dlalxtes.
Standard 2: Identification of neoDle with diabetes
2. The MIS will develop, implement uixl m«iit«>r strategies to identify people win* ilo not ktVAv they have dlalxles.
Standard 3: Empowering people with diabetes
3. All children. yvmn>* |>e»ple ami adults with dlalxles will receive a service which encourages partnership in dec Wort-making. supports tlx*m in managing their diabetes and hel|>*lliem to adopt aixl maintain a lx*althy lifestyle. Ihls will lx- reflected in an agreed an<l si i a red care plan in an appropriate formal and language. W here appropriate, parents and carers sh«>uUI lx* fully engaged in this process.
Standard 4: Clinical care of adults with diabetes
i. All adults with diabetes will receive high-quality care lhr«iglx«ut their lifetime, hx hiding support to optimise the c«»ntrol of their blood glucose, blorxl pressure aixl «her risk factors for developing the complications of diabetes.
Standards 5 & 6:  Clinical care of children and young people with diabetes
3. All children and young |X*ople with diabetes x\ ill receive orinsistently high-«|iiality care and they, with their families and «hers inv<Ked in tlvlr day-to-day care, will be -up|>orted to « »ptimise the c<mtn 4 « their hl«« *1 glucose and tlx-ir physical, psvclir «logical, intellectual, educational aixl s< xial developnx’nt.
<». All y««ung |xs »pie with dialxtes will experience a sin. * >th transit 1«m  ««1 «. are from paediatric diabetes services t«» adult «Ikilx-tes services. whether hospital or community-based, either directly or vti a young people's clinic. Tlx* transition will lx* organised In partnership with each individual aixl at an age appropriate to aixl agreed with them.
Standard 7: Management of diabetic emergencies
7. The Mis will develop, implement aixl monitor agreed protocols for rapid ami effective treatment of diabetic emergencies hy appr«priately trained hc-alth care professionals. Protocols will include* the management of acute complications and pnxwlures t*» minimise the risk of recurrence.
Standard 8:Care of people with dialrete* during admission to hospital
H. All children, young people and adults with dialxtes admitted to hospital, for wliatever reason. w ill receive cffeillve care »4 tlx*ir diabetes. WTxwver p<*ss|hle. llx*y will continue to lx* involved In decisions concerning the managcnxnt »4 their diabetes.
Standard 9: Diabetes and pregnancy
9. 1 he M is will develop. Implement aixl m««nllor |>»llcles that sevk l«» eni|xAver ami sup|*«ri women w ith pre-existing dialxies aixl those wlm develop dialxies «luring pregnancy to optimise the outcomes of their pregnancy.
10. All young |xs«pic* an«l adults with dlalxtes will receive regular surveillance l««r the long-term complications «4 dlalxles.
Standards 10.11 Ä 12: Detection and management of long-term complications
11. The Nils will develop. Implement aixl monitor agreed protocols and systems • if care 1« * ensure that all people wh<»«.level« p 1« »ng-term complications of dialxics receive timely, appropriate and effective Investigation ami treatment to res luce their ri>k «4 disability and premature death.
12. All |xs»pie w ith dlalxles requiring multi-agency sttpp«l will receive Integrated health and social care.
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T a b le  F .6 : S a m p le  size  a n d  r e s p o n s e  r a te
Surgeries Diabetics Minimum sample 
size at 95% 
confidence
Actual sample 
size used
Questionnaires
received
Response rate
i 426 202 203 131 64.53%
2 346 182 183 118 64.48%
3 211 136 137 86 62.77%
4 286 164 165 153 92.73%
5 214 138 138 103 74.64%
6 461 210 210 149 70.95%
7 145 105 106 75 70.75%
8 114 88 114 52 45.61%
9 239 148 148 109 73.65%
11 25 24 25 14 56.00%
12 51 45 51 22 43.14%
13 88 72 88 37 42.05%
23 471 212 212 120 56.60%
24 972 276 400 218 54.50%
Total 4049 2002 2180 1387 62.31%
2 7 9
m o n th s
T a b le  F .7 : P a t ie n ts  w h o  h a v e  h a d  a ll  th e  e s s e n t ia l  s e rv ic e s  in  th e  p re v io u s  12
Surgeries
Estimated proportion of diabetics 
who have had all the essential services 95% confidence interval 
in the previous 12 months Lower limit
95% confidence interval 
Upper limit
i 84.73% 79.60% 89.86%
2 88.98% 84.39% 93.58%
3 84.88% 79.04% 90.72%
4 90.20% 86.98% 93.41%
5 78.64% 72.93% 84.35%
6 80.54% 75.30% 85.77%
7 72.00% 64.92% 79.08%
8 75.00% 66.28% 83.72%
9 71.56% 65.30% 77.82%
11 64.29% 47.29% 81.28%
12 59.09% 43.44% 74.74%
13 78.38% 68.22% 88.53%
23 77.50% 71.04% 83.96%
24 67.89% 62.43% 73.35%
T a b le  F .8 : P a t ie n t  u n d e r s t a n d in g  a b o u t  d ia b e te s  a n d  i ts  m a n a g e m e n t
Surgeries Average estimated proportion of patien ts  
who understand enough about diabetes a n d  
its management
95% confidence interval 
Lower limit
95%  confidence interval 
U pper limit
i 77.82% 71.48% 84.16%
2 80.98% 74.86% 87.10%
3 80.66% 73.65% 87.67%
4 80.52% 75.72% 85.32%
5 75.60% 68.72% 82.48%
6 78.24% 72.34% 84.14%
7 82.80% 76.40% 89.20%
8 76.98% 67.84% 86.12%
9 74.32% 67.65% 80.99%
11 84.55% 69.76% 99.33%
12 76.63% 62.29% 90.97%
13 76.90% 65.24% 88.55%
23 76.00% 68.80% 83.21%
24 77.44% 72.17% 82.71%
2 8 0
T a b le  F .9 :  Q u a l i ty  o f  th e  d ia b e te s  s e rv ic e s  p r o v id e d  a t  th e  s u r g e r y
Surgeries Average estimated proportion of patients who 
answered ‘Always’ or ‘Most times’ regarding 
the quality of diabetes services provided at the 
surgery
95% confidence interval 
Lower limit
95% confidence interval 
Upper limit
i 83 .99% 7 8 .5 4 % 89.43%
2 84.20% 7 8 .6 1 % 89.78%
3 79.15% 7 2 .1 0 % 86.20%
4 90.47% 8 7 .1 0 % 93.85%
5 85.97% 8 0 .7 7 % 91.17%
6 76.32% 7 0 .4 3 % 82.21%
7 82.75% 7 6 .3 6 % 89.14%
8 78.46% 6 9 .8 9 % 87.04%
9 77.74% 7 1 .5 6 % 83.93%
11 82 .74% 6 8 .1 2 % 97.35%
12 88 .06% 7 7 .1 5 % 98.97%
13 74 .71% 6 3 .0 5 % 86.37%
23 80 .41% 7 4 .0 5 % 86.76%
24 86 .10% 8 1 .6 5 % 90.55%
T a b le  F .1 0 : P a t i e n t  E m p o w e r m e n t  r e g a r d in g  d i a b e t e s  c o n t r o l
Surgeries Average estimated proportion of patients 
who say that they feel ‘Confident’ or 
‘Very Confident’ in taking good control 
of their diabetes
95% confidence interval 
Lower limit
95% confidence interval 
Upper limit
i 87 .60% 8 2 .8 4 % 92.35%
2 90.60% 8 6 .2 9 % 94.91%
3 94 .19% 9 0 .3 7 % 98.00%
4 94 .70% 9 2 .2 4 % 97.16%
5 92 .00% 8 8 .1 1 % 95.89%
6 89.73% 8 5 .6 5 % 93.80%
7 88.00% 8 2 .8 7 % 93.13%
8 88.46% 8 2 .0 3 % 94.89%
9 89.72% 8 5 .4 3 % 94.01%
11 100.00% 10 0 .0 0 % 100.00%
12 81 .82% 6 9 .5 4 % 94.09%
13 94 .44% 8 8 .6 6 % 100.23%
23 86.55% 8 1 .2 5 % 91.86%
24 90 .23% 8 6 .7 3 % 93.74%
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T a b le  F . l l :  C o n s u l ta t io n s  w ith  D ia b e te s - r e la te d  S p e c ia l is ts
Surgeries Average N um ber of times each 
diabetic has had a consultation 
with a Ophthalmologist in 
the previous 12 months
Average N um ber of times each 
diabetic has had a consultation 
with a Diabetologist in 
the previous 12 months
Average Number o f  tim es each 
diabetic has had a consultation 
with a D ietician in 
the previous 12 months
l 1.73 0.2 0.96
2 1.52 0.14 0.92
3 1.73 0.17 1.19
4 1.52 0.4 1.83
5 1.49 0.38 0.91
6 1.48 0.12 0 .6 8
7 1.28 0.37 1.03
8 1.43 0.17 0.99
9 1.43 0.34 0.77
11 1.5 1 1
12 1.18 0.41 1.82
13 1.27 0.14 0.7
23 1.35 0.44 0.71
24 1 .88 0.15 0.85
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Table G.6: Sample size and response rate
Surgeries Diabetics Minimum sample 
size at 95% 
confidence
Actual sample 
size used
Questionnaires
received
Response rate
14 337 180 180 100 55.56%
15 217 139 139 110 79.14%
16 260 155 156 97 62.18%
17 202 133 133 118 88.72%
18 83 68 83 42 50.60%
19 175 120 121 106 87.60%
20 324 176 177 105 59.32%
21 48 43 48 22 45.83%
22 88 72 88 30 34.09%
Total 1734 1086 1125 730 64.89%
Table G.7: Patients who have had all the essential services in the previous 12
months
Surgeries Estimated proportion of diabetics 
who have had all the essential services in the previous 12 
months
14 74.29%
15 59.09%
16 92.86%
17 86.36%
18 88.00%
19 76.67%
20 85.57%
21 86.44%
22 75.47%
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Table G.8: Patient understanding
Surgeries
Average estimated proportion of patients who understand 
enough about diabetes and its management
14
15
16
17
18
19
20 
21 
22
78.19%
80.97%
80.39%
78.40%
83.53%
82.79%
84.98%
71.98%
78.78%
Table G.9: Quality of the diabetes services provided at the surgery
Surgeries
Average estimated p roportion  of patients who answered ‘Always’ 
o r  ‘M ost times’ regarding  the quality of diabetes services 
provided at the surgery
14
15
16
17
18
19
20 
21 
22
80.06%
81.04%
90.07%
89.51%
84.42%
85.34%
80.43%
58.30%
77.45%
Table G.10: Patient Empowerment regarding diabetes control
Surgeries A verage estimated proportion  of patients who say tha t they feel
‘Confident’ or
‘Very Confident* in taking good control 
o f the ir diabetes
14
15
16
17
18
19
20 
21 
22
91.00%
92.59%
92.63%
93.16%
95.12%
95.24%
89.32%
81.82%
90.00%
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Table G .ll:  Consultations with Diabetes-related Specialists
Surgeries Average N um ber of times each 
diabetic has had a consultation 
with a O phthalm ologist in 
the previous 12 months
Average N um ber of times each 
diabetic has had a consultation 
with a Diabetologist in 
the previous 12 months
Average N um ber of times each 
diabetic has had a consultation 
with a Dietician in 
the previous 12 months
14 1.52 0.42 0.89
15 1.2 0.65 1.28
16 1.46 0.37 0.71
17 1.53 0.2 0.59
18 1.58 0.57 0.66
19 1.49 0.23 0.82
20 1.39 0.45 0.8
21 1.32 1.68 0.77
22 1.1 0.4 0.8
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